netFormulary
 Report : A-Z of formulary items 14/10/2019 22:41:52
[Back]
 
Section Name Details
01.07.03 Phenol 5% in Oil Injection 
10.01.03 Abatacept Orencia® Abatacept Infusion
  • Consultant Rheumatologist use only for the treatment of RA. Supported for use in-line with NICE TA195 (Aug 2010) and NICE TA280 (Aug 2011)

    Abatacept 125mg prefilled syringe for subcutaneous injection (Orencia®)
  • Abatacept subcutaneous injection – supported clinically for patients with RA eligible to receive treatment with abatacept in-line with NICE TA280 and TA195 subject to an agreement with the Commissioners on the way forward with home delivery of treatment.

    Abatacept for juvenile idiopathic arthritis (in line with NICE TA373) is used at specialist centres only.
  • 08.01.05 Abemaciclib tablets  Verzenios®
    • Abemaciclib tablets (Verzenios®)

    Consultant Oncologist use only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    08.03.04.02 Abiraterone Acetate  
    • Abiraterone Acetate Tablets 
       
      Blueteq® registration and approval for use is required for this product before it may be dispensed.
    04.10.01 Acamprosate  Campral EC®
    • Acamprosate E/C Tablets

    Restricted to Specialist Alcohol Services recommendation only

    03.01.05 Acapella Vibratory PEP Therapy System Acapella®

    Acapella® is a medical device for use as a Positive Expiratory Pressure (PEP) device in patients with cystic fibrosis, COPD, ansthma and lung diseases to aid clearance of secretions.

    • On the recommendation of a specialist Respiratory Physiotherapist only.
    06.01.02.03 Acarbose 

    Acarbose 50mg tablets

    For existing patients only.

    02.02.07 Acetazolamide 
    • Acetazolamide Injection 

    Reserved for use on ICU to uncouple metabolic compensation to chronic Type II respiratory failure under care of anaesthetists.

    11.06 Acetazolamide Diamox®
    • Acetazolamide Tablets (250mg) (Diamox)
    • Acetazolamide MR Capsules (250mg) (Diamox SR)
      For use following consultant recommendation only
    11.06 Acetazolamide  
    • Acetazolamide Injection (500mg)
    12.01.01 Acetic Acid 2% w/w EarCalm®
    • Acetic Acid 2% Ear Spray
    11.08.02 Acetylcholine and Mannitol 
    • Acetylcholine 1%, mannitol 3% Intraocular Irrigation when reconstituted (preservative free)

      For Consultant Opthalmologist use only
    20 ACETYLCYSTEINE   Acetylcysteine Capsules 600mg

    Respiratory Consultants Only
    11.08.01 Acetylcysteine 5% with Hypromellose 0.35% Ilube®
    • Acetylcysteine 5% with Hypromellose 0.35% (with preservative)

      Consultant Ophthalmologist recommendation only - For existing patients only.
    05.03.02.01 Aciclovir  Green Traffic Light Aciclovir SF Suspension
    Green Traffic Light Aciclovir Dispersible Tablets
    Green Traffic Light Aciclovir Injection

    13.10.03 Aciclovir Zovirax®

    Aciclovir 5% Cream

    To be purchased by the patient over the counter from pharmacies where possible.

    13.05.02 Acitretin Neotigason® Acitretin Capsules

    Consultant dermatologist only
    03.01.02 Aclidinium Eklira® Genuair
  • Dry powder inhaler
  • Licensed for COPD
  • 03.01.04 Aclidinium/formoterol Duaklir® Genuair
  • Dry powder for inhalation via Genuair device
  • Licensed for COPD
  • 04.07.03 Actipatch® 
    • Actipatch®
       

     

    10.01.03 Adalimumab  Consultant Rheumatologist and Consultant Gastroenterologist use only.
    Supported for use in-line with
  • NICE TA143: Ankylosing spondylitis (May 2008)
  • NICE TA199: Psoriatic arthritis (August 2010)
  • NICE TA329: Ulcerative colitis (February 2015)

    Adalimumab for treating juvenile idiopathic arthritis (in line with NICE TA373) and plaque psoriasis in children and young people (NICE TA455) is used at specialist centres only.
  • 01.05.03 Adalimumab Subcutaneous Injection Humira®
  • Adalimumab Injection

    Consultant Gastroenterologist and Paediatricians only
    Supported for use in-line with NICE guidance
  • 09.03 Addiphos Solution  
    • Addiphos Solution (20mL)
    09.03 Additrace Solution 
    • Additrace Solution (10mL)
    02.03.02 Adenosine 
    • Adenosine Injection
    A5.09.02 Adjustable Velcro Compression Wraps 
    • Adjustable Velcro Compression Wraps

    For initiation by Lymphoedema Nursing Team only.

    02.07.03 Adrenaline (Epinephrine) 
    • Adrenaline (Epinephrine) Injection
    03.04.03 Adrenaline / Epinephrine EpiPen®, Emerade®

    Emerade®
     
    EpiPen®

    • Restricted to existing patients only
    03.04.03 Adrenaline / Epinephrine  Adrenaline Injection (1:1,000) 1mg in 1ml ampoule
    Adrenaline Injection (1:1,000) 1mg in 1ml syringe (MINIJECT)
    14.04 Adsorbed Diphtheria ( low dose) Tetanus Pertussis (Acellular Component) and Inactivated Poliomyelitis Vaccine Repevax®
    • For use in children under 10 years of age (booster doses)
    14.04 Adsorbed Diphtheria ( low dose) Tetanus Pertussis (Acellular Component) and Inactivated Poliomyelitis Vaccine Boostrix IPV®
    • Boostrix IPV is used in primary care for pregnant women in view of increasing number of cases of pertussis in babies.
    14.04 Adsorbed Diphtheria (low dose) Tetanus and Inactivated Poliomyelitis Vaccine  Revaxis®
    • For use in children over 10 and adults
    • Excipients may include neomycin, polymyxin B and streptomycin
    03.01.05 AeroChamber Plus® Drug delivery aid For use with all pressurised (aerosol) inhalers
    Standard device blue with mask or mouthpiece
    Infant device orange with mask
    Child device yellow with mask
    08.01.05 Afatinib Giotrif®
    • Afatinib Tablets (Giotrif®)


    27.14 Afex Active Starter Pack  1 High receptacle, 1 pair of briefs, 1 reusable collection bag (500ml 4-6 weeks), 1 cleaning container, 1 cleansing solution, 1 instructional DVD Order Code: A100-Plus brief code
    Pack Size: 1
    Drug Tariff Price £56.28
    27.14 Afex briefs waist 2X 44”-46” Order Code: A200- 2X-08
    Pack size: 1
    Drug Tariff Price £8.90
    27.14 Afex briefs waist XL 40”-42” Order Code: A200- XL-08
    Pack size: 1
    Drug Tariff Price £8.90
    27.14 Afex briefs waist 3X 48”-50” Order Code: A200- 3X-08
    Pack size: 1
    Drug Tariff Price £8.90
    27.14 Afex briefs waist large 36”-38” Order Code: A200- L-08
    Pack size: 1
    Drug Tariff Price £8.90
    27.14 Afex briefs waist small 28”-30” Order Code: A200- S-08
    Pack size: 1
    Drug Tariff Price £8.90
    27.14 Afex briefs waist medium 32"-34" Order Code: A200- M-08
    Pack size: 1
    Drug Tariff Price £8.90
    27.14 Afex collection bag stabiliser-high grip  Order Code: A710-S-09
    Pack size: 1
    Drug Tariff Price £3.99
    27.14 Afex high receptacle  Order Code: A300-F-08
    Pack size: 1
    Drug Tariff Price £29.99
    27.14 Afex low receptacle  Order Code: A300-L-08
    Pack size: 1
    Drug Tariff Price £29.99
    27.14 Afex low supersoft receptacle  Order Code: A300-S-08
    Pack size: 1
    Drug Tariff Price £29.99
    27.14 Afex Mobility Assisted Starter Pack  1 supersoft (90 -120 days) receptacle, 1 pair of briefs, 1 reusable collection bag(1200mls 4-6 weeks Order Code: A120-Plus brief code
    Pack Size: 1
    Drug Tariff Price £75.35
    27.14 Afex Sedentary Starter Pack  1 low receptacle, 1 pair of briefs, 1 reusable collection bag (1200mls 4-6 weeks), 1 cleaning container, 1 cleansing solution, 1 instructional DVD Order Code: A110-Plus brief code
    Pack Size: 1
    Drug Tariff Price £56.28
    27.14 Afex tube assembly complete  9 per year Order Code: A700-A-08
    Pack size: 1
    Drug Tariff Price £10.99
    27.14 Afex tube stabiliser  Order Code: A700-S-07
    Pack size: 1
    Drug Tariff Price £3.99
    27.14 Afex urine collection bags  1200ml leg bag Order Code: A400-L-08
    Pack size: 1
    Drug Tariff Price £17.39
    27.14 Afex urine collection bags  extra capacity Order Code: A400-E-08
    Pack size: 1
    Drug Tariff Price £17.39
    27.14 Afex urine collection bags  500ml vented bag Order Code: A400-V-08
    Pack size: 1
    Drug Tariff Price £17.39
    27.14 Afex urine collection bags  2000ml bed bag Order Code: A400-X-08
    Pack size: 1
    Drug Tariff Price £17.39
    27.14 Afex urine collection bags  500ml unvented bag Order Code: A400-B-08
    Pack size: 1
    Drug Tariff Price £17.39
    11.08.02 Aflibercept Eylea®
    • Aflibercept Solution for Injection

    Approved for use in line with NICE guidance:

    • NICE TA294 (wet age-related macular degeneration)
    • NICE TA305 (macula oedema secondary to central retinal vein occlusion)
    • NICE TA307 - NOT RECOMMENDED (metastatic colorectal cancer)
    • NICE TA346 (diabetic macular oedema)
    • NICE TA409 (macula oedema after branch retinal vein occlusion)

      Restricted to Consultant Ophthalmologist use only.
    04.03.04 Agomelatine Valdoxan®
    • Agomelatine Tablets

    Restricted to Consultant Psychiatrist initiation only

    09.02.02.02 Albumin Solution Human Albumin Zenalb® and Albunorm®
    • Albumin Human Solution 20% (100mL)
    • Albumin Human Solution 4.5% (500mL)
    18 Alcohol Dehydrated injection (Absolute alcohol) (Ethanol) 100%  Used in the management of poisoning with ethylene glycol/methanol.
    08.01.05 Alectinib capsules  Alecensa®
    • Alectinib Capsules (Alecensa®)

    Consultant Medical Oncologist use only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    06.06.02 Alendronic Acid 

    Green Traffic Light Standard tablets

    Standard once weekly tablets first choice over other alendronic acid formulations.
     
    Amber Traffic Light Dispersible tablets

    • Approved for the treatment of postmenopausal osteoporosis in patients unable to swallow standard alendronic acid tablets and as an alternative to denosumab injection or zoledronic acid infusion.
    • Restricted to use under recommendation from the Rheumatologists.
    09.06.04 Alfacalcidol 
    • Alfacalcidol (1α-hydroxycholecalciferol)

    Restricted to patients with severe renal impairment, who require the hydroxylated derivatives of vitamin D.

    04.07.02 Alfentanil 
    • Alfentanil Injection

    Restricted to theatre, ICU and palliative care consultant use only.

    15.01.04.03 Alfentanil  
  • Alfentanil Injection 1mg/2ml, 5mg/10ml
    For Theatre and ICU use only.

  • Alfentanil Injection 5mg/1ml
    For Palliative Care Consultant’s use only

  • Alfentanil Nasal Spray 5mg/5ml
    For Palliative Care Consultant’s use only

  • 07.04.01 Alfuzosin Hydrochloride 
    • Alfuzosin M/R tablets (Xatral XL®, Vasran XL®, Besavar XL®) - Licensed for use in acute urinary retention associated with benign prostatic hyperplasia in men over 65 yrs of age.
    • Alfuzosin tablets
    A5.03.03 Alginate dressing with silver Aquacel Ag+ Extra® Silver-containing dressing of choice at Airedale NHS Foundation Trust

    Antibacterial two layer hydrobiber dressing with silver:
  • 5cm x 5cm
  • 10cm x 10cm
  • 15cm x 15cm
  • 20cm x 30cm

    Please note, these dressings require prescription and careful monitoring of appropriate usage. Contact Tissue Viability for further advice
  • A5.03.03 Alginate dressing with silver Silvercel® Alternative silver-containing dressing product for community patients only

    Alginate and carboxymethylcellulose dressing impregnated with silver:
  • 2.5cm x 30.5cm rectangular
  • 5cm x 5cm square
  • 10cm x 20cm rectangular
  • 11cm x 11cm square

    Not available at Airedale NHS Foundation Trust

  • 03.04.01 Alimemazine Tartrate 

    Alimemazine Syrup
    Alimemazine Tablets

    Existing patients only

    Black for new patients based on disproportionatly higher cost compared with other sedating antihistamines

    02.12 Alirocumab  Praluent®
    • Alirocumab Subcutaneous Injection

    Approved in-line with NICE TA393 for treating primary hypercholesterolaemia and mixed dyslipidaemia as an adjunct to diet.

    Specialist initiation via the lipid clinic only.

    10.01.04 Allopurinol  Allopurinol Tablets
    Not to be used for acute attacks of gout.

    06.01.02.03 Alogliptin Vipidia®

    Supported for use in adult patients with Type 2 diabetes, to improve glycaemic control in combination with other glucose lowering medicinal products including insulin
     

    09.06.05 Alpha Tocopheryl Acetate 
    • Alpha Tocopheryl Acetate Suspension (500mg/5mL)

    Restricted for patients with malabsorption syndromes only.

    Vitamin E capsules (400units) to be purchased by the patients over the counter from pharmacies where possible.

    13.09 Alphosyl 2 in 1 ®  Alphosyl 2 in 1 shampoo
    07.04.05 Alprostadil Caverject®

    Alprostadil Injection

    07.04.05 Alprostadil MUSE®

    Alprostadil Applicator Muse
     

    07.04.05 Alprostadil cream Vitaros®

    Alprostadil (Vitaros®) cream

    Second-line treatment of erectile dysfunction (i.e. patients in whom oral PDE5 inhibitors are ineffective or contraindicated) and as an alternative to intracavernosal alprostadil injection or intraurethral alprostadil pellets.

    02.10.02 Alteplase 
    • Alteplase Injection

    Thrombolysis for ischaemic stroke:

    • Service for Airedale patients now provided at Bradford Teaching Hospitals.

     

    Thrombolysis for massive pulmonary embolism:

    • Prescribed and administered according to the instructions contained within the product packaging. Dosing information within the BNF.
    • At ANHSFT, 2 x 50mg vials are kept as ward stock in the Emergency Depertment and Intensive Care.
    01.02 Alverine Citrate  
  • Alverine Citrate Capsules

  • 04.09.01 Amantadine Hydrochloride Symmetrel®
    • Amantadine Capsules

    Restricted to Consultant Neurologist and Department of Elderly Medicine Physicians recommendation only in-line with NICE CG35: Parkinson's disease in the over 20s.

    02.02.03 Amiloride Hydrochloride 
    • Amiloride Hydrochloride Tablets
    • Amiloride Hydrochloride Solution
    03.01.03 Aminophylline   Green Traffic Light 
    Aminophylline tablets

    Red Traffic Light 
    Aminophylline injection
    02.03.02 Amiodarone 

    Amber Traffic Light  Amiodarone Tablets
    Red Traffic Light  Amiodarone Injection
    Note: 150mg/3ml strength is reserved for use in crash trolleys and crash boxes only.

    Amiodarone is for initiation by the consultant or specialist only and duration of treatment should be specified.
    Patients should be reviewed every 6 months by their GP and monitored carefully for adverse effects of amiodarone therapy, particularly:

    • Pulmonary toxicity - have a low threshold for suspecting amiodarone induced pulmonary toxicity (e.g. new/worsened cough or shortness of breath)
    • Arrhythmias (could be a sign of amiodarone induced arrhythmia or recurrence of original arrhythmia)
    • Monitor U&Es, LFTs (liver toxicity), and clinical signs of hyperthyroidism/hypothyroidism and thyroid function tests
    • Ask the patient if they have new onset/worsening visual disturbances; if so perform eye examination, and consider referral to ophthalmology to exclude optic neuropathy
    • Ask the patient if they have had skin reactions (bluish-grey skin discolouration or phototoxicity)
    • Check for potential drug interactions with amiodarone with current medicine regimen.
    • Consider stopping amiodarone in patients who were initiated with amiodarone for treatment of AF and who remain in asymptomatic AF despite adherence to amiodarone treatment.
       
    04.02.01 Amisulpride 
    • Amisulpride Tablets
    • Amisulpride Oral Solution

    Restricted to Psychiatry specialist recommendation only

    04.07.03 Amitriptyline 
    • Amitriptyline Tablets
    • Amitriptyline Solution

     For the treatment of neuropathic pain.

    04.03.01 Amitriptyline Hydrochloride 
    • Amitriptyline SF Solution
    • Amitriptyline Tablets

    Green Neuropathic pain

    Amber Depression


    Amitriptyline is not routinely recommended as an antidepressant but may be considered for neuropathic pain

    Use as an antidepressant restricted to Psychiatry Specialist recommendation only

    02.06.02 Amlodipine 
    • Amlodipine Tablets
    05.01.01.03 Amoxicillin   Green Traffic Light Amoxicillin Capsules
    Green Traffic Light Amoxicillin SF Suspension

    Green <br>
Traffic Light Amoxicillin SF Sachets (Restricted)
  • Not recommended for endocarditis prophylaxis - NICE CG64.
  • For use only where high doses of amoxicillin required (e.g. bronchiectasis).

    Green Traffic Light Amoxicillin Injection

  • 05.02 Amphotericin  Green Traffic Light Amphotericin SF Suspension
    Green Traffic Light Amphotericin Liposomal Injection
    09.01.04 Anagrelide 
    • Anagrelide

    Consultant Haematologist only

     

    08.03.04.01 Anastrozole Arimidex ®
  • Anastrazole Tablets

  • 12.03.01 Antacid with Oxetacaine  
    • Antacid with Oxetacaine Sugar Free Suspension

    Restricted for Oncology and Haematology patients only
    unlicensed unlicensed special ULM

    01.07.01 Anusol 
  • Anusol Suppositories
  • Anusol Cream
  • Anusol Ointment
  • 01.07.02 Anusol-HC 
  • Anusol HC Suppositories
  • Anusol HC Ointment
  • 02.08.02 Apixaban Eliquis®
    • Apixaban Tablets

    Prevention of stroke and systolic embolism in patients with non-valvular atrial fibrillation in-line with NICE.
     

    Treatment and prevention of DVT and or PE in line with NICE.

    04.09.01 Apomorphine 
    • Apomorphine Pens

    Restricted to Consultant Neurologist and Care of the elderly physician initiation only.

    27.13 Appeel No Sting Medical Adhesive Remover Spray  to ease removal of sheaths Order Code: 3500
    Pack size: 1
    Drug Tariff Price £8.94
    27.13 Appeel No Sting Medical Adhesive Remover wipes  to ease removal of sheaths Order Code: 3505
    Pack size: 30
    Drug Tariff Price £14.83
    11.08.02 Apraclonidine  Iopidine®
    • Apraclonidine 1% Eye Drops (24 X 0.25ml) (preservative free)

      For use following consultant recommendation only
    10.01.03 Apremilast Otezla® Consultant Rheumatologist Use only
  • Supported for use in line with NICE TA433 for the treatment of Active Psoriatic Arthritis.
  • Supported for other indications at specialist dermatology centres only.
  • 04.06 Aprepitant EMEND®
    • Aprepitant Capsules

    For use during cisplatin-based chemotherapy

    A2.03.01 Aptamil Pepti 1 and 2 
    12.01.03 Arachis Oil  Cerumol®
    • Arachis Oil (refined peanut oil) Ear Drops
    01.06.03 Arachis Oil Enema (130mL)  Primary care cost warning - expensive product

    Not suitable for patients with peanut allergy
    09.08.01 Arginine  
    • Arginine

    04.02.01 Aripiprazole 
    • Aripiprazole Tablets
    • Aripirazole Orodispersible Tablets

    Aripiprazole Oral Solution (note high cost, only use if the tablets or orodispersible tablets aren't appropriate)

    Restricted for Consultant Psychiatrist recommendation only.

    04.02.02 Aripiprazole Abilify Maintena®
    • Arpiprazole Depot Injection

    Restricted to Consultant Psychiatrist initiation only

    For 'named patient' use only

    15.02 Articaine Hydrochloride with Adrenaline 
  • Articaine with adrenaline 1 in 100,000
  • Articaine with adrenaline 1 in 200,000

    Gynaecology Consultants use only
  • 12.03.05 AS Saliva Orthana® 
    • AS Saliva Orthana® Spray

    Reserved for Oncologists, Haematologists and ENT consultants only.

    09.06.03 Ascorbic Acid 
    • Ascorbic Acid

    To be purchased by the patient over the counter from pharmacies where possible.

    04.07.01 Aspirin 
    • Aspirin Dispersible Tablets
    • Aspirin EC Tablets
    • Aspirin Suppositories
    02.09 Aspirin (antiplatelet)  First Choice
    Aspirin Dispersible Tablets

    Restricted Item Restricted Choice
    Aspirin EC Tablets
  • Restricted to patients already established on the enteric coated preparation.
  • Pregnant patients after 12 weeks of pregnancy in line with NICE antenatal pathways, as part of an ongoing audit. Due for review in March 2017.
  • 02.04 Atenolol  Green Traffic Light Atenolol Tablets
    Green Traffic Light Atenolol Syrup
    Red Traffic Light Atenolol Injection

    08.01.05 Atezolizumab infusion 
    • Atezolizumab infusion

    Atezolizumab infusion (in combination with nab-paclitaxel) is supported for use within the Early Access to Medicines Scheme for patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) whose tumours have PD-L1 expression ≥ 1%

    Atezolizumab infusion in combination with bevacizumab, paclitaxel and carboplatin is supported for use for treating advanced non-squamous non-small-cell lung cancer

    Consultant Oncologist use only

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

     

    04.04 Atomoxetine Strattera®
    • Atomoxetine Capsules 
    • Atomoxetine Oral Solution 

    Restricted to Consultant Psychiatrist and Paediatrician initiation only.

    For use in line with NICE NG87: Attention deficit hyperactivity disorder: diagnosis and management (March 2018) - See link at the bottom of the section.

    02.12 Atorvastatin 
    • Atorvastatin Tablets
    07.01.03 Atosiban  Atosiban 6.75mg injection
    Atosiban 37.5mg injection concentrate

    Use in accordance with protocol for pre-term labour between 28 and 33 weeks taking into account fibronectin test. For labour ward only.
    15.01.05 Atracurium Besilate injection 
  • Atracurium Injection
  • 15.01.03 Atropine 
  • Atropine Injection
  • Atropine Miniject
  • 11.05 Atropine Sulphate single use Minims® Atropine Sulphate
    • Atropine 1% Minims (preservative free)
      For use in patients where a preservative free product is necessary or an individual dose is required
    07.04.05 Aviptadil 25mcg /phentolamine 2mcg Invicorp® Third-line treatment of erectile dysfunction (i.e. patients in whom oral PDE5 inhibitors are ineffective or contraindicated) and as an alternative to intracavernosal alprostadil injection or intraurethral alprostadil pellets.

    Specialist initiation only.
    08.01.05 Axitinib Inlyta®

     Patients who require treatment of renal cell carcinoma should be referred to Leeds Teaching Hospital Trust

    Axitinib is not stocked at Airedale NHS Foundation Trust

    08.01.03 Azacitidine Vidaza®
    • Azacitidine Injection

     Supported for use in line with NICE TA218.

    08.02.01 Azathioprine  Amber Traffic Light  Azathioprine Tablets
    Red Traffic Light  Azathioprine injection
    10.01.03 Azathioprine  Consultant Rheumatologist use only
    11.04.02 Azelastine  Optilast®
    • Azelastine hydrochloride 0.05% Eye Drops (with preservative)
    05.01.05 Azithromycin 
  • Azithromycin Suspension
  • Azithromycin Tablets

    Reserved for genitourinary medicine, treatment of pneumonia in paediatric patients with penicillin allergy, treatment of or suspected Mycoplasma/Chlamydia and COPD exacerbation prophylaxis.
  • 05.01.02.03 Aztreonam Azactam®
  • Aztreonam Injection
  • 09.03 Babiven 
    • Babiven Start up
    • Babiven Maintenance
    10.02.02 Baclofen  Green Traffic LightBaclofen SF Liquid
    Green Traffic LightBaclofen Tablets
    Green Traffic LightBaclofen Intrathecal Injection
  • Restricted to use by consultant neurologist only
  • 27.01 Bard Biocath  Gauge/Ch size 12-16
    Order Code: D2264
    Drug Tariff Price £8.36
    27.01 Bard Biocath  Gauge/Ch size 12-16
    Order Code: D2268
    Drug Tariff Price £8.40
    27.05 Bard Flip Flo Catheter Valve  Order Code: BFF5
    Pack Size: 5
    Drug Tariff Price £12.89
    27.02 Bardex I.C. Foley Catheter.  Female Catheter (28 days only)
    Gauge/Ch size 12S-16S
    Order Code: D2369
    Drug Tariff Price £9.49
    27.02 Bardex I.C. Foley Catheter.  Standard length (28 days only)
    Gauge/Ch size 12S-22S
    Order Code: D2365
    Drug Tariff Price £9.49
    10.01.03 Baricitinib Olumiant®

    Consultant Rheumatologist Use only

    • Supported for use in line with NICE TA466 for the treatment of moderate to severe, active rheumatoid arthritis.
    • First-line JAK inhibitor for this indication.

     

     

    07.04.04 BCG bladder instillation  BCG Intravesical (12.5mg)Bladder Instillation
    BCG Reconstitution device

    For Consultant Urologists use in patients with carcinoma in situ of the bladder
    14.04 BCG Vaccine AJV  
    14.04 BCG vaccine diagnostic agent 
    • For Mantoux tests
    27.18 Beambridge male draining jug with tap*   Order Code: 6-50T
    Pack size: 1
    Drug Tariff Price £13.63
    27.18 Beambridge bridge urinal  Order Code: 6-18
    Pack size: 1
    Drug Tariff Price £13.63
    27.18 Beambridge female saddle urinal  Order Code: 6-26
    Pack size: 1
    Drug Tariff Price £13.63
    27.18 Beambridge funnel *  Order Code: 6-35
    Pack size: 1
    Drug Tariff Price £12.59
    27.18 Beambridge lady jug *  Order Code: 6-45
    Pack size: 1
    Drug Tariff Price £14.67
    03.02 Beclometasone Clenil Modulite®, QVAR® Note: Different brands of beclometasone inhalers do not provide equivalent doses, and are not interchangeable. Please prescribe by brand name.

    Clenil Modulite®
  • Beclometasone CFC-free metered dose inhaler
  • Licensed for asthma

    QVAR®
  • Beclometasone CFC-free Metered Dose Inhaler
  • Beclometasone CFC-free Autohaler
  • Beclometasone CFC-free Easi-Breathe inhaler
  • Licensed for asthma
  • 03.02 Beclometasone and formoterol Fostair®, Fostair® NEXThaler

    Fostair® , Fostair® NEXThaler

    • COPD: 100/6 metered dose inhaler and NEXThaler are licensed for COPD with FEV1 <50% of predicted.
    • Asthma: 100/6 and 200/6 metered dose inhaler and NEXThaler are licensed for asthma.
       
       
    12.02.01 Beclometasone Dipropionate Beconase®, Nasobec®
    • Beclometasone Dipropionate Nasal Spray

    Please prescribe as Beconase® 200 dose in Primary Care.

    03.02 Beclometasone, formoterol and glycopyrronium  Trimbow®

          Trimbow®    

    • Metered Dose Inhaler
    • For use in patients with moderate to severe COPD who are not adequately treated by a combination of inhaled corticosteroid and a LABA.
    08.01.01 Bendamustine 
    • Bendamustine Injection

    Blueteq® registration and approval for use is required for this product before it may be dispensed.
     
    Bendamustine is also available for other indications funded by the CDF

    02.02.01 Bendroflumethiazide 
    • Bendroflumethiazide Tablets
    03.04.02 Benralizumab  Benralizumab Injection

    For the treatment of severe eosinophilic asthma. Supported for use in-line with NICE TA565 (March 2019).

    Available via referral to specialist tertiary respiratory centres.
    18 Benzatropine 2mg tablets  Used in the management of poisoning with severe parkinsonian symptoms.
    10.01.04 Benzbromarone 

    Consultant Rheumatologist use only.

    • Third-line treatment of chronic gout
    • Unlicensed medicine: Additional paperwork required for dispensing at ANHSFT
    12.03.03 Benzocaine, Tyrothricin Tyrozets®
    • Benzocaine, Tyrothricin Lozenges
    12.03.01 Benzydamine Difflam®
    • Benzydamine Oral Spray
    • Benzydamine Mouthwash (Oral Rinse)
    05.01.01.01 Benzylpenicillin 
  • Benzylpenicillin Injection
  • 18 Berlin Blue soluble  Used in the management of poisoning with thallium.
    04.06 Betahistine Dihydrochloride Serc®
    • Betahistine Tablets
    06.03.02 Betamethasone 

    Green Traffic Light  Oral preparations

    • Betamethasone Sodium Phosphate Tablets


     Red Traffic Light  Injectable preparations

    • Betamethasone Sodium Phosphate Injection (4mg/1mL)
    11.04.01 Betamethasone  Betnesol®
    • Betamethasone 0.1% Eye Ointment
    13.04 Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% Diprosalic® Betamethasone diproprionate 0.05%, salicylic acid 3% (Diprosalic Ointment)
    13.04 Betamethasone (as Valerate) 0.025% Betnovate-RD® Betamethasone Valerate 0.025% Cream (Betnovate RD)
    13.04 Betamethasone (as Valerate) 0.1% Betnovate® Betamethasone Valerate 0.1% Scalp Application (Betnovate)
    Betamethasone Valerate 0.1% Ointment (Betnovate)
    Betamethasone Valerate 0.1% Cream (Betnovate)
    12.01.01 Betamethasone 0.1%  Betnesol®, Vistamethasone®
    • Betnesol Drops
    • Vistamethasone Drops
    11.04.01 Betamethasone 0.1% with Neomycin 0.5%  Betnesol N®
    • Betamethasone 0.1% Neomycin 0.5% Eye Drops (Betnesol N) (with preservative)
    12.02.03 Betamethasone Sodium Phosphate 0.1% with Neomycin Sulphate 0.5% Betnesol N®
    • Betamethasone 0.1%, Neomycin 0.5%  Eye/Ear/Nose Drops
    12.01.01 Betamethasone with Neomycin Betnesol N® Vista-Methasone N®
    • Betamethasone 0.1% Neomycin Sulphate 0.5% Eye/Ear/Nose Drops
    11.06 Betaxolol Hydrochloride Betoptic®
    • Betaxolol 0.5% and 0.25% Eye Drops (with preservative)
    • Betaxolol 0.25% Eye Drops Single dose M/R (preservative free)

      For use following consultant recommendation only
    08.01.05 Bevacizumab Avastin®
    • Bevacizumab Infusion

    Bevacizumab is only available for via the CDF. For further information see the link below.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    02.12 Bezafibrate 
    • Bezafibrate Tablets
    • Bezafibrate MR Tablets

    Not routinely recommended.

    Restricted to existing patients or specialist recommendation only.

    08.03.04.02 Bicalutamide 
  • Bicalutamide Tablets

  • 11.06 Bimatoprost Lumigan®
    • Bimatoprost Eye Drops (300micrograms/ml) (with preservative
    • Bimatoprost Eye Drops (300micrograms/ml) (with preservative
    • Bimatoprost Single Use Eye Drops (300micrograms/ml) (preservative free)

      For use following consultant recommendation only
    11.06 Bimatoprost with Timolol Ganfort®
    • Bimatoprost 300micrograms/ml, timolol maleate 5mg/ml (with preservative)
    • Bimatoprost 300micrograms/ml, timolol maleate 5mg/ml (preservative free)

      For use following consultant recommendation only
    12.03.05 Biotene® 
    • Biotene® Oral Balance Gel

    Reserved for patients who can't tolerate the alternative options. Not routinely stocked at ANHSFT.

    06.01.01.02 Biphasic Insulin Aspart NovoMix® 30
    • 3mL pen filled device (FlexPen)
    • 3mL cartridge compatible with Novopen 5 and Junior Novopen

      Note the number after the name of the insulin refers to the percentage of rapid acting insulin.

      Please state the brand name on all prescriptions for insulin
    06.01.01.02 Biphasic Insulin Lispro Humalog® Mix 25
    • 3mL pen filled device (Kwikpen)
    • 3mL cartridge compatible with Humapen Savvio

      Note the number after the name of the insulin refers to the percentage of rapid acting insulin.

      Please state the brand name on all prescriptions for insulin
    06.01.01.02 Biphasic Insulin Lispro Humalog® Mix 50
    • 3mL pen filled device (Kwikpen)
    • 3mL cartridge compatible with Humapen Savvio

      Note the number after the name of the insulin refers to the percentage of rapid acting insulin.

      Please state the brand name on all prescriptions for insulin
    06.01.01.02 Biphasic Isophane Insulin Humulin® M3
    • 10mL vial
    • 3mL pen filled device (Kwikpen)
    • 3mL cartridge compatible with Humapen Savvio

      Note: Mixtard 30 and Humulin M3 contain 30% short acting soluble insulin & 70% isophane insulin

      Please state the brand name on all prescriptions for insulin
    06.01.01.02 Biphasic Isophane Insulin Insuman® Comb 25

    Biphasic Isophane insulin 300unit/3mL SoloStar (Insuman® Comb 25)

    Restricted to existing patients only

    Please state the brand name on all prescriptions for insulin

    12.02.03 BIPP 
    • BIPP Gauze (1.25cm x 1m, 2.5cm x 1m)
    01.06.02 Bisacodyl  
  • Bisacodyl E/C Tablets
  • Bisacodyl Suppositories
  • 01.03.03 Bismuth subsalicylate 

    De-Noltab® (tripotassium dicitratobismuthate) tablets have been discontinued.

    For bismuth-based H.pylori eradication regimens,  Pepto-Bismo® (bismuth subsalicylate 262.5mg) chewable tablets may be used as an alternative at a dose of 2 tablets four time a day (off-licence use).

     

    02.04 Bisoprolol 
    • Bisoprolol Tablets
    08.01.02 Bleomycin 
  • Bleomycin Injection
  • Bleomycin Infusion

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 05.03.03.02 Boceprevir Victrellis®
  • Boceprevir Capsules

    Use supported for the treatment of hepatitis C (genotype 1) in combination with peginterferon and ribavirin in-line with NICE TA 253 (April 2012). Use restricted to the Consultant Gastroenterologists.

    Funding to be agreed with NHSE
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 08.01.05 Bortezomib Velcade®
    • Bortezomib Injection

    Bortezomib is also available for some indications via the CDF list. See link below for further information.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    08.01.05 Bosutinib Bosulif®
    • Bosutinib Tablets

      Consultant Haematologist use only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

     

    18 Botulinum antitoxin  Used in the management of poisoning with botulism.
    04.09.03 Botulinum Toxin Type A Xeomin®
    • Botulinum A Toxin (Xeomin® Injection)
    04.09.03 Botulinum Toxin Type A Botox®
    • Botulinum A Toxin (Botox® Injection)

    Restricted to Consultant Urologist/Neurologist/Orthopaedic/Maxillofacial use only.

    All other requests should be authorised by a senior clinical pharmacist. Botox units are not equivalent to units of other brands.

    04.09.03 Botulinum Toxin Type A Dysport®
    • Botulinum A Toxin (Dysport®)

    For treatment of focal spasticity in children with cerebral palsy as an alternative to the Botox® brand.

    Use restricted to Consultant Paediatricians.

    Dysport units are not equivalent to units of other brands.

    08.01.05 Brentuximab infusion Adcetris®
    • Brentuximab infusion

    For treatment of CD30-positive cutaneous T-cell lymphoma in-line after at least one other therapy (second-line) with NICE TA577. 

    Consultant Haematologist use only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    08.01.05 Brigatinib tablets Alunbrig®
    • Brigatinib tablets (Alunbrig®)

    Consultant Medical Oncologist use only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    11.06 Brimonidine Tartrate 
    • Brimonidine 0.2% Eye Drops (with preservative)

      For use following consultant recommendation only
    11.06 Brimonidine Tartrate with Timolol  Combigan®
    • Brimonidine 0.2% , Timolol 0.5%) (with preservative) Combigan Eye Drops

      For raised intra-ocular pressure in open angle glaucoma and for ocular hypertension when a beta-blocker alone is not adequate, apply twice a day.

      For use following consultant recommendation only
    11.06 Brinzolamide 1% with Timolol 0.5%  Azarga®
    • Brinzolamide 1% with Timolol 0.5% Eye Drops (with preservative)

      For use following consultant recommendation only
    11.06 Brinzolamide® Azopt
    • Brinzolamide 10mg/ml Eye Drops (with preservative)

      For use following consultant recommendation only
    10.01.03 Brodalumab 

    Available via specialist centres only.

    01.05.02 Budesonide  Jorveza®
    • Budesonide 1mg orodispersible tablets (Jorveza®)

    For the treatment of eosinophilic oesophagitis. Full 6 week course to be supplied by ANHSFT.

    01.05.02 Budesonide  
  • Licensed and supported for the treatment of Crohn's Disease:
    Budesonide EC Capsules (Budenofalk®)
    Budesonide Granules (Budenofalk®)
    Budesonide MR Capsules (Entocort®) - Specialist recommendation only - ensure brand is specified.

  • Licensed and supported for the treatment of Ulcerative colitis
    Budesonide rectal foam (Budenofalk®) - An alternative option for patients unable to tolerate or unable to administer hydrocortisone rectal foam enemas. Specialist recommendation only.
    Budesonide MR tablets (Cortiment®) - Supported for the treatment of mild to moderate Ulcerative colitis for patients in whom systemic steroids are unacceptable or inappropriate. Specialist recommendation only - ensure brand name is stated.

    Prescribers are requested to specify brand names, to ensure the appropriately licensed brand is chosen.
  • 03.02 Budesonide Pulmicort®

    Pulmicort® Turbohaler

    • Licensed for asthma

      Restricted Item Pulmicort® Respules
    • Reserved for existing patients in whom inhaled steroids are unsuitable or ineffective.
    • Consultant Paediatrician recommendation only
    12.02.01 Budesonide Rhinocort Aqua®
    • Budesonide Nasal Spray
    03.02 Budesonide and formoterol Duoresp® Spiromax, Symbicort® Turbohaler

    Green Duoresp® Spiromax

    • Dry powder inhaler
    • Licensed for asthma
    • Licensed for COPD if FEV1<50% predicted

    Amber Symbicort® MDI

    • Licensed for COPD if FEV1<70% predictedRestricted to specialist recommendation only

    Green Restricted Item Symbicort® Turbohaler

    • Dry powder inhaler
    • Restricted to existing patients only
    • Licensed for asthma
    • Licensed for COPD if FEV1 <50% predicted
    • Restricted to existing patients only as a more cost effective alternative is available, which provides the same clinical benefit.
    02.02.02 Bumetanide 
    • Bumetanide Tablets

    Bumetanide is considerably more expensive than furosemide and offers no clinical advantage.

    15.02 Bupivacaine Hydrochloride with Glucose 
  • Bupivacaine with Glucose Spinal Injection
  • 15.02 Bupivicaine with Epinephrine 
  • Bupivicaine 0.5% Epinephrine (Adrenaline) 1:200,000

    Theatre use only
  • 04.07.02 Buprenorphine 
    • Buprenorphine transdermal patches - Not to be used for opioid naïve patients.
    • BuTrans® 7-day release patches.
    • Transtec® 4-day release patches.
    • Hapoctasin® 3-day release patches
    • Butec® 7-day release patches Primary care use only - preferred brand in primary care
      Reletrans®
      7-day release patches Primary care use only

     

    Buprenorphine patches are reserved for:

    • Elderly patients requiring chronic pain relief who are unable to take oral opioid medication or who are non-compliant with syringe drivers.
    • For selected oncology patients.
    • Consider use in place of morphine in cases of renal impairment
    • Long term use is discouraged and patients should undergo regular review
    • Please prescribe Butec® brand in Primary Care, as it is the most cost-effective.
    • Please note: Butrans® and Butec® 7-day patches are clinically equivalent. Patients may be switched between brands appropriately when required.
       
       
      Red Traffic Light Buprenorphine injection
    04.10.03 Buprenorphine Subutex®
    • Buprenorphine Sublingual Tablets
    04.10.03 Buprenorphine and Naloxone Suboxone®
    • Suboxone® Sublingual Tablets 

    Restricted to specialist substance misuse services only, or for existing patients only.

    Restricted for treatment of opioid addiction.

    04.10.02 Bupropion Zyban®
    • Bupropion Prolonged Release Tablets

    For primary care use only.

    04.01.02 Buspirone Hydrochloride 
    • Buspirone Tablets
       

    Restricted to Consultant Psychiatrist recommendation only for short term treatment of anxiety

    03.04.03 C1 Esterase Inhibitor Berinert®

    For the acute, emergency treatment of hereditary angioedema, following recommendation by a consultant immunologist at Leeds.

    Stock available in Accident and Emergency.

    In an emergency, further stock may be obtained from Leeds or Manchester hospitals. Contact details in Pharmacy Stores or on-call folder.

    08.01.05 Cabazitaxel Jevtana®
    • Cabazitaxel Concentrate for Infusion

      Blueteq® registration and approval for use is required for this product before it may be dispensed.
    06.07.01 Cabergoline  Consultant Endocrinologist, Neurologist and Obstetrician initiation only
    20 CAFFEINE BASE 10mg/ml  Caffeine citrate Solution (50mg/5ml)
    20 CAFFEINE CITRATE 10mg/ml INJ   Caffeine citrate Injection (10mg/ml)
    13.03 Calamine  Calamine Lotion
    13.05.02 Calcipotriol 50mcg/g ointment 

    Calcipotriol 50mcg/g ointment

    09.06.04 Calcitriol 
    • Calcitriol (1,25-dihydroxycholecalciferol)

    Restricted to patients with severe renal impairment, who require the hydroxylated derivatives of vitamin D.

    09.06.04 Calcium and Ergocalciferol Tablets
    • Calcium and Ergocalciferol (vitamin D2)

    Reserved for existing patients only.

    09.05.01.01 Calcium Carbonate 
    • Calcium Carbonate
    09.05.01.01 Calcium Chloride 
    • Calcium Chloride 10% Miniject (100mg in 1ml - 0.68mmol/ml) (10ml)
    08.01 Calcium Folinate 
  • Calcium Folinate Tablets
  • Calcium Folinate Injection
  • Calcium Folinate Infusion

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 09.05.01.01 Calcium Gluconate 
    • Calcium Gluconate 10% Injection (0.23mmol/ml) (10mL)
    09.05.01.01 Calcium Lactate 
    • Calcium Lactate
    09.05.01.01 Calcium Syrup® (Alliance) 
    • Calcium

    The use of Alliance Calcium Syrup® is restricted for the treatment of hypocalcaemia in paediatric patients.

    Adult patients should receive treatment with chewable or effervescent calcium preparations.

    Effervescent calcium tablets should be used for adult patients requiring nasogastric administration.

    A2.04.01.02 Calogen / Calogen Extra Shots®  

    Calogen Emulsion (Strawberry)
    Calogen Emulsion (unflavored)  
    Calogen Extra Shots (neutral)
    Calogen Extra Shots (strawberry)

    Equivalent product for prescribing in community only

    • No community formulary equivalent due to zero/low protein.
    • Prescribe Calogen Extra Shot (contains some protein) rather than Calogen. Ideal dose: 40ml
      3x daily.
    • Consider switching to a formulary product on review,eg a 125 ml sip feed split into smaller doses.
    A2.04 Calogen Extra Shots  Calogen Extra Shots (Neutral) (6X 40ml)
    Calogen Extra Shots (Strawberry) (6X 40ml)

    For use only on recommendation of a dietitian
    06.01.02.03 Canagliflozin  Invokana® Approved for use for type two diabetes as an alternative to dapagliflozin in patients with poor renal function and in line with NICE TA315.
    02.05.05.02 Candesartan 
    • Candesartan Tablets
    08.01.03 Capecitabine 
    • Capecitabine Tablets
       
    10.03.02 Capsaicin  Capsaicin cream 0.025% (Zacin®)
  • For use by Consultant Rheumatologist for symptomatic relief in osteoarthritis. Second line after NSAIDs

    Capsaicin cream 0.075% (Axsain®)
  • Restricted - For neuropathic pain and phantom limb pain only.
  • 02.05.05.01 Captopril 
    • Captopril Tablets
    • Captopril Oral Solution    

    Take care with liquid preparations. Potential for error.
     

    • Captopril 5mg/5ml oral solution is used for neonatal patients at ANHSFT.
    • Captopril 25mg/5ml oral solution is recommended for older children by the tertiary centre in Leeds.
    04.08.01 Carbamazepine 
  • Carbamazepine SF Liquid
  • Carbamazepine Tablets
  • Carbamazepine MR Tablets
  • Carbamazepine Suppositories

    Green Traffic Light Carbamazepine for the management of trigeminal neuralgia
    Amber Traffic Light Carbamazepine for the management of epilepsy, or for use as a mood stabiliser. (Restricted to consultant initiation only)

    The MHRA recommends that patients should be maintained on a specific manufacturer’s product.
    In Primary Care - Tegretol MR is a cost-effective brand
  • 06.02.02 Carbimazole 

    Specialist recommendation only.

    03.07 Carbocisteine Mucodyne® Carbocisteine Capsules
    Carbocisteine Syrup
    11.08.01 Carbomer 980 Clinitas Gel®, Viscotears®
    • Carbomer 980 Eye Gel - Clinitas®    
    • Carbomer 980 Liquid Gel - Viscotears®
    • Liquid Gel  Single Dose Unit Eye Gel - Viscotears®)
    A5.02.08 Carbon Dressing Carboflex Carboflex Dressing 10 x 10cm
    Carboflex Dressing 8 x 15cm
    Carboflex Dressing 15 x 20cm

    These are available on request for malodorous fungating wounds only. They are stand alone dressings that help
    1. Stop bleeding
    2. Absorb exudate
    3. Reduce odour
    A5.02.08 Carbon Dressing Clinisorb ® Clinisorb dressing 10cm x 10cm
    Clinisorb dressing 10cm x 20cm
    Clinisorb dressing 15cm x 25cm (will be ordered in if required)

    These are first line for malodorous wounds and can be used in conjunction with other dressings.
    08.01.05 Carboplatin 
  • Carboplatin Injection
  • Carboplatin Infusion

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 07.01.01 Carboprost 

    Carboprost Injection

    08.01.05 Carfilzomib Kyprolis®
    • Carfilzomib infusion

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    09.08.01 Carglumic Acid 
    • Carglumic acid

    In current use for treatment of inborn errors of metabolism.

    11.08.01 Carmellose Sodium 
    • Carmellose Sodium 0.5% Single Dose Eye Drops (preservative free) Xailin Fresh® 
    • Carmellose sodium  1% Single Dose Eye Drops (preservative free)
    • Carmellose Sodium 0.5% Eye Drops (with preservative).
    12.03.01 Carmellose Sodium Orabase®
    • Carmellose Sodium Oral Paste
    A2.05.02 Carobel Powder®  
    02.04 Carvedilol 
    • Carvedilol Tablets

    Restricted to Consultant cardiologist use only.

    05.02 Caspofungin 
  • Caspofungin Infusion

    Use supported for systemic fungal infections third line after amphotericin B and oral voriconazole
  • 27.03 Cathejell Mono 12.5g  Order Code: CJM12501
    pack Size: 1
    Drug Tariff Price £0.85
    27.03 Cathejell Mono 8.5g  Order Code: CJM08501
    pack Size: 1
    Drug Tariff Price £0.80
    27.03 Cathejell with lidocaine 12.5g  Order Code: CJL12501
    Pack Size: 1
    Drug Tariff Price £1.25
    27.03 Cathejell with lidocaine 8.5g 

    nifedipin fass

    nifedipin weichkapseln link nifedipin je
    Order Code: CJL08501
    Pack Size: 1
    Drug Tariff Price £1.20
    07.04.04 Catheter Patency Solutions 

    Sodium chloride 0.9% bladder irrigation (Urotainer)

    Solution G (100mL solution contains citric monohydrate acid, light magnesium oxide, sodium bicarbonate, disodium edetate in water for injections)

    13.02.02 Cavilon® Barrier Cream 

    Cavilon Barrier Cream


    This product is expensive but very effective if used appropriately. Apply sparingly. If the ‘afterfeel’ is oily you have applied too much. Cavilon barrier cream should not be applied to broken skin

    13.02.02 Cavilon® Film 

    Cavilon Film Spray

    Protective transparent barrier film. Alcohol free formulation is pain free on broken skin.

    05.01.02 Cefaclor 
  • Cefaclor Capsules
  • Cefaclor Suspension
  • 05.01.02 Cefalexin 
  • Cefalexin Capsules
  • Cefalexin Syrup
  • 05.01.02 Cefixime  
  • Cefixime Tablets

    Reserved for the treatment of gonorrhoea, on the advice of a consultant microbiologist only.
  • 05.01.02 Cefotaxime 
  • Cefotaxime Injection
  • 05.01.02 Ceftazidime 
  • Ceftazidime Injection

  • 05.01.02 Ceftriaxone 
  • Ceftriaxone Injection

  • 05.01.02 Cefuroxime  
  • Cefuroxime Injection (750mg strength vials)
  • 11.08.02 Cefuroxime Aprokam®
    • Cefuroxime 50mg Injection (for intracameral use)
       
      For Eye theatre use only.
    10.01.01 Celecoxib 
  • Celecoxib Capsules
    For patients at a particularly high risk of developing gastrodoudenal ulceration or bleeding and after assessing their cardiovascular risk (see CSM advice above).
  • 02.04 Celiprolol Hydrochloride 
    • Celiprolol 200mg Tablets

    Reserved for existing patients only.

    08.01.05 Ceritinib capsules  Zykadia®
    • Ceritinib Capsules (Zykadia®)


    Consultant Medical Oncologist use only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    10.01.03 Certolizumab Pegol  Consultant Rheumatologist use only.
  • Supported for use in line with NICE TA186: Rheumatoid arthritis (February 2010)
  • Available as a treatment option for treating active psoriatic arthritis after inadequate response to DMARDs (NICE TA445)
  • 03.04.01 Cetirizine  Cetirizine sugar free Solution
    Cetirizine Tablets
    08.01.05 Cetuximab Erbitux®
    • Cetuximab Infusion

    Available via NHSE. See the link below for further information.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    04.01.01 Chloral Hydrate 
    • Chloral Hydrate Solution (500mg/5ml strength kept at ANHSFT)

    For specialist use only
    Take care - other strengths available

    08.01.01 Chlorambucil 
  • Chlorambucil Tablets

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 05.01.07 Chloramphenicol  Red Traffic Light Chloramphenicol Capsules
  • Consultant microbiologist recommendation only.
    Red Traffic Light Chloramphenicol Injection
  • Item not stocked in pharmacy but can be obtained on request
  • 11.03.01 Chloramphenicol  Brochlor®, Chloromycetin®
    • Chloramphenicol 0.5% Eye Drops (preservative free)
    • Chloramphenicol 1% Eye Ointment (with preservative)
    • Chloramphenicol 0.5% Minims (preservative free)

      Chloramphenicol has a broad spectrum of activity and is the drug of choice for superficial eye infections. Chloramphenicol eye drops are well tolerated and the recommendation that chloramphenicol eye drops should be avoided because of an increased risk of aplastic anaemia is not well founded.
    12.01.01 Chloramphenicol 
    • Chloramphenicol 5% Ear Drops
    04.01.02 Chlordiazepoxide Hydrochloride 
    • Chlordiazepoxide Capsules
    13.11.02 Chlorhexidine Hibi® Hibi liquid hand rub
    (Chlorhexidine gluconate 0.5% in isopropyl alcohol 70%)
    13.11.02 Chlorhexidine acetate  Chlorhexidine acetate 0.02% Irrigation
    12.03.04 Chlorhexidine Gluconate 
    • Chlorhexidine Gluconate Mouthwash
    • Chlorhexidine Gluconate Dental Gel
    13.11.02 Chlorhexidine Gluconate 0.015% with Cetrimide 0.15% Tisept® Tisept sachets
    13.11.02 Chlorhexidine Gluconate 0.05% Unisept® Unisept sachets - approved for use in ophthalmology theatres only, for patients with an allergy to iodine.
    13.11.02 Chlorhexidine Gluconate 2% in Isopropyl Alcohol 70%  Chlorhexidine Gluconate 2% in Isopropyl Alcohol 70%

    Restricted for Skipton Renal Unit Only.
    12.02.03 Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin®
    • Chlorhexidine Hydrochloride 0.1%, Neomycin Sulphate 0.5% Nasal Cream
    15.02 Chloroprocaine injection 
    • Chloroprocaine 10mg/mL injection

    Approved as an alternative to prilocaine for spinal anaesthesia in day case surgical procedures lasting less than 40 minutes (Anaesthetist use only)

    05.04.01 Chloroquine 
  • Chloroquine Syrup
  • Chloroquine Tablets

    Malaria prophylaxis is available Over the Counter or on Private Prescription. See links above for travel websites.
  • 02.02.01 Chlorothiazide 
    • Chlorothiazide Suspension
    03.04.01 Chlorphenamine Maleate Piriton®

    Green Traffic Light Chlorphenamine Tablets
    Chlorphenamine Syrup
     
    Green Traffic LightChlorphenamine injection

    04.02.01 Chlorpromazine 
    • Chlorpromazine Tablets
    • Chlorpromazine Syrup
    • Red Chlorpromazine Injection

    Restricted to Consultant Psychiatrist only 

    12.03.01 Choline Salicylate Bonjela® Adult
    • Choline Salicylate Oral Gel

    For patients over 16 years only.

    06.05.01 Chorionic Gonadotrophin Pregnyl®
    03.02 Ciclesonide Alvesco® Ciclesonide inhaler
  • Metered dose inhaler
  • Licensed for asthma
  • Restricted to patients who develop oropharyngeal thrush with other inhaled corticosteroids
  • 08.02.02 Ciclosporin 
  • Ciclosporin Capsules
  • Ciclosporin Oral Solution
  • 10.01.03 Ciclosporin  Restricted for use within agreed protocols under the supervision of appropriate specialists.
  • Ciclosporin Capsules
  • Ciclosporin liquid
    Please prescribe by the brand name
  • 11.99.99.99 Ciclosporin 0.1% Ikervis®
    • Ciclosporin 0.1% Eye Drops 

    For consultant ophthalmologist initiation and monitoring in line with NICE TA369.

    20 CICLOSPORIN eye drops 2% pf 10ml 
    01.03.01 Cimetidine 
  • Cimetidine Tablets

    For existing patients only or where Ranitidine is not suitable
  • 06.06.01 Cinacalcet Mimpara® Consultant Endocrinologist initiation only, for the treatment of hyperparathyroidism in patients unsuitable for surgery.
    09.05.01.02 Cinacalcet 
    • Cinacalcet

    For Hypercalcaemia of primary hyperparathyroidism or parathyroid carcinoma

    04.06 Cinnarizine Stugeron®
    • Cinnarizine Tabets
    02.12 Ciprofibrate 
    • Ciprofibrate Tablets

    Not routinely recommended.

    Restricted to existing patients or specialist recommendation only.

    05.01.12 Ciprofloxacin  Green Traffic Light Ciprofloxacin Tablets
    Green Traffic Light Ciprofloxacin Suspension

    Green Traffic Light Ciprofloxacin infusion (Restricted)
  • Only for use in patients that cannot take oral ciprofloxacin. There is absolutely no benefit over oral formulations otherwise.
  • 11.03.01 Ciprofloxacin  Ciloxan®
    • Ciprofloxacin 0.3% Eye Drops (with preservative)

      For Consultant Ophthalmologist recommendation only.
    12.01.01 Ciprofloxacin  
    • Ciprofloxacin 0.3% Ear Drops

    Under recommendation of consultant ENT surgeon only.

    EAR drops not available, but EYE drops are acceptable to use in the ear (See BNF section 12.1.2). Usually 2-3 drops, 3-4 times daily. (unlicensed use)

    08.01.05 Cisplatin 
  • Cisplatin Infusion
  • Cisplatin Injection

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 04.03.03 Citalopram Cipramil®
    • Citalopram Tablets
    • Citalopram Oral Drops
      Note: 4 oral drops (8mg) are equivalent to a 10mg tablet
      Please prescribe the dose by number of drops rather than milligrams.
    08.01.03 Cladribine 
  • Cladribine Injection (LITAK® for subcutaneous injection))
  • Cladribine Injection (Leustat® for intravenous infusion)

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 05.01.05 Clarithromycin  Green Traffic Light Clarithromycin Tablets
    Green Traffic Light Clarithromycin Suspension
    Green Traffic Light Clarithromycin Injection in Sodium Chloride
    05.01.06 Clindamycin  Green Traffic Light Clindamycin Capsules
    Green Traffic Light Clindamycin Injection

    07.02.02 Clindamycin 

    Clindamycin Vaginal Cream

    13.06.01 Clindamycin 1% Dalacin T®

    Clindamycin 1% topical solution

    04.08.01 Clobazam 
    • Clobazam Tablets
    • Clobazam Suspension

      MHRA recommends that the need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer taking into account factors such as seizure frequency and treatment history.
    13.04 Clobetasol Propionate 0.05% Dermovate® Clobetasol 0.05% Cream (Dermovate)
    Clobetasol 0.05% Ointment (Dermovate)
    NOT TO BE USED ON THE FACE

    Take care when prescribing
    Clobetasol propionate and Clobetasone butyrate
    13.04 Clobetasone Butyrate 0.05% Eumovate®

    Clobetasone 0.05% Ointment (Eumovate)
    Clobetasone 0.05% Cream (Eumovate)

    Take care when prescribing
    Clobetasol propionate and Clobetasone butyrate

    06.05.01 Clomifene Citrate 

    For use following consultant recommendation only

    04.03.01 Clomipramine Hydrochloride 
    • Clomipramine Capsules
    • Clomipramine MR Tablets 

    Restricted to psychiatry specialist recommendation only

    04.08.01 Clonazepam 
    • Clonazepam SF Solution
    • Clonazepam Tablets

    Restricted to specialist initiation only

    Refer to the BDCT Psychotropic formulary below if recommended by psychiatry.

    MHRA recommends that the need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer taking into account factors such as seizure frequency and treatment history.

    Red Traffic Light  Clonazepam Injection

    04.08.02 Clonazepam 
    • Clonazepam Injection
    02.05.02 Clonidine Hydrochloride 

    Green Traffic Light Clonidine Tablets
    Red Traffic Light Clonidine Injection - Reserved for use in Theatres and ICU only.

    02.09 Clopidogrel 
    • Clopidogrel Tablets
    07.02.02 Clotrimazole  Clotrimazole Cream
    Clotrimazole Pessaries
    12.01.01 Clotrimazole 1%  Canesten®
    • Clotrimazole 1% Solution

    Under recommendation of consultant ENT surgeon only.

    13.10.02 Clotrimazole 1% solution 

    Clotrimazole 1% Solution in macrogol 400 (polyethylene glycol 400)

    It is particularly suitable for use on hairy skin and in fungal infections of the outer ear (otitis externa) and middle ear (otomycoses).

    13.10.02 Clotrimazole Cream  Clotrimazole 1% Cream
    04.02.01 Clozapine Clozaril®
    • Clozapine Tablets

    Restricted for Consultant Psychiatrist use only.

    • Registration needed for all patients on this treatment.
    • Service managed by BDCT. Contact 01274 363230 (Linfield Mount Pharmacy) in normal working hours for information or assistance.
    02.02.04 Co-amilofruse  
    • Co-amilofruse Tablets

    Prescribing of combination diuretics is restricted to patients in whom compliance is a problem.

    02.02.04 Co-amilozide 
    • Co-amilozide Tablets

    Prescribing of combination diuretics is restricted to patients in whom compliance is a problem.

    05.01.01.03 Co-Amoxiclav  Green Traffic Light Co-amoxiclav Tablets
    Green Traffic Light Co-amoxiclav SF Suspension
    Green Traffic Light Co-amoxiclav Injection

    Co-amoxiclav is associated with an increased risk of Clostridium difficile infection compared with other antibiotics. It should be used only in line with the antibiotics policy.
    04.09.01 Co-Beneldopa Madopar®
    • Co-beneldopa Capsules
    • Co-beneldopa MR Capsules
    • Co-beneldopa Dispersible Tablets
    04.09.01 Co-Careldopa Sinemet®
    • Co-careldopa Tablets
    • Co-careldopa MR Tablets
    04.09.01 Co-Careldopa and Entacapone Stalevo®, Stanek®
    • Stalevo Tablets

    Restricted to patients with Parkinson’s disease requiring triple therapy with levodopa, carbidopa and entacapone

    13.06.02 Co-Cyprindiol 2000/35
    (Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms)
     Dianette®
    Co-Cyprindiol 2000/35 Tablets (cyproterone acetate 2mg, ethinyloestradiol 35micrograms) (Dianette)
    13.06.02 Co-Cyprindiol 2000/35
    (Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms)
     Clairette®

    Co-Cyprindiol 2000/35 Tablets (cyproterone acetate 2mg, ethinyloestradiol 35micrograms) (Clairette)

    13.06.02 Co-Cyprindiol 2000/35
    (Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms)
     Teragezza®

    Co-Cyprindiol 2000/35 Tablets (cyproterone acetate 2mg, ethinyloestradiol 35micrograms) (Teragezza)

    01.06.02 Co-Danthramer 
  • Co-Danthramer Strong Capsules (dantron/poloxamer)
  • Co-Danthramer Suspension (dantron/poloxamer)
  • Co-Danthramer Strong Suspension (dantron/poloxamer)

    The indications for dantron are limited by its potential carcinogenicity (based on rodent carcinogenicity studies) and evidence of genotoxicity.

    It should only be used for constipation in terminally ill patients of all ages.

    Primary care cost warning: Expensive product
  • 01.06.02 Co-Danthrusate  
  • Co-Danthrusate (dantron/docusate sodium)

    The indications for dantron are limited by its potential carcinogenicity (based on rodent carcinogenicity studies) and evidence of genotoxicity.

    It should only be used for constipation in terminally ill patients of all ages.
  • 03.09.01 Codeine Linctus BP 
    01.04.02 Codeine Phosphate  
  • Codeine Phosphate Tablets (30mg)
  • 04.07.02 Codeine Phosphate 

    Green Traffic Light Codeine phosphate Tablets
    Green Traffic Light Codeine phosphate Syrup
    Red Traffic Light Codeine phosphate Injection

    10.01.04 Colchicine 
  • Colchicine Tablets
    Dosing information varies between sources. Usual prescribed dosage is as follows, and is described in the BNF:

    For the treatment of acute gout: 500 micrograms three times a day until symptoms relieved. Maximum 6mg per course. The course should not be repeated within three days

    For short-term prophylaxis when starting allopurinol therapy: 500 micrograms twice a day.

    See SPC and BNF for full prescribing information.
  • 09.06.04 Colecalciferol 
    • Colecalciferol 300,000units/1mL Injections
    09.06.04 Colecalciferol (vitamin D3)  Various
    • Colecalciferol

    25,000units/1mL solution (InVita-D3) restricted to patients with swallowing difficulties.

    Oral Drops (200units per 3 drops)

    09.06.04 Colecalciferol (vitamin D3) capsules 
    • Colecalciferol 20,000units capsules - for vitamin D deficiency.

    Colecalciferol preparations offering doses up to 1000units are available to buy over the counter. All patients should be encouraged to purchase this if appropriate.

    09.05.01.01 Colecalciferol and calcium carbonate Accrete®
    • Accrete D3 Film-coated tablets (contraindicated in patients who have a hypersensitivity to the active substances or any of the excipients (including soya or peanuts).
    • Accrete D3 One a Day Chewable tablets
    09.05.01.01 Colecalciferol and calcium carbonate Several brands

    Second choice calcium/colecalciferol preparations.

    • Calceos® (This product contains partially hydrogenated soyabean oil, therefore is contraindicated in patients who are allergic to peanuts or soya)
    • Calcium carbonate 1.25g (Calcium 500mg Ca2+12.5mmol)
    • Colecalciferol 10micrograms (400units)

     

    • Calcichew D3 Forte® chewable tablets
    • Calcium carbonate 1.25g (Calcium 500mg Ca2+12.5mmol)
    • Colecalciferol 10micrograms (400units)

     

    • Calcichew D3® chewable tablets (contains a small quantity of soya oil and is therefore contraindicated in patients who are allergic to peanuts or soya)
    • Calcium carbonate 1.25g (Calcium 500mg Ca2+12.5mmol)
    • Colecalciferol 5micrograms (200units) 

     

    • Cacit D3® sachets
    • Calcium carbonate 1.25 gram (Calcium 500mg)
    • Colecalciferol (440units)
    • Reserved for patients unable to chew or swallow tablets

     

    • Adcal D3® Caplets
    • Calcium carbonate 750mg (Calcium 300mg Ca2+)
    • Colecalciferol (Vitamin D3) 5micrograms (200units)
    • Alternative to Adcal D3 chewable tablets for patients who require a gelatin-free preparation

     

    • Adcal D3 Dissolve® effervescent tablets
    • Calcium carbonate 1.5g (Calcium 600mg Ca2+ 15.1mmol)
    • Colecalciferol (Vitamin D3) 10micrograms (400units)
    • Reserved for patients unable to chew or swallow tablets

     

    02.12 Colestyramine Questran®
    • Colestyramine Powder for Oral Suspension
    01.09.02 Colestyramine Sachets 
    05.01.07 Colistimethate sodium  

    Red

    • IV infusion

              Consultant microbiologist recommendation only

       

     Amber

    • Injection given via nebuliser

      For use under respiratory specialist recommendation only for the treatment for bronchiectasis.


       
      Due to the risk of neurotoxic and nephrotoxic side-effects to staff and other patients, nebulised colomycin must only be administered through a Side-Steam Plus device obtainable from Ward 7 stock).

      In inpatient areas, nebulisation ideally should take place in a side-room with an open window. Where another location must be used, the patient must be able to sit with the nebuliser with the door closed and the window open for the duration of the nebulisation. If administration does not occur in a side room, one hour should pass before the room is used by staff or other patients.
    10.03.01 Collagenase clostridium histolyticum injection  

    Collagenase clostridium histolyticum injection

    For Dupuytren’s contracture in-line with NICE TA459 ( Mr Knight’s use only. Prior approval may be required from CCG before use).

    13.02.01 Colloidal Oats  

    Aveeno Cream

    These are expensive and should only be used when other products have been tried.

    Please try and use the cheapest brand available.

    27.08 Coloplast aquasleeve leg bag holder extra large 65+ cm Order Code: 783708
    Pack size: 4
    Drug Tariff Price £7.86
    27.08 Coloplast aquasleeve leg bag holder large 47-64cm Order Code: 783694
    Pack size: 4
    Drug Tariff Price £8.03
    27.08 Coloplast aquasleeve leg bag holder medium 40-46cm Order Code: 783686
    Pack size: 4
    Drug Tariff Price £8.03
    27.08 Coloplast aquasleeve leg bag holder small 24-33cm Order Code: 783678
    Pack Size: 4
    Drug Tariff Price £8.03
    27.08 Coloplast aquasleeve leg bag holder standard 34-39cm Order Code: 783680
    Pack size: 4
    Drug Tariff Price £8.03
    27.12 Coloplast Conveen Security Plus Leg bags 350ml 30cm tubing non sterile Order Code: 5164
    Pack size: 10
    Drug Tariff Price £23.96
    27.12 Coloplast Conveen Security Plus Leg bags 350ml 50cm tubing non sterile Order Code: 5165
    Pack size: 10
    Drug Tariff Price £23.96
    27.12 Coloplast Conveen Security Plus Leg bags 500ml 30cm tubing non sterile Order Code: 5160
    Pack size: 10
    Drug Tariff Price £23.96
    27.12 Coloplast Conveen Security Plus Leg bags  Order Code: 5161
    Pack size: 10
    Drug Tariff Price £23.96
    27.02 Coloplast Folysil  Standard length only (long term catheter 12 weeks)
    Gauge/Ch size 12-16
    Order Code: AA8C
    Drug Tariff Price £6.19
    27.01 Coloplast Folysil silicone  Gauge/Ch size 12-16
    Order Code: AA8A
    Drug Tariff Price £6.02
    27.01 Coloplast Folysil silicone  Gauge/Ch size 12-16
    Order Code: AA8B
    Drug Tariff Price £6.02
    06.04.01.01 Combined continuous HRT tablet 

    Bleed free HRT use if:

    • amenorrhoeic >1yr
    • >54 years of age
    • >3yrs on sequential HRT
       
    06.04.01.01 Combined continuous transdermal HRT 

    Bleed free HRT use if:

    • amenorrhoeic >1yr
    • >54 years of age
    • >3yrs on sequential HRT
       
    06.04.01.01 Combined cyclical HRT tablet 

    For patients with:

    • Intact uterus
    • Peri-menopausal - under 1 year or amenorrhoea
       
    06.04.01.01 Combined cyclical transdermal HRT 

    For patients with:

    • Intact uterus
    • Peri-menopausal - under 1 year or amenorrhoea
       
    07.03.01 Combined Hormonal Contraceptives Femodene®, Millinette 20®, Millinette 30®, Femodette® Ethinylestradiol/gestodene
    Millinette® is the preferred brand for prescribing in primary care
    07.03.01 Combined Hormonal Contraceptives Microgynon®, Rigevidon® Ethinylestradiol/levonorgestrel
    Rigevidon® is the preferred brand for prescribing in primary care
    07.03.01 Combined Hormonal Contraceptives Loestrin 20®, Loestrin 30® Ethinylestradiol/Norethisterone
    07.03.01 Combined Hormonal Contraceptives Evra® Evra Transdermal patches
    07.03.01 Combined Hormonal Contraceptives Logynon®, Triregol® Ethinylestradiol/levonorgestrel
    Triregol® is the preferred brand for prescribing in primary care
    07.03.01 Combined Hormonal Contraceptives Norimin® Ethinylestradiol/noresthisterone
    07.03.01 Combined Hormonal Contraceptives Cilest® Ethinylestradiol/norgestimate
    07.03.01 Combined Hormonal Contraceptives Marvelon®, Mercilon®, Gedarel® Ethinylestradiol/desogestrel
    Gedarel® is the preferred brand for prescribing in primary care
    07.03.01 Combined Hormonal Contraceptives Yasmin®, Lucette® Ethinylestradiol/drospirenone
    Lucette® is the preferred brand for prescribing in primary care
    07.03.01 Combined Hormonal Contraceptives Levest® Ethinylestradiol/Levonorgestrel
    05.03.01 Combivir  Combivir Tablets

    Reserved for patients as part of a HIV treatment plan under a HIV specialist consultant
    or
    Used for the purposes of HIV Post-Exposure Prophylaxis (PEP), in accordance with the local protocol
    A2.02.02.03 Complan® Shake   Equivalent product for prescribing in community only
  • Complan Shake sachet – add 200 ml full fat milk
  • Aymes Shake sachet – add 200 ml full fat milk
  • 09.02.02.01 Compound Sodium Lactate Intravenous Infusion 

    tolterodin 2 mg

    tolterodin pfizer 4mg tolterodinhandko.website tolterodin pfizer 4mg
    • Sodium Lactate Compound Infusion (500mL, 1L)
    13.02.02 Conotrane® 

    Conotrane Cream

    Barrier cream containing at least 10% dimeticone. Skin protection against incontinence.

    07.04.02 Contiform vaginal pessary 

    Contiform vaginal pessary

    For occasional use during exercise in women with stress urinary incontinence.

    To be initiated and starter pack to be supplied by specialist woman's health physiotherapist. Further supplies to be provide by GP.

    27.12 Conveen Activa bag 250ml  Order Code: 25501
    Pack size: 10
    Drug Tariff Price £26.46
    27.12 Conveen Optima latex free self-adhesive sheath standard length 40mm Order Code: 22040
    Pack size: 30
    Drug Tariff Price £49.32
    27.12 Conveen Optima latex free self-adhesive sheath shorter length 35mm Order Code: 22135
    Pack size: 30
    Drug Tariff Price £49.32
    27.12 Conveen Optima latex free self-adhesive sheath standard length 35mm Order Code: 22035
    Pack size: 30
    Drug Tariff Price £49.32
    27.12 Conveen Optima latex free self-adhesive sheath shorter length 25mm Order Code: 22125
    Pack size: 30
    Drug Tariff Price £49.32
    27.12 Conveen Optima latex free self-adhesive sheath standard length 30mm Order Code: 22030
    Pack size: 30
    Drug Tariff Price £49.32
    27.12 Conveen Optima latex free self-adhesive sheath shorter length 30mm Order Code: 22130
    Pack size: 30
    Drug Tariff Price £49.32
    27.12 Conveen Optima latex free self-adhesive sheath standard length 25mm Order Code: 22025
    Pack size: 30
    Drug Tariff Price £49.32
    27.12 Conveen Optima latex free self-adhesive sheath shorter length 21mm Order Code: 22121
    Pack size: 30
    Drug Tariff Price £49.32
    27.13 Conveen prep wipes  used prior to applying sheaths to add adhesion Order Code: 62042
    Pack size: 54
    Drug Tariff Price £10.13
    01.04.02 Co-Phenotrope Lomotil®
    •  Co-Phenotrope

    Available from Specialist Manufacturers Only

    05.01.08 Co-trimoxazole  Green Traffic Light Co-trimoxazole Tablets
    Green Traffic Light Co-trimoxazole Syrup
  • Reserved for prophylaxis and treatment of Pneumocystis carnii Pneumonia (PCP) and prophylaxis of spontaneous bacterial peritonitis

    Green Traffic Light Co-trimoxazole Injection
  • Reserved for prophylaxis and treatment of Pneumocystis carnii Pneumonia (PCP).
  • NB: This product has a short expiry once reconstituted.

  • 08.01.05 Crizotinib Xalkori®
    • Crizotinib Capsules (Xalkori®)
       


    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    13.03 Crotamiton Eurax® Crotamiton 10% Cream (Eurax)
    Crotamiton 10% Lotion (Eurax)
    04.06 Cyclizine Valoid®
    • Cyclizine Tablets
    • Cyclizine Injection
    • Cyclizine Liquid (unlicensed medicine)
    11.05 Cyclopentolate Hydrochloride Mydrilate®
    • Cyclopentolate 1% Eye Drops (with preservative)
    • Cyclopentolate 1% Minims (preservative free)
    • Cyclopentolate 0.5% Minims (preservative free)
      For use in patients where a preservative free product is necessary or an individual dose is required
    08.01.01 Cyclophosphamide 
  • Cyclophosphamide Suspension
  • Cyclophosphamide injection
  • Cyclophosphamide Tablets
  • Cyclophosphamide Infusion

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 10.01.03 Cyclophosphamide  Restricted for use within agreed protocols under the supervision of appropriate specialists.
    03.04.01 Cyproheptadine Periactin®

    Cyproheptadine Tablets
     

    Used as an antidote to Serotonin syndrome. Kept in Accident and Emergency.

    06.04.02 Cyproterone Acetate 
    08.03.04.02 Cyproterone Acetate 
  • Cyproterone Tablets

  • 08.01.03 Cytarabine 
  • Cytarabine Injection

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 02.08.02 Dabigatran etexilate Pradaxa®
    • Dabigatran etexilate Capsules

    Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) who meet the criteria of the West Yorkshire Cardiac Network. Use in-line with NICE.
     

    Treatment and secondary prevention of DVT and PE in-line with NICE.

    08.01.05 Dacarbazine 
  • Dacarbazine Injection
  • Dacarbazine Infusion

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 05.03.03.02 Daclatasvir Daklinza®
  • Daclatasvir (Daklinza®)

    For the treatment of hepatitis C in line with NICE TA364. Use restricted to Consultant Gastroenterologists only.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 08.01.05 Dacomitinib Vizimpro®
    • Dacomitinib Tablets

     

    Consultant Oncology use only

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    06.07.02 Danazol  Consultant recommendation only
    10.02.02 Dantrolene Sodium 
    15.01.08 Dantrolene Sodium 
  • Dantrolene Injection

  • Malignant hypothermia.
  • All stock is kept in theatre. If additional stock is required, obtain from Bradford Royal Infirmary - in line with our arrangement for shared stock holding.
  • In normal working hours, contact BRI Pharmacy stores on 01274 364243
  • Out of hours, follow Stores SOP 7013 - Obtraining an item urgently, which has the necessary contact details.
  • 06.01.02.03 Dapagliflozin  Forxiga® For use by the diabetic team as dual therapy for the treatment of type 2 diabetes in-line with NICE TA288,TA390 and TA418.
    05.01.10 Dapsone  Dapsone Tablets

  • For second-line prophylaxis of Pneumocystis pneumonia (PCP), in patients who are unable to take co-trimoxazole.
  • Specialist recommendation only
  • 05.01.07 Daptomycin 
  • Daptomycin Injection

    Restricted for prescribing by Consultant Microbiologist or for the use by the Airedale Collaborative Care team in the treatment of outpatients with penicillin allergy for cellulitis
  • 08.01.05 Daratumumab infusion   Darzalex®
    • Daratumumab infusion (Darzalex®)

    Consultant Haematologist use only. 

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    09.01.03 Darbepoetin alfa Aranesp®
    • Darbepoetin alfa

    For renal patients at Skipton Renal Unit
    For treating anaemia in patients undergoing chemotherapy
    By subcutaneous or intravenous injection.

    05.03.03.02 Dasabuvir Exviera®
  • Dasabuvir (Exviera®)

    For the treatment of hepatitis C in line with NICE TA365. Use restricted to Consultant Gastroenterologists only.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 08.01.05 Dasatinib Sprycel®
    • Dasatinib Tablets

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    09.01.03 Deferasirox Exjade®
    • Desferasirox

    Supported for treatment of chronic iron overload. Haematology use only.

    Oral iron chelator, is licensed for treatment of iron overload in patients with thalassaemia major in whom desferrioxamine is contra-indicated or is not tolerated.

    09.01.03 Deferiprone 
    • Deferiprone

    Oral iron chelator, is licensed for treatment of iron overload in patients with thalassaemia major in whom desferrioxamine is contra-indicated or is not tolerated.

    08.03.04.02 Degarelix Injection 
    • Degarelix Subcutaneous Injection

      Treatment is to be initiated by a Consultant Urologist and the loading dose (120mg) provided by the Trust. Subsequent maintenances doses (80mg) are to be provided by the patient’s GP.
       
    06.05.02 Demeclocycline 

    For the treatment of hyponatraemia resulting from inappropriate secretion of antidiuretic hormone. Consultant endocrinologist initiation only.

    05.01.03 Demeclocycline Hydrochloride 
  • Demeclocycline Capsules

    Reserved for treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
  • 06.06.02 Denosumab Xgeva®, Prolia® Red Traffic Light Denosumab Injection 120mg (Xgeva®)
  • Supported for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with bone metastases from solid tumours (excluding prostate) in line with NICE TA265.

    Amber Traffic Light Denosumab 60mg pre-filled syringe (Prolia®)
  • Supported for the treatment of postmenopausal osteoporosis in women at risk of fracture who are unable to tolerate oral bisphosphonates or comply with their specific dosage instructions, in line with NICE TA204.
  • Its use should be recommended by a secondary care physician experienced in the use of this drug with appropriate guidance on monitoring and duration of use. The treatment can then be started in primary care using the Shared Care Guideline.
  • 09.01.03 Desferrioxamine mesilate 
    • Desferrioxamine
    15.01.02 Desflurane (240mL)  For the maintenance of anaesthesia in obese or elderly, confused patients by anaesthetists trained in low-flow technique.
    06.05.02 Desmopressin 
    • Desmopressin Nasal Spray
    • Desmopressin Injection Red
    • Desmopressin S/L Tablets
    • Desmopressin Tablets

    Amber Diabetes insipidus

    Green Nocturnal enuresis                          

     

    07.03.02.01 Desogestrel Cerazette®, Cerelle

    Desogestrel Tablets 

    04.06 Dexamethasone   Green Traffic Light Dexamethasone tablets
    Green Traffic Light Dexamethasone soluble tablets
    Red Traffic Light Dexamethasone (as sodium phosphate)injection
    Note: the dose is expressed in mg of dexamethasone base.

    Restricted to use by Consultant Haematologist and Oncologists for prevention of nausea and vomiting induced by highly emetogenic chemotherapy
    06.03.02 Dexamethasone 

    Green Traffic Light  Oral preparations

    • Dexamethasone Tablets
    • Dexamethasone SF Solution
    • Dexamethasone soluble tablets 

    Green Traffic Light  Injectable preparations

    • Injectable preparations for palliative care only in Primary Care


      Red Injectable preparations

    • Dexamethasone (base 3.3mg/1mL injection - as sodium phosphate). Ensure the dose is always prescribed as dexamethasone base.

     

    11.04.01 Dexamethasone Maxidex®, Dropodex®
    • Dexamethasone 0.1% Eye Drops (with preservative)
      Ensure Maxidex® brand is prescribed in primary care.

      Restricted Item Dexamethasone 0.1% Minims® (preservative free)
      For use in patients requiring a preservative free product only
    11.04.01 Dexamethasone  Ozurdex®
    • Dexamethasone Intravitreal Implant

    Supported for specialist use only in line with  NICE TA229 (macular oedema secondary to retinal vein occlusion)and TA349 (diabetic macular oedema).

    11.04.01 Dexamethasone with Neomycin and Polymyxin B sulphate Maxitrol®
    • Maxitrol Eye Drops (with preservative)
      (dexamethasone 0.1%, hypromellose 0.5%, neomycin sulphate 0.35%, polymyxin B sulphate 6000units/ml)
    • Maxitrol Eye ointment (with preservative)
      (dexamethasone 0.1%, neomycin sulphate 0.35%, polymyxin B sulphate 6000units/ml)
    12.01.01 Dexamethasone, Framycetin Sulphate and Gramicidin Sofradex®
    • Dexamethasone (Sodium Metasulphobenzoate) 0.05%, Framycetin Sulphate 0.5%, Gramicidin 0.005% Ear/Eye Drops
    12.01.01 Dexamethasone, Neomycin and Glacial Acetic Acid Otomize®
    • Dexamethasone 0.1%, Neomycin Sulphate 3250units/ml, Glacial Acetic acid 2% Ear Spray
    04.04 Dexamfetamine Amfexa®
    • Dexamfetamine Tablets
    • Dexamfetamine Oral Solution

     Restricted to Consultant Psychiatrist and Paediatrician initiation only.

    For use in line with NICE NG87: Attention deficit hyperactivity disorder: diagnosis and management (March 2018) - See link at the bottom of the section.

    04.01.01 Dexmedetomidine Dexdor®
    • Dexmedetomidine Injection

    Approved for “off-licence” nasal or buccal administration for sedative pre-medication in children

    Approved for sedation of adult patients on ICU requiring a sedation level of RASS 0 to -3

    Consultant Anaesthetist use only

    A2.02 Dextrose Monohydrate Powder 
    04.07.02 Diamorphine 
    • Diamorphine Injection 5mg

     Use restricted to:

    • A&E (intranasal use only in children)
    • Labour ward (obstetric use)
    • Theatre & Recovery - For IT/ IV/ epidural use, mainly for obstetric cases 

    Higher strength preparations restricted to use in pharmacy aseptics only.

    04.01.02 Diazepam 
    • Diazepam Tablets
    • Diazepam Solution
    04.08.02 Diazepam  Green Traffic Light Diazepam Rectal Tubes
    Red Traffic Light Diazepam Emulsion Injection
    Red Traffic Light Diazepam Injection
    10.01.01 Diclofenac Sodium 

    Maximum total daily dose 150mg
     
    Diclofenac Sodium E/C Tablets

    • Restricted within ANHSFT for use in maternity patients post caesarian section only

    Diclofenac sodium injection

    • Restricted for use when a NSAID is required and the oral / rectal route is unavailable /unsuitable. 

    Diclofenac Sodium Suppositories

    • Restricted to patients who are unable to take oral medicines or in whom oral medication is inappropriate.
       

    Diclofenac Sodium dispersible Tablets

    • Expensive product. Reserved for use in patients with:
      a. nasogastric tubes
      b. paediatric patients who are unable to swallow tablets and in whom ibuprofen syrup is unsuitable.
    11.08.02 Diclofenac Sodium  Voltarol®
    • Diclofenac Sodium 0.1% Eye Drops (with preservative)
    • Diclofenac Sodium 0.1% Single Dose Eye Drops (preservative free)

      For use following consultant recommendation only
    10.03.02 Diclofenac Sodium Gel 
  • Ibuprofen is first choice NSAID gel
  • Diclofenac 1% gel is a second line choice where Ibuprofen gel is unsuitable or for existing patients.
  • 05.03.01 Didanosine 
  • Didanosine E/C Capsules
  • Didanosine Tablets

    Reserved for patients as part of a HIV treatment plan under a HIV specialist consultant
  • 08.03.01 Diethylstilbestrol Stilboestrol®
  • Diethylstilbestrol Tablets

    For the treatment of prostate cancer under the recommendation of Consultant Oncologist.
  • 02.01.01 Digoxin 

    Green Traffic Light Digoxin Tablets
    Green Traffic Light Digoxin Elixir
    Green Traffic Light Digoxin Injection

     

    Please note: there is a difference in bioavailability between the tablets and elixir.

    02.01.01 Digoxin specific antibody fragments 40mg Digifab®
    • For the treatment of digoxin toxicity. All stock is in A&E. Further stock can be obtained from BRI. Consult Toxbase or Poisons Centre in Newcastle for further information if required.

      National Poisons Information Centre: 0344 892 0111
    04.07.02 Dihydrocodeine 

    Green Traffic Light Dihydrocodeine Solution
    Green Traffic Light Dihydrocodeine Tablets
    Green Traffic Light Dihydrocodeine MR Tablets  
    Red Traffic Light Dihydrocodeine Injection

    01.07.04 Diltiazem  Anoheal®
    • Diltiazem Cream 2%

      For patients with chronic anal fissures unresponsive to topical nitrates - Unlicensed indication
    02.06.02 Diltiazem 
    • Diltiazem MR Capsules
    • Diltiazem MR Tablets

    Please ensure the brand is specified on the prescription.

    When prescribing long acting diltiazem for a new patient, please use either Diltiazem LA 180mg, 240mg or 300mg.
    This allows the pharmacy to dispense the brand of diltiazem, which is cost-effective across primary and secondary care.

    Patients who are admitted who are already taking LA diltiazem should be maintained on their current brand unless the dose is changed for other reasons.

    Please note: Diliazem XL should only be prescribed once daily.

    18 Dimercaprol (BAL)  Used in the management of poisoning with arsenic.
    18 Dimercaprol 100mg/2mL injections  Used in the management of poisoning with heavy metals.
    08.02.04 Dimethyl fumarate Tecfidera®
    • Dimethyl fumarate Capsules

      Available in line with NICE TA320 at the following specialist centres:
      Leeds Teaching Hospital Trust, Sheffield Teaching Hospital, Hull and East Yorkshire, York and Mid Yorks Trusts.
    13.10.04 Dimeticone Hedrin®

    Dimeticone 4% Lotion

    To be purchased by the patient over the counter from pharmacies where possible.

    07.01.01 Dinoprostone Propess®

    Dinoprostone Vaginal Delivery System

    07.01.01 Dinoprostone Prostin E2®

    Dinoprostone Vaginal Gel

    13.02.01 Diprobase®  Diprobase Cream

    Diprobase Ointment
    02.09 Dipyridamole 
    • Dipyridamole SF Suspension
    • Dipyridamole Tablets
    • Dipyridamole MR Capsules

      Supported for use in-line with NICE TA210
    02.09 Dipyridamole and Aspirin Asasantin® Retard
    • Asasantin® Retard MR Capsules

    Supported for use in-line with NICE TA210.

    Where patients require aspirin and dipyridamole modified release the combination product Asasantin® is the most economical.

    08.01 Disodium Folinate 
  • Disodium Folinate Injection

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 06.06.02 Disodium Pamidronate 
    02.03.02 Disopyramide 

    Green Traffic Light Disopyramide Capsules
    Red Traffic Light Disopyramide Injection: Restricted to consultant cardiologist use only.

    07.04.01 Distigmine Bromide Ubretid® Specialist drug
    04.10.01 Disulfiram Antabuse®
    • Disulfiram Tablets

    Restricted to Specialist Alcohol Services recommendation only

    18 DMPS (unithiol) capsules  Used in the management of poisoning with heavy metals.
    18 DMPS (unithiol) injection  Used in the management of poisoning with heavy metals.
    18 DMSA (succimer) capsules  Used in the management of poisoning with heavy metals.
    02.07.01 Dobutamine 
    • Dobutamine Infusion
    08.01.05 Docetaxel 
    • Docetaxel Injection


    01.06.02 Docusate Sodium 
  • Docusate Sodium Capsules
  • Docusate Sodium SF Solution
  • Docusate Sodium Micro Enema
  • 04.06 Domperidone Motilium®
    • Domperidone Tablets
    • Domperidone SF Suspension

     
    Domperidone should be used at the lowest effective dose for short-term use (less than one week)

    04.11 Donepezil Aricept®
    • Donepezil Tablets
    • Donepezil Orodispersible Tablets
       

    For the treatment of moderate Alzheimer’s disease.

    Restricted to Consultant Psychiatrist and Department of Elderly Medicine Physician recommendation only.

    For use in-line with NICE TA217 (June 2018).

    02.07.01 Dopamine 
    • Dopamine Infusion
    02.07.01 Dopexamine 
    • Dopexamine Injection

    Reserved for Consultant Anaesthetists use on ICU.

    11.06 Dorzolomide 
    • Dorzolamide Unit Dose Eye Drops 2% (preservative free)

      For use following consultant recommendation only
    11.06 Dorzolomide 2% with Timolol 0.5% Cosopt®
    • Dorzolamide hydrochloride 2%, timolol 0.5% (with preservative)
    • Dorzolamide hydrochloride 2%, timolol 0.5% (without preservative)

      For use following consultant recommendation only
    03.05.01 Doxapram Hydrochloride 
    02.05.04 Doxazosin 
    • First Choice
      Doxazosin Tablets

    • Restricted Choice
      Black 
      Modified release doxazosin offers no additional clinical benefit, and is significantly more expensive than standard release preparations.

              Not for routine prescribing in primary care in-line with NHSE recommendation (2017).

     

    04.03.01 Doxepin 
    • Doxepin Capsules

    Restricted to psychiatry specialist recommendation only

    08.01.02 Doxorubicin Hydrochloride 
    • Doxorubicin Injection
    • Doxorubicin Liposomal Injection
       
    05.01.03 Doxycycline  Green Traffic Light Doxycycline Capsules
    Green Traffic Light Doxycycline Dispersible Tablets
  • Doxycycline dispersible tablets are considerably more expensive than capsules

    Green Traffic Light Doxycycline Injection (Restricted)
  • Use supported for the treatment of malignant pleural effusions by Respiratory Consultant.
  • 04.06 Doxylamine with pyridoxine 
    • Doxylamine with Pyridoxine gastro-resistant Tablets
    13.02.02 Drapolene® 

    Drapolene Cream

    02.11 Dried Prothrombin Complex Octaplex®
    • Dried Prothrombin Complex

    All stock located in and supplied by the Pathology Department.

    02.03.02 Dronedarone 
    • Dronedarone Tablets

    Reserved for Consultant Cardiologist use only for patients with paroxysmal AF in whom first-line agents have been ineffective or not tolerated, in line with NICE TA197.

    04.06 Droperidol Xomolix®
    • Droperidol Injection 

    Restricted to Consultant Anaesthetist use only for the prevention and treatment of PONV in adult patients in whom other IV antiemetics are ineffective or contraindicated.

    06.01.02.03 Dulaglutide  Trulicity®
  • Supported for the treatment of type 2 diabetes as an alternative to exenatide LA for patients already established on a daily GLP-1 agonist who would benefit from once-weekly dosing and who are unable to receive treatment with exenatide LA
  • Specialist initiation only
  • 04.03.04 Duloxetine Cymbalta®
    • Duloxetine Capsules. Cymbalta brand only 

    Restricted to Psychiatry Specialist recommendation only

    04.07.03 Duloxetine Cymbalta®
    • Duloxetine Capsules

    For the treatment of neuropathic pain.

    07.04.02 Duloxetine Yentreve®

    Duloxetine capsules (20mg, 40mg) (Yentreve®)

    Consultant Urologist / Gynaecologist use only for stress urinary incontinence as an alternative to surgical treatment.

    A2.04.01.02 Duocal® Super Soluble   To be used on the recommendation of a dietitian only
    13.05.03 Dupilumab Dupixent®
    • Dupilumab Injection

    Available at specialist tertiary centres

    08.01.05 Durvalumab 
    • Durvalumab Infusion

    Supported for treatment of locally advanced non small-cell lung cancer after platinum-based chemo radiation in-line with NICE TA578.

    Consultant oncologist use only.

    06.04.02 Dutasteride 

    Specialist recommendation use only for patients intolerant of alfa blockers who require a fast onset of action and who are unsuitable for surgery

    13.02.01 E45®  E45 Cream
    09.01.03 Eculizumab Injection Soliris®
    • Eculizumab

    Specialist Treatment Centre Only

    02.08.02 Edoxaban Lixiana®
    • Edoxaban Tablets

    Preventing stoke and systemic embolism in people with non-valvular atrial fibrillation in-line with NICE.
     

    Treating and preventing deep vein thrombosis and pulmonary embolism in-line with NICE.

    10.02.01 Edrophonium Chloride  Neurologist use only
  • Unlicensed product - to be purchased at the request of a consultant neurologist.
  • 05.03.01 Efavirenz  Efavirenz Capsules (200mg)

    Reserved for patients as part of a HIV treatment plan under a HIV specialist consultant
    05.03.03.02 Elbasvir-grazoprevir Zepatier® For the treatment of hepatitis C in line with NICE TA413. Use restricted to Consultant Gastroenterologists only.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
    A2.01.01.02 Elemental 028® Extra 
    09.01.04 Eltrombopag Revolade®
    • Eltrombopag

    Treatment option for chronic immune (idiopathic) thrombocytopenic purpura in-line with NICE TA293. Consultant haematologist use only.

    01.04.02 Eluxadoline Truberzi
    • Eluxadoline film-coated Capsules
      Approved for treating irritable bowel syndrome with diarrhoea in-line with NICE TA471.Consultant Gastroenterologist initiation only.
    13.02.01.01 Emollient Bath Additive Infacare® Infacare Liquid

    For ward 14 only
    13.02.01.01 Emollient Bath Additive Aveeno® Aveeno Bath Oil

    These are expensive and should only be used when other products have been tried
    13.02.01.01 Emollient Bath Additive Oilatum® Oilatum Emollient
    13.02.01 Emollient preparation Epaderm® Epaderm ointment
    Epaderm cream

    These preparations are expensive and should only be used when other products have been tried
    13.02.01 Emollient preparation cream Zerobase® Zerobase Cream

    Zerobase should be used as an equivalent, more economical, alternative to Diprobase in new patients. If patients come in on Diprobase they can continue on it.

    Excipients include cetosteryl alcohol, chlorocresol
    13.02.01 Emollient preparation cream Zerocream® Zerocream Cream

    Zerocream should be used as an equivalent, more economical, alternative to E45 cream in new patients. If patients come in on E45 cream they can continue on it.
    06.01.02.03 Empagliflozin Jardiance® For the treatment of type two diabetes in-line with NICE TA336. Use restricted to Specialist initiation only.
    13.02.01 Emulsifying Ointment BP  Emulsifying Ointment BP
    02.05.05.01 Enalapril  
    • Enalapril Tablets
    A2.03.01 Enfamil AR Powder 
    04.09.01 Entacapone Comtess®
    • Entacapone Tablets 200mg

    Restricted to consultant neurologist or care of the elderly physician initiation only

    05.03.03.01 Entecavir Baraclude® For the treatment of Hepatitis B in line with NICE TA153.
    08.03.04.02 Enzalutamide Xtandi®
    • Enzalutamide Capsules (Xtandi®) 

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    02.07.02 Ephedrine 
    • Ephedrine Injection
    12.02.02 Ephedrine Hydrochloride 
    • Ephedrine Hydrochloride Nasal Drops
    08.01.02 Epirubicin hydrochloride 
  • Epirubicin Injection

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 02.02.03 Eplerenone 
    • Eplerenone Tablets

    Eplerenone is reserved for patients who develop intolerable gynaecomastia with spironolactone under recommendation of Consultant Cardiologists only.

    09.01.03 Epoetin alfa Eprex®
    • Epoetin alfa

    For the treatment of anaemia in patients undergoing chemotherapy.

    Not routinely used for the treatment of anaemia prior to surgery, except in the following circumstances in line with NICE CG24 - Blood Transfusion:

    • The patient meets the criteria to receive a blood transfusion, but declines it because of religious beliefs or other reasons.
    • The appropriate blood type is not available because of the patient's red cell antibodies.

    Administered by subcutaneous or intravenous injection.

    Subcutaneous injection of Eprex is contra-indicated in patient with chronic renal failure


     

    09.01.03 Epoetin beta NeoRecormon®
    • Epoetin beta

    By subcutaneous or intravenous injection.
    For treating anaemia in patients undergoing chemotherapy By subcutaneous or intravenous injection.

    02.08.01 Epoprostenol Flolan®
    • Epoprostenol Infusion
    02.05.05.02 Eprosartan 
    • Eprosartan Tablets

    Reserved for existing patients only.

    09.06.04 Ergocalciferol Injection 
    • Ergocalciferol 300,000unit/1mL Injection
    07.01.01 Ergometrine Maleate 

    Ergometrine Injection

    07.01.01 Ergometrine Maleate and Oxytocin Syntometrine®

    Syntometrine Injection

    08.01.05 Eribulin   Halaven®
    • Eribulin Solution for Injection


    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    08.01.05 Erlotinib 
    • Erlotinib Tablets


    06.01.02.03 Ertugliflozin Steglatro®
    • Ertugliflozin Tablets 

    For as monotherapy or in combination with metformin treatment of Type 2 diabetes in-line with NICE TA572.

    05.01.05 Erythromycin  Green Traffic Light Erythromycin Tablets
    Green Traffic Light Erythromycin Ethyl Succinate SF Suspension

    Green Traffic Light Erythromycin Lactobionate Injection (Restricted)
  • Reserved for aseptic unit only. Reserved for use as prokinetic agent in patients who are unable to take oral medication.
  • 04.03.03 Escitalopram Cipralex®
    • Escitalopram Tablets
    • Escitalopram Oral Solution
    01.03.05 Esomeprazole Nexium® Reserved for Consultant Gastroenterologist initiation for severe oesophagitis (grade C and D) and for patients who have had limited response to 1st line omeprazole and lansoprazole despite maximum dose.
    07.02.01 Estradiol 

    Estradiol Vaginal Tablets

    07.02.01 Estriol  Estriol vaginal cream
    10.01.03 Etanercept  Consultant Rheumatologist use only.
    Supported for use in-line with:
  • NICE TA143: Ankylosing spondylitis (May 2008)
  • NICE TA199: Psoriatic arthritis (August 2010)

    Etanercept for treating juvenile idiopathic arthritis (in line with NICE TA373) and plaque psoriasis in children and young people (NICE TA455) is used at specialist centres only.
  • 06.06.01 Etelcalcetide Parsabiv® For the treatment of secondary hyperparathyroidism in adults with chronic kidney disease, on haemodialysis in line with NICE TA448 (June 2017).
  • Etelcalcetide is available via referral to specialist centres only.
  • 05.01.09 Ethambutol  
  • Ethambutol Tablets
  • 08.03.01 Ethinylestradiol 
  • Ethinylestradiol Tablets

    For the treatment of prostate cancer under the recommendation of Consultant Oncologist.
  • 04.08.01 Ethosuximide 
  • Ethosuximide Capsules
  • Ethosuximide Syrup

    It is usually unnecessary to ensure that patients are maintained on a specific manufacturer’s product unless there are specific concerns such as patient anxiety, and risk of confusion or dosing errors.
  • 15.02 Ethyl Chloride Cryogesic® Spray
    15.01.01 Etomidate injection 
  • Etomidate Injection
  • 07.03.02.02 Etonorgestrel Nexplanon®

    Etonogestrel Implant (Nexplanon)

    Routinely given by appropriately trained GP's.

    08.01.04 Etoposide 
  • Etoposide Capsules
  • Etoposide Injection
  • Etoposide Infusion

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 10.01.01 Etoricoxib 
  • Etoricoxib Capsules
    For patients at a particularly high risk of developing gastrodoudenal ulceration or bleeding and after assessing their cardiovascular risk (see CSM advice above).
  • 08.01.05 Everolimus Afinitor®
    • Everolimus Tablets (Afinitor®)

      Blueteq® registration and approval for use is required for this product before it may be dispensed.
    02.12 Evolocumab Repatha®
    • Evolocumab Subcutaneous Injection

    Approved in-line with NICE TA394 for treating primary hypercholesterolaemia and mixed dyslipidaemia as an adjunct to diet.

    Specialist initiation via the lipid clinic only.

    08.03.04.01 Exemestane Aromasin®
  • Exemestane Tablets

  • 06.01.02.03 Exenatide Byetta®, Bydureon®

    Exenatide pre-filled pens 250micrograms/mL  - Byetta®

    • Specialist Initiation Only

    Exenatide MR Injection 2mg - Bydureon®

    • For patients who have already been established on the TWICE DAILY formulation and who would benefit from a change to ONCE WEEKLY preparation.
    • Supported for use in-line with NICE NG28 (May 2017)
    02.12 Ezetimibe 
    • Ezetimibe Tablets

    Supported for use in-line with NICE TA385

    02.11 Factor VIIa (Recombinant) NovoSeven
    • Factor VIIa (Recombinant) 

    All stock located in and supplied by the Pathology Department.

    Use Restricted to Consultant Haematologist only.

    10.01.04 Febuxostat  Febuxostat Tablets
  • Restricted to use in patients with chronic hyperuricaemia who are unable to tolerate allopurinol or in whom allopurinol is contra-indicated.
  • Supported for use in-line with NICE TA164 Dec 2008.
  • 02.06.02 Felodipine 
    • Felodipine Tablets
    • Felodipine MR Tablets

    Following recommendation of Consultant Cardiologist.

    02.12 Fenofibrate 
    • Fenofibrate Tablets
    • Fenofibrate Capsules

    Not routinely recommended.

    Restricted to existing patients or specialist recommendation only.

    04.07.02 Fentanyl 

    Green Traffic Light Fentanyl Transdermal Patches

    • Please ensure that the brand prescribed is written on the discharge prescription
    • Not to be used in opioid naïve patients.
    • Low cost brand such as Mezolar® advised in primary care.

    Red Fentanyl Injection

    Black Fentanyl Sublingual Tablets (Abstral®)

    • Reserved for the treatment of breakthrough cancer pain in patients in whom standard treatments (morphine or oxycodone) are ineffective or not tolerated
    • Not for routine prescribing in primary care in-line with NHSE recommendation (2017).

    Black Fentanyl Lozenges (Actiq®)

    15.01.04.03 Fentanyl injection 
  • Fentanyl Injection
  • 09.01.01.02 Ferric Carboxymaltose Ferinject®
    • Ferric Carboxymaltose

    For Consultant Haematologists and Consultant Obstetricians and Gynaecologists use only.

    Facilities for cardiopulmonary resuscitation must be at hand.

    A single dose of Ferrinject should not exceed 1000mg of iron (or 15mg/kg).

    Do not administer 1000mg of iron more than once a week.

    Administer via IV bolus or IV infusion.

    Refer to SPC for rates.

    09.01.01.01 Ferric Maltol Ferracru®
    • Ferric maltol

    Restricted use for the treatment of iron-deficiency anaemia in patients with inflammatory bowel disease only, as an alternative to intravenous iron.

    Consultant gastroenterologist recommendation only.

    12 week course.

    09.01.01.01 Ferrous Fumarate 
    • Ferrous fumarate

     

    09.01.01.01 Ferrous Gluconate 
    • Ferrous gluconate
    09.01.01.01 Ferrous Sulphate 
    • Ferrous sulphate

     

    03.04.01 Fexofenadine Telfast® Fexofenadine tablets
    09.01.06 Filgrastim Nivestim®, Zarzio® and Neupogen®
    • Filgrastim

    Consultant Haematologist, Oncologist and paediatric use only

     

    • Nivestim® is the current biosimilar generic of choice for most indications.
    • Zarzio® is restricted for consultant haematologist use only in patients undergoing stem cell harvesting.
    • Neupogen® For specifically agreed paediatric patients.

    Filgrastim must be prescribed by brand – where no brand is specified then the prescriber should be contacted, but Zarzio should be used for most prescriptions other than for specifically agreed paediatrics patients.

    06.04.02 Finasteride 
    06.01.06 Flash Glucose Monitoring Systems FreeStyle Libre

    Diabetes Specialist Initiation Only

    Commissioned for monitoring glucose levels in adults and children over 4 years of age with Type 1 diabetes in line with the West Yorkshire and Harrogate Health and Care Partnership commissioning policy.

     

    02.03.02 Flecainide 

    Amber Traffic Light Flecainide Tablets: Restricted to specialist recommendation only.
    Red Traffic Light Flecainide Syrup: Unlicensed medicine. Restricted to consultant cardiologist use.
    Red Traffic Light Flecainide Injection: Restricted to consultant cardiologist use only.

    13.02.01 Flexitol® Heel Balm  Flexitol® Heel Balm

    Flexitol® Heel Balm is a 25% urea based, highly concentrated, non-greasy, moisturising balm, clinically formulated and medically proven to hydrate dry, cracked diabetic heels and feet.

    Please prescribe by brand.
    05.01.01.02 Flucloxacillin   Green Traffic Light Flucloxacillin Capsules
    Green Traffic Light Flucloxacillin Syrup
    Green Traffic Light Flucloxacillin Injection
    05.02 Fluconazole  Green Traffic Light Fluconazole Capsules
    Green Traffic Light Fluconazole Suspension
    Green Traffic Light Fluconazole Injection
    Green Traffic Light Fluconazole Infusion

    05.02 Flucytosine Ancotil®
  • Flucytosine Infusion

    Restricted for the treatment of cryptococcosis meningitis under the advice of a consultant microbiologist.

  • 08.01.03 Fludarabine Phosphate 
  • Fludarabine Tablets
  • Fludarabine Infusion

    Supported for use in line with NICE TA116 and TA29.
  • 06.03.01 Fludrocortisone Acetate Florinef®
    13.04 Fludroxycortide  Haelan® Haelan tape

    To be used for over granulation
    15.01.07 Flumazenil injection 
  • Flumazenil Injection
  • 12.01.01 Flumetasone Pivulate with Clioquinol Locorten Vioform®
    • Flumetasone Pivulate 0.02%, Clioquinol 1% Ear Drops
       

    Contraindicated in iodine sensitivity.

    11.08.02 Fluorescein Sodium Minims®
    • Fluorescein Sodium 2% Minims (preservative free)
       
    11.04.01 Fluorometholone  FML®
    • Fluorometholone 0.1% Eye Drops (with preservative)
    08.01.03 Fluorouracil 
  • Fluorouracil Injection
  • Fluorouracil Infusion

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 13.08.01 Fluorouracil 5% cream Efudix® For specialist or GPwSI initiation only.
    04.03.03 Fluoxetine Prozac®
    • Fluoxetine Capsules
    • Fluoxetine Liquid
    04.02.01 Flupentixol 
    • Flupentixol Tablets
       

    Restricted to Psychiatry specialist recommendation only

    04.02.02 Flupentixol Decanoate 
    • Flupentixol Decanoate Injection

    Restricted to Psychiatry Specialist initiation only

    04.03.04 Flupentixol dihydrochloride Fluanxol®
    • Flupentixol Dihydrochloride Tablets

    Restricted to Consultant Psychiatrist initiation only

    04.02.02 Fluphenazine Decanoate 
    • Fluphenazine Decanoate Injection

    Restricted to Psychiatry Specialist initiation only

    Note: the licensed product has been discontinued. An unlicensed, imported product is available.

    08.03.04.02 Flutamide 
  • Flutamide Tablets
  • 03.02 Fluticasone Flixotide®

    Flixotide

    • Accuhaler
    • Metered dose inhaler
    • Licensed for asthma
    • Note: 125/250 MDI and 250/500 accuhaler are licensed for patients over 16 years only.
    • Restricted for existing patients only, as a more cost effective alternative is avaialble, which provides the same clinical benefit.
    12.02.01 Fluticasone  
    • Formulary: Fluticasone Furoate 27.5mcg (Avamys® Nasal Spray)
    • Second Choice: Fluticasone Propionate 50mcg (Flixonase® Nasal Spray)
    • Restricted: Fluticasone Propionate 400mcg (Flixonase® Nasule Drop) Consultant recommendation only.
    03.02 Fluticasone and formoterol Flutiform® Flutiform ®
  • Metered dose inhaler
  • Licensed for asthma
  • 03.02 Fluticasone and salmeterol Sirdupla®, Seretide®,Sereflo®

    Use most cost effective preparation currently

    Sereflo® metered dose inhaler preparations:

    • Metered dose inhaler
    • Regular treatment of moderate to severe asthma where long acting β2-agonist and inhaled corticosteroid is appropriate.

    Sirdupla® metered dose inhaler preparations:

    • Metered dose inhaler
    • Licensed for asthma
       

    Seretide® Evohaler preparations:

    • Monitored dose inhaler
    • Licensed for asthma.
    • Restricted to patients with asthma under 18 years
    • Patents with COPD who require an MDI, for whom a switch to a COPD-licensed MDI LABA/Inhaled corticosteroid product (e.g. Fostair) is inappropriate
    • Patients who prefer volumatic spacer to aerochamber spacer, as Sirdupla only fits aerochamber plus devices.

      Restricted Item Seretide Accuhaler®
    • Dry powder inhaler
    • Restricted to existing patients only
    • Licensed for asthma
    • Licensed for COPD if FEV1 <60% predicted
    • Restricted to existing patients only, as more cost effective alternatives are available, which provide the same clinical benefits.
    03.02 Fluticasone and vilanterol Relvar Ellipta® Relvar Ellipta® 92/22
  • Dry powder inhaler
  • Licensed for asthma
  • Licensed for COPD if FEV1 <70% predicted

    Relvar Ellipta® 184/22
  • Dry powder inhaler
  • Licensed for asthma only
  • 03.02 Fluticasone, umeclidinium and vilanterol Trelegy®

    Trelegy®

    • For use in patients with moderate to severe COPD who are not adequately treated by a combination of inhaled corticosteroid and a LABA.
    A5.02.05 Foam Dressing ActivHeal Foam® Activheal Foam Non-Adhesive Dressing 7.5cm x 7.5cm
    Activheal Foam Non-Adhesive Dressing 10cm x 18cm

    These dressings do require a secondary dressing for fixing

    Will be bought in if required
    A5.02.05 Foam dressing (with adhesive) Tegaderm Foam Adhesive® Standard foam dressing (with adhesive border) of choice for Airedale NHS Foundation Trust patients
  • Square foam dressing including adhesive border 8.8cm x 8.8cm (pad 5cm x 5cm)
  • Square foam dressing including adhesive border 14cm x 14cm (pad 10cm x 10cm)
  • Oval foam dressing including adhesive border 14cm x 15cm (pad 10cm x 11cm)
  • Oval foam dressing including adhesive border 19cm x 22.2cm (pad 14cm x 17.1cm)
  • Circular foam dressing including adhesive border 14cm x 14cm (circular pad 7.6cm x 7.6cm)
  • A5.02.03 Foam dressing with silicone UrgoTul Absorb Border ® Specialist foam dressing of choice for Airedale NHS Foundation Trust patients
    Foam dressing with silicone adhesive border with soft adherent TLC (Technology Lipido-Colloid) layer
  • 8cm x 8cm
  • 10cm x 10cm
  • 13cm x 13cm
  • 15cm x 20cm
  • 20cm x 20cm (sacrum)

    UrgoTul Absorb Border® should be reserved for delicate or problematic skin
  • 09.01.02 Folic Acid 
    • Folic acid 5mg tablets

    For patients with a BMI greater than 30. Consult current guidelines for appropriate dose in other situations.

     

    • Folic acid 400mcg tablets 

    For the prevention of neural tube defects in pregnancy to be purchased over the counter by patients where possible. 

    02.08.01 Fondaparinux Sodium Arixtra®
    • Fondaparinux Sodium Injection

    Approved indications:

    • First-line anti-thrombin therapy in the initial management of patients presenting with Acute Coronary Syndromes (ACS) in-line with NICE CG94: unstable angina and NSTEMI.
    • For patients who need anticoagulation who refuse to be treated with a porcine derived low molecular weight heparin (LMWH).

      Note:
    • The needle shield of the prefilled syringe contains latex so not to be used in patients with latex allergy.
    • Fondaparinux is not licensed for use in pregnancy.
    03.01.01.01 Formoterol  Atimos®, Oxis®, Foradil® Formoterol
  • Turbohaler
  • Licensed for asthma and COPD (but combination devices preferred for asthma)
  • A2.02.02.03 Forticreme® Complete Assorted   Equivalent product for prescribing in community only
  • Fresubin 2kcal Crème 125 g
  • Ensure Plus Crème 125g
  • A2.02.01.02 Fortijuce® Assorted  Equivalent product for prescribing in community only
  • Fortijuce 200 ml
  • Fresubin Jucy 200 ml
  • A2.01.03.03 Fortini Multifibre  
    A2.02.02.03 Fortisip® 2kcal Assorted  
    A2.02.02.03 Fortisip® Compact Assorted   Equivalent product for prescribing in community only
  • Fortisip Compact 125 ml
  • Fresubin Energy 200 ml
  • A2.02.02.03 Fortisip® Compact Fibre 
    A2.02.02.03 Fortisip® Compact Protein   Equivalent product for prescribing in community only
  • Fortisip Compact Protein 125 ml
  • Fresubin kcal 200 ml
  • A2.02.02.03 Fortisip® Extra Assorted   Equivalent product for prescribing in community only
  • Fortisip Compact Protein 125 ml
  • Fresubin kcal 200 ml
  • A2.02.02.01 Fortisip® Yoghurt Style Assorted  Equivalent product for prescribing in community only
  • Not formulary equivalent. If none of the formulary products are suitable, consider continuing in the community.
  • 05.01.07 Fosfomycin Sachets 3g Monuril® Reserved for the treatment of urinary tract infections associated with Extended-Spectrum Beta-Lactamase producing organisms (ESBLs) following advice from Microbiology

    13.10.01.01 Fucidin cream 

    Fusidic acid 2% cream

    08.03.04.01 Fulvestrant 
  • Fulvestrant Injection

    Not recommended for use.
  • 02.02.02 Furosemide 

    Green Traffic Light Furosemide Tablets
    Green Traffic Light Furosemide SF Solution
    Green Traffic Light Furosemide Injection

    11.03.01 Fusidic Acid  
    • Fusidic Acid 1% MR Eye Drops (with preservative)

      Fusidic acid is useful for staphylococcal infections.
    23.01 Gadolinium Magnevist® Pre-filled syringe

    For MR joint arthrography.

    Radiology use only.
    04.11 Galantamine 
    • Galantamine Solution
    • Galantamine Tablets
    • Galantamine MR Tablets

    Restricted for BDCT, 8mg tablets must not be halved, If 4mg are required, use the oral solution.

    For use in-line with NICE TA217 (June 2018).

    Gatalin®is the brand preferred by Airedale Wharfedale Craven CCG

    05.03.02.02 Ganciclovir 
  • Ganciclovir Injection

    Under Consultant Microbiologist recommendation only
  • 11.03.03 Ganciclovir 0.15%  Virgan®

    Ganciclovir Ophthalmic Gel

    • Following global discontinuation of aciclovir 3% eye ointment  due to repeated challenges in guaranteeing a sustainable product supply.
    • Clinical information on the switch and the licensing details (which differ from aciclovir) are available on the Ganciclovir eye gel SPC or on the switch memo from UKMi on the SPS website.
    01.01.02 Gaviscon Advance Liquid  Restricted to:
  • Patients who require reduced salt intake
  • Use in A&E as pre-packs only (within ANHSFT)
  • 01.01.02 Gaviscon Infant Dual Sachets  For paediatric use only
    01.01.02 Gaviscon Tablets 
    27.06 GB Fix It (Abdominal Strap)  Order Code: 10645B
    Pack Size: 5
    Drug Tariff Price £14.92
    27.06 GB Fix It (leg strap)  Order Code: 10644A
    Pack Size: 5
    Drug Tariff Price £13.64
    08.01.05 Gefitinib 
    • Gefitinib Tablets

    09.02.02.02 Gelatin Gelaspan®
    • Succinylated gelatin

    To replace the use of Volpex® for plasma volume replacement.

    12.03.01 Gelclair® 
    • Gelclair Oral Gel

    ENT, Oncology and Haematology use only.

    08.01.03 Gemcitabine 
    • Gemcitabine Injection
       
    05.01.04 Gentamicin 
  • Gentamicin Injection

    Guidance for Adult patients
    All treatment courses of Gentamicin should be prescribed on a Gentamicin prescription chart, available from the Pharmacy department, unless the patient is receiving therapy for endocarditis.

    2mg/kg prophylaxis doses (e.g. pre-operative prophylaxis, prophylaxis prior to catheter removal) should be prescribed on the inpatient chart.

    Guidance for all patients
    All patients receiving treatment courses of gentamicin should have daily urea and electrolyte blood tests and be monitored for signs of acute renal impairment.
  • 11.03.01 Gentamicin  Genticin®
    • Gentamicin 0.3% Eye Drops (with preservative)

      Gentamicin is a broad spectrum antibiotic and is also effective for infections caused by Pseudomonas aeruginosa
    12.01.01 Gentamicin 0.3% Genticin®
    • Gentamicin 0.3% Ear/Eye Drops
    12.03.05 Glandosane® 
    • Glandosane® Artificial Saliva Spray
    05.03.03.02 Glecaprevir/pibrentasvir tablets 
  • Glecaprevir/pibrentasvir tablets

    For the treatment of hepatitis C in-line with NHS England commissioning.
    Use restricted to Consultant Gastroenterologists only.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 06.01.02.01 Glibenclamide 

    Reserved for existing patients only

    06.01.02.01 Gliclazide 

    Gliclazide 80mg tablets - no restriction on use
     

    06.01.02.01 Glimepiride 
    06.01.04 Glucagon GlucaGen® HypoKit Glucagon (GlucaGen) Hypokit (1mg)
    18 Glucarpidase  Used in the management of poisoning with methotrexate.
    06.01.04 Glucose Gel  Glucose gel (80g)
    09.02.02.01 Glucose Intravenous 
    • Glucose 5% Infusion (100mL, 250mL, 500mL, 1L)
    • Glucose 10%, 20%, 50% Infusion (500mL)
    • Glucose 50% Injection (50mL)
    A2.02 Glutamine Sachets 5g Adamin-G

    Treatment to be initiated on the recommendation of a Specialist Paediatric Dietician with expertise in managing specialist metabolic conditions only.

    01.06.02 Glycerol  
  • Glycerol 1g Suppositories (infant)
  • Glycerol 2g Suppositories (child)
  • Glycerol 4g Suppositories (adult)
  • 01.07.04 Glyceryl Trinitrate  
  • Glyceryl Trinitrate 0.2% Ointment

    Unlicensed product manufactured by Huddersfield Royal Infirmary
  • 02.06.01 Glyceryl Trinitrate  Green Traffic Light Glyceryl Trinitrate Spray
    Green Traffic Light Glyceryl Trinitrate S/L Tablets
    Green Traffic Light Glyceryl trinitrate Patches
    Red Traffic Light Glyceryl Trinitrate Infusion
    01.07.04 Glyceryl Trinitrate Rectal Ointment Rectogesic®
  • Glyceryl Trinitrate 0.4% Ointment

    For the treatment of anal fissures
  • 07.04.04 Glycine 

    Glycine Irrigation (1L, 3L Easyflow)

    15.01.03 Glycopyrrolate (glycopyrronium) bromide  
  • Glycopyrronium bromide Tablets
  • Glycopyrronium bromide Oral Liquid
    For use by Community Paediatricians for prevention of excessive salivation and reduction of secretions in patients who cannot tolerate or who do not respond to hyoscine patches.

  • Glycopyrronium bromide Injection
  • 03.01.04 Glycopyrronium and indacaterol Ultibro®Breezhaler
    • Capsules for inhalation via Breezhaler® device
    • Licensed for COPD
    03.01.02 Glycopyrronium inhaler Seebri breezhaler® Seebri breezhaler® device
  • Licensed for COPD

    Note: Product strength can be expressed as either 55 micrograms of glycopyrronium bromide, or as 44 micrograms of glycopyrronium.
  • 10.01.03 Golimumab 

    Consultant Rheumatologist and Consultant Gastroenterologist use only.
    Supported for use in-line with:

    • NICE TA220: Psoriatis arthritis (April 2011)
    • NICE TA225: Rheumatoid arthritis (June 2011)
    • NICE TA233: Ankylosing spondylitis (August 2011)
    • NICE TA329: Ulcerative colitis (February 2015)
    • NICE TA497: Non-radiographic axial spondyloarthritis (January 2018)
    01.05.03 Golimumab Subcutaneous Injection Simponi®
  • Golimumab Subcutaneous Injection

    Consultant Gastroenterologist
    Supported for use in-line with NICE guidance
  • 06.05.01 Gonadorelin  Gonadorelin Injection (100micrograms)(GnRH; LH-RH)
    06.07.02 Goserelin implant Zoladex®

    Reserved for patients with breast cancer only

    04.06 Granisetron Sancuso®
    • Granisetron Transdermal Patch 

    Restricted for use for the prevention of chemotherapy induced nausea and vomiting in patients with swallowing difficulties who are undergoing multi-day chemotherapy regimens.

    05.02 Griseofulvin 
  • Griseofulvin Suspension
  • Griseofulvin Tablets
  • 02.05.03 Guanethidine Monosulphate 
    • Guanethidine monosulphate Injection

    Consultant Anaesthetists use only.

    Item not stocked in pharmacy

    10.01.03 Guselkumab Tremfya®

    Consultant rheumatologist use only

    • Guselkumab subcutaneous injection
    • Supported for use in line with NICE TA521 (June 2018)
    • Guselkumab for treating moderate to severe plaque psoriasis (in line with NICE TA521) is available at specialist centres only.
    09.08.02 Haem Arginate Normasang®
    • Haem Arginate

    Only to be used following advice, authorisation and supply from the National Acute Porphyria Service (NAPS).

    NAPS provides clinical advice and support as well as authorisation and provision of haem arginate treatment 24 hours a day, seven days per week. The out of hours service is provided in rotation from one of the three centres and can be contacted through the University Hospital of Wales switch board: 029 20747747

    For further information, and to obtain supply, see the link to NAPS below.

    14.04 Haemophilus influenzae type B (Hib) & Neisseria meningitides serotype C (Men C) Conjugate Vaccine Menitorix®
    03.01.05 Haleraid® Drug Delivery Device Haleraid (120-dose, 200-dose)

    Not available for prescribing in primary care
    04.02.01 Haloperidol 
    • Haloperidol Capsules
    • Haloperidol Tablets
    • Haloperidol SF Solution
    • Green Haloperidol Injection (palliative care indication only)
       

    Restricted to Psychiatry specialist recommendation only

    04.02.02 Haloperidol decanoate 
    • Haloperidol Decanoate Injection

    Restricted to Psychiatry Specialist initiation only

    02.08.01 Heparin 
    • Heparin Calcium Injection (5000units/0.2ml)
      Unfractionated heparin for use as thromboprophylaxis in patients with CrCl <15mL/min. See guidelines below.
    • Heparin Sodium Injection (other strengths)

      Restricted Item Heparin Sodium 500units in Sodium Chloride 0.9%(500ml)
      Restricted for use in CCU and theatre only.

      Restricted Item Heparin Sodium 1,000 units in sodium chloride 0.9% (500ml)
      Restricted for use in x-ray and cardiac catheter lab only

      Amber Traffic Light Heparin Sodium 100units/ml or 50units/ml injection
      Following specialist recommendation only, for adult patients with Hickman lines or Portacaths, usually under the care of a haematologist or oncologist.

      Amber Traffic Light Heparin Sodium 50units/5ml injection
      Restricted for use in paediatric and neonatal central lines only, following consultant recommendation.
    13.13 Heparinoid 0.3% Hirudoid® Hirudoid cream
    Hirudoid gel
    14.04 Hepatitis A paediatric vaccines Havrix Junior Monodose®
    • For use in children aged 1-15 years
    • VAQTA Paediatric® and Epaxal® are alternative brands available in primary care.
    14.04 Hepatitis A vaccine  Havrix Monodose®
    • Alternative brands are available in primary care.
    14.04 Hepatitis A vaccine with Hepatitis B vaccine  Various brands
    • For Primary Care use only - not stocked at ANHSFT
    • Twinrix adult®
    • Twinrix Paediatric®
    • Ambirix® (for Paediatric use)
    14.04 Hepatitis A vaccine with typhoid vaccine Hepatyrix®
    • For primary care use only - not stocked at ANHSFT
    14.05.02 Hepatitis B immunoglobulin 

    Hepatitis B immunoglobulin

    • Requests for supply should be made to the haematology department.
    14.04 Hepatitis B vaccine Single Component  Engerix B® HBvaxPRO ®
    • HBvaxPRO ® - Second choice vaccine for non- or poor-responders or as an alternative brand in primary care
    27.16 Hollister faecal collector 50cm tubing non sterile 1000ml Order Code: 9821
    Pack size: 10
    Drug Tariff Price £43.47
    27.16 Hollister faecal collector 50cm tubing non sterile 500ml Order Code: 9822
    Pack size: 10
    Drug Tariff Price £43.47
    27.13 Hollister Retracted Penis Pouch  Order Code: 9811
    Pack size: 10
    Drug Tariff Price £28.07
    A5.03.01 Honey dressing products Advancis Activon® Honey product dressing range of choice at Airedale NHS Foundation Trust

    Advancis Activon® tube
    100% medical grade Manuka honey
  • 25g tube

    Advancis Algivon Plus®
    Reinforced alginate dressing with 100% manuka honey
  • 5cm x 5cm
  • 10cm x 10cm
  • 2.5cm x 20cm (ribbon)

    Actilite®
    Non-adherent viscose net dressing coated with 99% manuka honey and 1% manuka oil.
  • 5cm x 5cm
  • 10cm x 10cm
  • 10cm x 20cm

    Not for use in patients with known sensitivity or allergy to honey, bee stings, bee products or tea tree oil.
  • A5.03.01 Honey dressing products Medihoney® Honey dressing product range of choice for community patients

    Medihoney tube®
    Medihoney Wound gel®
    Medihoney Apinate®
    Medihoney gel sheet®
    Medihoney tulle dressing®

    Not available at Airedale NHS Foundation Trust
    14.05.03 Human anti-D immunoglobulin Rhophylac®, D-Gam®

    Routine antenatal anti-D prophylaxis should be offered to all non-sensitised pregnant women who are rhesus D negative, in line with NICE TA156
     

    • Human anti-D immunoglobulin 1500 units (Rhophylac®)
    • Restricted for antenatal prophylaxis
       
    • Human anti-D immunoglobulin 250 units or 500 units (D-Gam®)
    • Requests for supply should be made to the haematology department.
    14.04 Human papilloma virus vaccine Gardasil®
    • Vaccination is usually performed in schools.
    • Not kept in stock at Airedale NHS Foundation Trust
    10.03.01 Hyaluronidase Hyalase®
    02.05.01 Hydralazine  Green Traffic Light Hydralazine Tablets
    Red Traffic Light Hydralazine Injection
    06.03.02 Hydrocortisone 

     Green Oral preparations

    • Hydrocortisone Tablets
       

     Green Injectable preparations

    • Hydrocortisone Sodium phosphate Injection (500mg/5mL)
    • Hydrocortisone Sodium succinate Injection (100mg)

    Hydrocortisone kit

    Where a ‘hydrocortisone kit’ is prescribed for use in the event of an Addisonian crisis,  the following should be supplied, along with  the PIL for hydrocortisone sodium succinate 100mg injection and the a copy of the leaflet “How to give an emergency injection of Solu-Cortef”:

    • Hydrocortisone sodium succinate injection 100mg x 2
    • Water for injection 10ml x 2
    • Orange safety needle x 4
    • Syringes 2ml x 2
    • 1 small, sharps bin

    GP may replace out of date hydrocortisone injection providing other items in   the kit are in date.

    12.03.03 Hydrocortisone 
    • Hydrocortisone Muco-adhesive Buccal Tablets
    13.04 Hydrocortisone  Hydrocortisone 0.5% Ointment
    Hydrocortisone 0.5% Cream
    Hydrocortisone 1% Cream
    Hydrocortisone 1% Ointment
    Hydrocortisone 2.5% cream
    13.04 Hydrocortisone 1% with Clotrimazole 1% Canesten HC® Hydrocortisone 1% clotrimazole 1% (Canesten HC Cream)
    13.04 Hydrocortisone 1% with Miconazole Nitrate 2% Daktacort® Hydrocortisone 1% miconazole nitrate 2% (Daktacort Cream)
    Hydrocortisone 1% miconazole nitrate 2% (Daktacort Ointment)
    01.05.02 Hydrocortisone acetate 
  • Hydrocortisone Acetate Rectal Foam
  • 10.01.02.02 Hydrocortisone acetate  For intra-articular or periarticular injection.
    13.04 Hydrocortisone Acetate 1% with Fusidic Acid 2% Fucidin H® Hydrocortisone Acetate 1% with Fusidic Acid 2%
    (Fucidin H®)
    12.01.01 Hydrocortisone Acetate and Gentamicin Gentisone HC®
    • Hydrocortisone Acetate 1%, Gentamicin 0.3% Ear Drops
    13.04 Hydrocortisone Butyrate Locoid® Hydrocortisone Butyrate 0.1% Cream
    A5.02.04 Hydrofiber® technology dressing Exufiber® Hydrofiber® dressing of choice for community patients only


    Not available at Airedale NHS Foundation Trust
    A5.02.04 Hydrofiber® technology dressing Aquacel Extra® Hydrofiber® dressing of choice at Airedale NHS Foundation TrustGelling fibre extra absorbent dressing
  • 5cm x 5cm
  • 10cm x 10cm
  • 15cm x 15cm
  • 2cm x 45cm ribbon

    Alternative specialist foam dressing product for community patients only
  • A5.02.01 Hydrogel ActivHeal Hydrogel® Hydrogel of choice at Airedale NHS Foundation Trust
    Activheal Hydrogel
  • 8g
  • 15g
  • A5.02.01 Hydrogel Intrasite Gel® Hydrogel of choice for community patients only
  • 8g
  • 15g

    Not available at Airedale NHS Foundation Trust
  • A5.02.01 Hydrogel sheet KerraLite® Hydrogel sheet (adhesive and non-adhesive) of choice for Airedale NHS Foundation Trust and community patients
    KerraLite® Cool (Hydrogel dressing sheet non adhesive)
  • 12cm x 8.5cm
  • 18cm x 12.5cm

    KerraLite® Cool Adhesive (Hydrogel dressing sheet adhesive)
  • 8cm x 8cm
  • 11cm x 11cm
  • 15cm x 15cm

    Note: To be ordered in for individual patients on the request of the Tissue Viability Nurse Specialists only at ANHSFT
  • 13.11.06 Hydrogen Peroxide Solution BP  Hydrogen Peroxide 6% Solution
    13.02.01 Hydromol®  Hydromol Ointment
    04.07.02 Hydromorphone 
    • Hydromorphone Capsules
    • Hydromorphone M/R Capsules

    Restricted to palliative care consultant recommendation, for patients who are intolerant to morphine.

    Red Traffic Light Hydromorphone Injection - ANHSFT use only

    09.01.02 Hydroxocobalamin 
    • Hydroxocobalamin

     

    18 Hydroxocobalamin  Cyanokit®

    Used in the management of poisoning with cyanides (replaces Dicobalt edetate) 

    08.01.05 Hydroxycarbamide 
  • Hydroxycarbamide Capsules

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 10.01.03 Hydroxychloroquine  Hydroxychloroquine Tablets
    Consultant Rheumatologist use only
    11.08.01 Hydroxyethylcellulose Minims® Artificial Tears
    • Hydroxyethylcellulose 0.44%, Sodium Chloride 0.35% Single Dose Eye Drops (Minims Artificial Tears) 

      For use following consultant recommendation only, in patients where a preservative free product is necessary
    11.08.01 Hydroxypropyl Guar Systane Balance®, Systane Ultra ®
    • Hydroxypropyl (with preservative) GuarSystane Balance® 
    • Hydroxypropyl (with preservative) GuarSystane Ultra®

      For Consultant Ophthamologist Recommendation Only
    03.04.01 Hydroxyzine Hydrochloride Atarax®, Ucerax® Hydroxyzine Tablets
    Hydroxyzine Syrup
    01.02 Hyoscine Butylbromide  
  • Hyoscine Butylbromide Injection
  • Hyoscine Butylbromide Tablets
  • 04.06 Hyoscine Hydrobromide Kwells®
    • Hyoscine hydrobromide tablets
      Restricted Item Hyoscine hydrobromide injection
      Restricted Item Hyoscine hydrobromide patch
      Restricted for the treatment of excessive salivation and for the reduction of secretions.
    15.01.03 Hyoscine Hydrobromide  
  • Hyoscine hydrobromide Injection
  • 11.08.01 Hypromellose 

    Hypromellose is the first choice treatment for tear deficiency. It may need to be instilled frequently (e.g. hourly) for adequate relief.

    • Hypromellose 0.3% Eye Drops (with preservative)
    • Xailin Hydrate® hypromellose 0.3% Eye Drops (preservative free)
    06.06.02 Ibandronic Acid 

    Green Traffic Light Ibandronic acid 150mg tablets

    • As an option for the treatment of post-menopausal osteoporosis, in line with NICE TA464.

    Amber Traffic Light Ibandronic acid 50mg tablets

    • For the use of Oncology Consultants for reduction of bone damage in bone metastases in breast cancer.
    • For post-menopausal women with breast cancer to reduce the risk of recurrence, for three years (unlicensed indication).
    08.01.05 Ibrutinib Imbruvica®
    • Ibrutinib capsules

    Consultant Haematologist use only

    Ibrutinib is only available via the CDF. For further information see the link below.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

     

    07.01.01.01 Ibuprofen 

    Ibuprofen Injection

    For treatment of patent ductus arteriosus

    10.01.01 Ibuprofen 
  • Ibuprofen Tablets
  • Ibuprofen suspension
  • 10.03.02 Ibuprofen gel Fenbid®, Ibuleve®, Ibugel®. Ibuprofen gel (5%)
  • The most cost effective choice in primary care is Fenbid® gel 100g.
  • 02.08.02 Idarucizumab injection Praxbind®
    • Idarucizumab Injection

    For the urgent reversal of dabigatran etexilate.

    The protocol for the management of bleeding, and urgent reversal in patients receiving dabigatran is available on AireShare.

    08.01.05 Idelalisib Zydelig®
    • Idelalisib Tablets


    02.05.01 Iloprost 
    • Iloprost Injection

    Supported for the treatment of digital ulceration in line with NHSE commissioning policy A13/P/e below.

    Consultant rheumatologist recommendation only.

    Unlicensed medicine: Additional paperwork required for dispensing at ANHSFT

    08.01.05 Imatinib 
    • Imatinib Tablets


    04.03.01 Imipramine Hydrochloride 
    • Imipramine Tablets

    Restricted to psychiatry specialist recommendation only

    13.07 Imiquimod Aldara®

    Imiquimod 5% cream

    Restricted for use under direction of specialist only.

    14.04 Inactivated Influenza Vaccine (Syringe) 
    • Routine immunisation is provided by GP surgeries, community pharmacies and other primary care providers.
    • Vaccination is provided by ANHSFT for staff via Employee Health and Wellbeing Services.
    • Vaccination is provided by ANHSFT for patients post splenectomy.
    • Patients admitted throughout the influenza season (including patients cared for at Bradford District Care Trust under Mental Health Act section) may be provided with vaccination on an individual patient basis, following discussion with the Senior Clinical Pharmacist for Antimicrobials.
    • Refer to SPC for full list of excipients.
    03.01.01.01 Indacaterol Onbrez® Breezhaler Indacaterol
  • Dry powder inhaler (Capsule)
  • Licensed for COPD
  • 02.02.01 Indapamide 
    • Indapamide Tablets
    • Indapamide MR Tablets
    10.01.01 Indometacin 
  • Indometacin Capsules
    Restricted for short term use in patients with acute attack of gout if other drugs have failed.
  • 14.04 Infanrix hexa, Powder and suspension for suspension for injection Infanrix hexa ®
    • Infanrix® hexa vaccine (DTaP/IPV/Hib/HepB Hexavalent vaccine)

      For use in the routine childhood immunisation schedule. Infanrix® hexa will replace Pediacel® and Infanrix®/IPV+Hib for routine childhood immunisations at 8, 12 and 16 weeks of age.
    A2.01.03.02 Infatrini  For use on the recommendation of a dietitian only
    A2.03.01 Infatrini 
    A2.01.03.02 Infatrini Peptisorb  For use on the recommendation of a dietitian only
    10.01.03 Infliximab  Consultant Rheumatologist and consultant gastroenterologist use only.

    Supported for use in-line with:
  • NICE TA143: Ankylosing spondylitis (May 2008)
  • NICE TA199: Psoriatis arthritis(August 2010)
  • NICE TA329: Ulcerative colitis (February 2015)
  • 01.05.03 Infliximab infusion Remicade®
  • Infliximab Intravenous Infusion

    Consultant Gastroenterologist and Paediatricians only
    Supported for use in-line with NICE guidance
  • 14.04 Influenza vaccine (Intranasal) Fluenz Tetra®
    • Fluenz Tetra® is for intranasal vacination in children in accordance with DoH Influenza vaccination programme
    • For primary care use only - Not stocked at ANHSFT
    15.02 Instilla Quill  For Family Planning Clinics only
    27.03 Instillagel 11ml (male)  Order Code: 40-011
    Pack Size: 10
    Drug Tariff Price £15.76
    27.03 Instillagel 6ml (female)  Order Code: 40-006
    Pack Size: 10
    Drug Tariff Price £14.05
    06.01.01.01 Insulin Actrapid®

    Green Traffic Light 10mL(s) vials

    Red Traffic Light A 50units/50mL preparation is available for sliding scale insulin regimens for inpatients only. This is an unlicensed medicine.

    Please state the brand name on all prescriptions for insulin

    06.01.01.01 Insulin 100 units in 1mL  Humulin S®
    • 10mL vial

    Please state the brand name on all prescriptions for insulin

    06.01.01.01 Insulin 500 units in 1mL Humulin R®

    Humulin R insulin 500units /mL (20mL)

    Humulin R U-500 Kwikpen (500units /mL)


    Reserved for existing patients only, by consultant diabetologists only.

     

    06.01.01.01 Insulin Aspart  NovoRapid®
    • 10mL vial
    • 3mL prefilled device (FlexPen)
    • 3mL cartridge compatible with Novopen 4 and Junior Novopen

      Please state the brand name on all prescriptions for insulin
    06.01.01.01 Insulin Aspart  Fiasp®
    • 10mL vial
    • 3mL prefilled device (FlexTouch Pen)
    • 3mL cartridge

    Specialist initiation only

    Please state the brand name on all prescriptions for insulin

    06.01.01.02 Insulin Degludec Tresiba®
    • Insulin degludec 100units/mL Penfill cartridge
    • Insulin degludec 100units/mL pre-filled pen
    • Insulin degludec 200units/mL prefilled pen (Tresiba Flextouch®)

      High strength preparations restricted for recommendation by Consultant Diabetologists only as follows:
    • Patients with insulin resistance requiring treatment with >300units / day

      Please state the brand name on all prescriptions for insulin
    06.01.01.02 Insulin Detemir Levemir®
  • 3ml pen filled device (FlexPen / Innolet device)
  • 3ml cartridge compatible with Novopen 4 and Junior NovoPen

    Please state the brand name on all prescriptions for insulin
  • 06.01.01.02 Insulin Glargine Lantus®, Abasaglar®

    Lantus®

    • 10mL vial
    • 3mL pen filled device (SoloStar pen)
    • 3mL cartridge compatible with Clickstar device

      Abasaglar®(biosimilar)
    • 3mL pen filled device (Kwikpen)
    • 3mL cartridge compatible with Savvio device

      Please state the brand name on all prescriptions for insulin
    06.01.01.02 Insulin glargine 300units/mL Toujeo®

    Approved for patients who have a high daily insulin requirement.

    • 450units / pen (SoloStar pen)
    • 900units / pen (DoubleStar pen)


    Diabetes consultant initiation only
    Please state the brand name on all prescriptions for insulin

    06.01.01.01 Insulin Glulisine Apidra®
    • 3mL prefilled device (Solostar pen)
    • 3mL cartridge compatible with ClikSTAR pen

      For consultant recommendation only

      Please state the brand name on all prescriptions for insulin
    06.01.01.01 Insulin Lispro Humalog®

    Green Traffic Light 100units/mL preparation

    • 10mL vial
    • 3mL prefilled device (Kwikpen)3mL cartridge compatible with HumaPen Luxura


     Amber Traffic Light 200units/mL preparation

    • 3mL prefilled device (Kwikpen)
      Approved for patients with a high daily insulin requirement only.
      Consultant recommendation

      Please state the brand name on all prescriptions for insulin
    08.02.04 Interferon Alfa 
  • Interferon Alfa-2A Injection

    Reserved for Consultant Haematologist use
  • 09.03 Intralipid 
    • Intralipid 20% (100mL, 500mL)
    07.03.04 Intra-uterine Contraceptive Devices UT 380 Standard® UT 380 standard coil
    07.03.04 Intra-uterine Contraceptive Devices TT 380 Slimline® TT-380 slimline coil
    07.03.04 Intra-uterine Contraceptive Devices Flexi-T® 300 Flexi T 300
    07.03.04 Intra-uterine Contraceptive Devices GyneFix® Gynefix interval
    07.03.04 Intra-uterine Contraceptive Devices Nova-T® 380 Nova -T 380
    07.03.04 Intra-uterine Contraceptive Devices T-Safe® CU 380 A T-Safe 380A
    07.03.04 Intra-uterine Contraceptive Devices UT 380 Short® UT 380 short coil
    07.03.02.03 Intra-uterine Progestogen Only System Mirena®, Jaydess®, Kyleena®

    Ensure intra-uterine systems are prescribed by brand name.

    • Mirena®
    • Jaydess®
    • Kyleena®
    13.11.04 Iodine 1% aqueous solution  Iodine 1% aqueous solution (York formula)
    06.02.02 Iodine and Iodide Lugols®

    Specialist recommendation only.

    A5.03.02 Iodine ointment Iodosorb® Iodine ointment of choice at Airedale NHS Foundation Trust
    Cadexomer ointment with iodine
  • 10g
  • A5.03.02 Iodine Ointment Iodoflex Alternative iodine ointment for community patients only
    Cadexomer ointment with iodine
  • 10g

    Not available at Airedale NHS Foundation Trust
  • 03.01.02 Ipratropium Bromide Atrovent®
    • Metered dose inhaler (MDI use only for patients who cannot tolerate long-acting antimuscaranic antagonist) (LAMA)
    • Nebuliser solution
    02.05.05.02 Irbesartan 
    • Irbesartan Tablets

    Also supported for the treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen.

    08.01.05 Irinotecan Hydrochloride 
    • Irinotecan Injection
       
    09.01.01.02 Iron Dextran CosmoFer®
    • Iron-III Hydroxide Dextran Complex

    Consultant Haematologist use only

    Facilities for cardiopulmonary resuscitation must be at hand

    Dose calculated according to body weight and iron deficit

    Cumulative dose administered in single doses of 100mg (may be increased to 200mg) of iron given not more than 3 times a week or

    As a total dose infusion up to a total replacement dose of 20mg iron / kg body weight.

    Slow IV injection or IV infusion (preferred route) or IM injection

    09.01.01.02 Iron Sucrose Venofer®
    • Iron-Hydroxide Sucrose Complex

    Consultant Haematologist use only

    Reserved for patients who need to attend clinic every 4-6 weeks to maintain blood count.

    Facilities for cardiopiulmonary resuscitation must be at hand

    Dose calculated according to body weight and iron deficit

    Cumulative dose administered in single doses of 100mg (may be increased to 200mg) of iron given not more than 3 times a week.

    Slow IV injection or IV infusion (preferred route)

    01.08 Irypump Colostomy Irrigation Irypump®

    On the recommendation of a stoma nurse specialist only.

    15.01.02 Isoflurane (250mL) 
    05.01.09 Isoniazid 
  • Isoniazid Elixir
  • Isoniazid Injection
  • Isoniazid Tablets
  • 06.01.01.02 Isophane Insulin Insulatard®
    • 10mL vial
    • 3mL pen filled device (Innolet device)
    • 3mL cartridge compatible with Novopen 5 and Junior Novopen

      Please state the brand name on all prescriptions for insulin
    06.01.01.02 Isophane Insulin Humulin® I
    • 10mL vial
    • 3mL pen filled device (Kwikpen)
    • 3mL cartridge compatible with HumaPen Savvio

      Please state the brand name on all prescriptions for insulin
    02.07.01 Isoprenaline 
    • Isoprenaline Injection

    Note: Two salts available

    • Isoprenaline sulfate 2.25mg in 2ml
    • Isoprenaline hydrochloride 2mg in 2ml.
      Check dose calculations carefully
    02.06.01 Isosorbide Dinitrate 

    Green Traffic Light Isosorbide Dinitrate Tablets - Reserved for existing patients only.
    Red Traffic Light Isosrbide Dinitrate Injection

    02.06.01 Isosorbide Mononitrate  First choice
    Isosorbide Mononitrate Tablets (standard release)

    Restricted choice
    Isosorbide mononitrate MR Capsules
    Isosorbide mononitrate MR Tablets
  • Slow or modified release preparations of isosorbide mononitrate are more costly than their short acting equivalents. In addition, there is little evidence to suggest that they are any more effective in treating the symptoms of angina.

    Please prescribe the following strength-specific brands in primary care:
  • Chemydur XL or Monomil XL 60mg
  • Generic isosorbide mononitrate MR 40mg, 50mg or 25mg
  • 13.06.02 Isotretinoin  Isotretinoin Capsules

    Consultant Dermatologist and GPwSI use only

    Isotretinoin should only be prescribed by or under the supervision of a consultant dermatologist or GPwSI with expertise in the use of systemic retinoids for the treatment of severe acne and a full understanding of the risks of isotretinoin therapy and monitoring requirements.
    • Warn patients and their family that isotretinoin might cause psychiatric disorders such as depression, anxiety, and in rare cases suicidal thoughts. Tell them to watch out for symptoms.
    • When prescribing isotretinoin to patients with a history of depression, carefully consider the balance of benefits of treatment against the possible risk of psychiatric disorders.
    • Monitor all patients for signs of depression and refer for appropriate treatment if necessary. Stopping isotretinoin may not be enough to alleviate symptoms and further psychiatric or psychological evaluation may be necessary.
    01.06.01 Ispaghula Husk Fybogel®, Ispagel®
  • Fybogel Sachets
  • 02.06.03 Ivabradine 
    • Ivabradine Tablets

    Supported for use following recommendation Consultant Cardiologist use only for treatment of angina in patients intolerant of a beta-blocker and calcium channel blocker.

    Supported for the treatment of chronic heart failure inline with NICE TA267. Treatment must be initiated, monitored and the dose tritrated by a heart failure specialist before responsibility for prescribing be transferred to primary care under a shared care agreement.

    08.01.05 Ixazomib Ninralo®
    • Ixazomib capsules

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    13.05.03 Ixekizumab Talz®
    • Ixekizumab Injection

    Approved for severe, active psoriatic arthritis in-line with NICE TA537

    (Consultant rheumatologist use only)

     Approved for use in line with NICE TA442 at specialist dermatology centres only. Not available at Airedale NHS Foundation Trust.

    A5.02.06 Kaltostat  For community patients only

    Alginate standard dressing
  • 10cm x 20cm
  • 15cm x 25cm
  • 5cm x 5cm
  • 7.5cm x 12cm
  • 30cm x 60cm
  • 2g packing

    Not available at Airedale NHS Foundation Trust

  • 15.01.01 Ketamine injection 
  • Ketamine Injection
  • 13.09 Ketoconazole  Ketoconazole Shampoo
    11.08.02 Ketorolac 0.5%  Acular®
    • Ketorolac 0.5% Eye Drops (5ml) with preservative

      For use following consultant recommendation only
    15.01.04.02 Ketorolac Trometamol 
  • Ketorolac Trometamol Injection

    Consultant Anaesthetists use only or under the advice of the Palliative Care Team.
  • 06.01.06 Ketostix  Ketostix testing strips
    A2.03.02 Kindergen®   For use on the recommendation of a dietitian only
    01.06.05 Klean-Prep Sachets  Four sachets when reconstituted with water to 4 litres provides an iso osmotic solution for bowel evacuation prior to colonic surgery, colonoscopy, or radiological examination. Use in accordance with Trust procedures.
    02.04 Labetalol 

    Green Traffic Light Labetalol Tablets
    Restricted for use:

    • in pregnant hypertensive patients


     
    Red Traffic Light Labetalol Injection
    Restricted for use:

    • In pregnant hypertensive patients
    • In theatre for the treatment of intraoperative hypertension
    • In ICU for the treatment of malignant hypertension
    02.06.02 Lacidipine 
    • Lacidipine Tablets

    Reserved for existing patients only.

    04.08.01 Lacosamide  Vimpat®
    • Lacosamide Tablets
    • Lacosamide Syrup
    • Lacosamide Solution for Infusion
       

    Adjunctive treatment of focal seizures with or without secondary generalisation when at least two other antiepileptics recommended by NICE (carbamazepine or lamotrigine) in conjunction with a second-line antiepileptic (levetiracetam, sodium valproate) have failed to control seizures.

    It is usually unnecessary to ensure that patients are maintained on a specific manufacturer’s product unless there are specific concerns such as patient anxiety, and risk of confusion or dosing errors.

    01.06.04 Lactulose 
  • Lactulose Solution

  • 04.08.01 Lamotrigine 
    • Lamotrigine Tablets
    • Lamotrigine Dispersible Tablets
    • Lamotrigine (Lamictal) Chewable/ Dispersible Tablets

    MHRA recommends that the need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer taking into account factors such as seizure frequency and treatment history.

    Restricted to Consultant Neurologist initiation only (epilepsy)

    Restricted to Consultant Psychiatrist initiation only if being used as a mood stabiliser

    06.01.06 Lancets One Touch Ultra Soft One Touch Ultra Soft Lancets
    08.03.04.03 Lanreotide 
    • Lanreotide Injection
    01.03.05 Lansoprazole  Zoton® First choice
  • Lansoprazole Capsules

    Restricted choice
  • Lansoprazole Orodispersible Tablets (Fastabs)

    Restricted to:
  • Patients with swallowing difficulties
  • Patients with enteral feeding tubes. Contact Pharmacy (ANHSFT) or Medicines Management team (AWC CCG) for advice on administration if required
  • Orodispersible tablets are not suitable for use in compliance aids.
  • 11.06 Latanoprost  Monopost®, Xalatan®
    • Latanoprost 50micrograms/ml Eye Drops (with preservative)
    • Latanoprost 50micrograms/ml Eye Drops (preservative free)

      For use following consultant recommendation only
    11.06 Latanoprost with Timolol  Xalacom®
    • Latanoprost 50micrograms/ml, Timolol 5mg/ml (with preservative)

      For use following consultant recommendation only
    10.01.03 Leflunomide  Consultant Rheumatologist use only
    08.02.04 Lenalidomide  Revlimid®
    • Lenalidomide Capsules

    Use restricted to Consultant Haematologists only.
     
    Lenalidomide is also available for other indications via the Cancer Drugs Fund.

    02.06.02 Lercanidipine Hydrochloride 
    • Lercanidipine Hydrochloride Tablets
    08.03.04.01 Letrozole 
  • Letrozole Tablets

  • 06.07.02 Leuprorelin Acetate Prostap®
    08.03.04.02 Leuprorelin Acetate 
  • Leuprorelin Injection

  • 05.05.04 Levamisole 
    • Levamisole 50mg/5mL Oral Suspension

    For initiation by Tertiary Centres for Paediatric Nephrotic Syndrome.

    04.08.01 Levetiracetam Keppra®
    • Levetiracetam Tablets
    • Levetiracetam Oral Solution


    It is usually unnecessary to ensure that patients are maintained on a specific manufacturer’s product unless there are specific concerns such as patient anxiety, and risk of confusion or dosing errors.

    Red Traffic Light Levetiracetam infusion 

    Green Levetiracetam infusion (For palliative care use only)

    11.06 Levobunolol Hydrochloride Betagan®
    • Levobunolol 0.5% Eye Drops (with preservative)
    • Levobunolol 0.5% Single Dose Eye Drops (preservative free)

      For use following consultant recommendation only
    15.02 Levobupivacaine 
  • Levobupivicaine 25mg/10ml
  • Levobupivicaine 50mg/10ml (single wrap)
  • Levobupivicaine 50mg/10ml (double wrap)
  • 15.02 Levobupivacaine with Fentanyl 
  • Fentanyl 2micrograms/ml with Levobupivicaine 0.1% in sodium chloride 0.9% (250ml)
  • 09.08.01 Levo-Carnitine 
    • Levo-Carnitine

     

    05.01.12 Levofloxacin  Green Traffic Light Levofloxacin Tablets
    Green Traffic Light Levofloxacin Infusion
    11.03.01 Levofloxacin  Oftaquix®
    • Levofloxacin 0.5% Eye Drops (with preservative)
    • Levofloxacin 5mg/ml Eye Drops (preservative free)

      For Consultant Ophthalmologist recommendation only for severe eye infections.
    04.02.01 Levomepromazine 
    • Levomepromazine Tablets
    • Green Levomepromazine Injection (palliative care indication only)
       

    Restricted to Psychiatry specialist recommendation only

    04.06 Levomepromazine Nozinan®
    • Levomepromazine Tablets
    • Levomepromazine Injection

    Restricted for palliative care or Psychiatry Consultant recommendation only.

    07.03.05 Levonorgestrel Levonelle®, Upostelle® levonorgestrel 1500 micrograms
    Upostelle® is the preferred brand for prescribing in primary care
    06.02.01 Levothyroxine  Levothyroxine tablets - no restrictions

    Restricted Item Levothyroxine oral solution - Very high cost in comparison to tablets. Please consider whether the liquid is absolutely necessary. Please note levothyroxine oral solution is not licensed for adminstration via enteral feeding tubes.

  • Note liquid preparations of different strengths are available - Please counsel patients appropriately to ensure the volume administered corresponds with the intended dose.
  • 27.05 Libra Lever Catheter Valve  Order Code: 10540A
    Pack Size: 5
    Drug Tariff Price £12.25
    02.03.02 Lidocaine 
    15.02 Lidocaine 

    Green <br>
Traffic Light Lidocaine 4% Topical Solution
    Green <br>
Traffic Light Lidocaine 1% Injection
    Green <br>
Traffic Light Lidocaine 2% Injection
    Green <br>
Traffic Light Lidocaine 1% Miniject
    Green Traffic Light Lidocaine (Lignocaine) 10% Spray

     

    Black Lidocaine 5% medicated plasters (Restricted)

    • For the treatment of neuropathic pain in cancer patients in whom pregabalin/gabapentin have been ineffective/not tolerated.
    • Prescribing restricted to Consultants in Haematology, Oncology and Palliative Care.
    • Use is to be audited.

      Not for routine prescribing in primary care in-line with NHSE recommendation (2017).

    15.02 Lidocaine 1%, adrenaline 0.1% and tetracaine 0.5% 
  • LAT® Gel (lidocaine 1%, adrenaline 0.1% and tetracaine 0.5%)

    For suturing of wounds in paediatric patients
  • 15.02 Lidocaine 2.5% with Prilocaine 2.5% EMLA®
  • Emla Cream (5g) with dressings (Lidocaine 2.5%/Prilocaine 2.5%)
  • 15.02 Lidocaine 4% Cream LMX4®
  • Lidocaine 4% Cream with dressings (LMX4)

    Used for surface anaesthesia of the skin prior to venous cannulation or venepuncture
  • 15.02 Lidocaine 5% and Phenylephrine 0.5% 
  • Lidocaine 5% + Phenylephrine 0.5% Nasal Spray

    Consultant ENT surgeons and Anaesthetists performing awake fibreoptic intubations.
  • 12.03.01 Lidocaine Hydrochloride , Cetalkonium Chloride  Bonjela® Teething Gel
    • Lidocaine Hydrochloride , Cetalkonium Chloride Teething Gel
    11.07 Lidocaine Hydrochloride 4% with Fluorescein 0.25% Minims®
    • Lidocaine Hydrochloride 4% with Fluorescein 0.25%
    15.02 Lidocaine with Adrenaline 
  • Lidocaine 1% Adrenaline 1:200,000 Injection
  • Lidocaine 2% Adrenaline 1:200,000 Injection
  • Lidocaine 2% Adrenaline 1:80,000 Cartridge
  • 15.02 Lidocaine2% with Chlorhexidine 0.25% Instillagel®
  • Instillagel Syringe
  • 01.06.07 Linaclotide 
  • Linaclotide

    For patients with IBS with constipation who had failed treatment on conventional laxatives and analgesics. Treatment is to be initiated by a hospital specialist via a GP Advice Note. Patients will be reviewed by a hospital specialist after 4 and 26 weeks of treatment to assess effectiveness
  • 06.01.02.03 Linagliptin Trajenta®

    Use supported for the treatment of type 2 diabetes, as an alternative to sitagliptin, in patients with moderate to severe renal impairment. Specialist recommendation use only.

    05.01.07 Linezolid 
  • Linezolid Tablets

    Linezolid is a third line antibiotic, to be used only with the agreement of Consultant Microbiologist’s and a senior pharmacist.
    Potential for the development of resistance, side effects, interactions and it’s high cost mean this antibiotic should be reserved for infections resistant to or non-responsive to vancomycin.
    Patients should be is monitored for blood dyscrasias (weekly FBC) and interactions (Linezolid shares MAOI interactions).
    Other serious side effects can occur with medium to long-term use(>14 days).
  • 06.02.01 Liothyronine injection  Not routinely stocked at Airedale pharmacy. If required, obtain urgently from BRI.
  • In normal working hours, contact BRI Pharmacy stores on 01274 364243
  • Out of hours, follow Stores SOP 7013 - Obtaining an item urgently, which has the necessary contact details.
  • 06.02.01 Liothyronine tablets 
    • Liothyronine Tablets

    Consultant Endocrinologist Initiation only

    Commissioned for treatment of primary hypothyroidism in line with the West Yorkshire and Harrogate Health and Care Partnership commissioning policy and the South West Yorkshire Area Prescribing Committee Shared Care Guideline.

    09.01.06 Lipegfilgrastim Lonquex®
    • Lipegfilgrastim

    Neutropenia prophylaxis for highly myelosuppressive chemotherapy for patients who do not tolerate daily filgrastim injections.

    Restricted to consultant haematologists/oncologist use only.

    13.10.05 LiquiBand®  Liquiband Flow Control tissue adhesive
    Liquiband tissue adhesive
    11.08.01 Liquid Paraffin 
    • Xailin Night® Eye Ointment (preservative free)
      (white soft paraffin 57.3%, liquid paraffin 42.5%, wool alcohols 0.2%)

      Eye ointments containing a paraffin may be used to lubricate the eye surface, especially in cases of recurrent corneal epithelial erosion. They may cause temporary vision disturbance and are best suited for application before sleep. Ointments should not be used during contact lens wear.
    13.02.01 Liquid Paraffin / White soft paraffin 50:50   Liquid Paraffin / White soft paraffin 50:50
    20 LIQUID PARAFFIN STERILE (20ml) 
    06.01.02.03 Liraglutide Victoza®
    • Liraglutide should be started only if patients have persistent nausea when on exenatide.
    • Supported for use in-line with NG28 (May 2017)

     BlackLiraglutide (Saxenda) for the treatment of obesity. Not routinely  commissioned.

    04.04 Lisdexamfetamine Elvanse>®
    • Lisdexamfetamine Capsules

    Restricted to Consultant Psychiatrist and Paediatrician initiation only.

    For use in line with BDCT formulary for attention deficit hyperactivity disorder in children and adolescents.

    02.05.05.01 Lisinopril 
    • Lisinopril Tablets
    04.02.03 Lithium 
    • Lithium Carbonate M/R Tablets (Priadel®)
    • Lithium Citrate Liquid (Priadel®)
    • Lithium Citrate Syrup (Li-Liquid®)
    • Lithium Carbonate M/R Tablets (Camcolit®) Restricted - Reserved for existing patients only

    Lithium citrate tetrahydrate 509mg is equivalent to lithium carbonate 200mg. Preparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment. 

    06.01.02.03 Lixisenatide subcutaneous injection Lyxumia® For the treatment of Type 2 diabetes in-line with NICE recommendations for the use of a GLP-1 agonist and as a cost effective alternative to exenatide or liraglutide.
    11.04.02 Lodoxamide  Alomide®
    • Lodoxamide 0.1% Eye Drops (with preservative)
    04.03.01 Lofepramine 
    • Lofepramine Tablets
    • Lofepramine SF Oral Suspension

    Restricted to Psychiatry specialist recommendation only

    01.04.02 Loperamide 
  • Loperamide Capsules
  • Loperamide SF Syrup
  • 05.03.01 Lopinavir with Ritonavir Kaletra® For use as part of HIV post-exposure prophylaxis regimen, stock is held in accident and emergency
    03.04.01 Loratadine  Loratadine Syrup
    Loratadine Tablets
    04.01.02 Lorazepam 

    Green Traffic Light Lorazepam Tablets

    Red Traffic Light Lorazepam Injection

    04.08.02 Lorazepam 
    • Lorazepam Injection
    02.05.05.02 Losartan 
    • Losartan Tablets
    11.04.01 Loteprednol  Lotemax®
    • Loteprednol 0.5% (Lotemax) with preservative

      Treatment of post operative inflammation following ocular surgery.
    03.01.05 Low range peak flow meter Pulmo-Aide®

    Peak flow meter (Pulmo-Aide low range)

    01.02 Lubiprostone Amitiza® Approved for use in line with NICE TA 318 (July 2014)

    Lubiprostone recommended as an option for treating chronic idiopathic constipation in adults when treatment with at least two laxatives from different classes, at the highest recommended doses for at least six months, has failed to provide adequate relief and for whom invasive treatment for constipation is being considered.

    Treatment should be recommended by a consultant gastroenterologist via a treatment advice note. Patients should only be prescribed a two week supply and not given any further supply until they have been reviewed by their General Practitioner.
    04.02.01 Lurasidone 
    • Lurasidone Tablets

    Restricted for Psychiatry specialist recommendation only.

    01.06.04 Macrogols Laxido®, Movicol®
  • Laxido Orange Sachets
  • Movicol paediatric sachets
  • Movicol Liquid
    An alternative to Laxido sachets for use in patients with dysphagia who require thickened fluids.
  • 09.05.01.03 Magnesium Aspartate Magnaspartate®
    • Magnesium L-Aspartate Dihydrate Sachets (10mmol) (Magnaspartate)

     

    09.05.01.03 Magnesium Glycerophosphate 
    • Magnesium glycerophosphate chewable tablets - more cost effective
    • Magnesium glycerophosphate oral solution
    09.05.01.03 Magnesium Sulphate 
    • Magnesium Sulphate 20% Injection (20mL,50mL)
    • Magnesium Sulphate 50% Injection (50mL)
    • Magnesium Sulphate infusion 20mmol in 100mL sodium chloride 0.9% (Unlicensed)
    • Magnesium Sulphate 50% Injection (5g/10mL) (For aseptics use only)
    13.10.04 Malathion 0.5% Derbac-M®

    Malathion 0.5% Liquid (Derbac M)

    27.13 Manfred Sauer p.hold 2cm Penis Holder Order Code: PHN
    Pack size: 1
    Drug Tariff Price £3.58
    27.13 Manfred Sauer p.hold 4cm Penis Holder Order Code: PHW
    Pack size: 1
    Drug Tariff Price £3.58
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  medium 28mm Order Code: 97.28
    Pack size: 30
    Drug Tariff Price £45.53
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  small 22mm Order Code: 97.22
    Pack size: 30
    Drug Tariff Price £45.53
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  medium 26mm Order Code: 97.26
    Pack size: 30
    Drug Tariff Price £45.53
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  large 37mm Order Code: 97.37
    Pack size: 30
    Drug Tariff Price £45.53
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  medium 30mm Order Code: 97.30
    Pack size: 30
    Drug Tariff Price £45.53
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  large 40mm Order Code: 97.40
    Pack size: 30
    Drug Tariff Price £45.53
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  large 35mm Order Code: 97.35
    Pack size: 30
    Drug Tariff Price £45.53
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  small 20mm Order Code: 97.20
    Pack size: 30
    Drug Tariff Price £45.53
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  small 24mm Order Code: 97.24
    Pack size: 30
    Drug Tariff Price £45.53
    27.12 Manfred Sauer P-Sure latex free, self adhesive sheath  large 32mm Order Code: 97.32
    Pack size: 30
    Drug Tariff Price £45.53
    27.18 Manfred Sauer uribag (female)  Order Code: URIBagF
    Pack size: 1
    Drug Tariff Price £13.72
    27.18 Manfred Sauer uribag (male)  Order Code: URIbag
    Pack size: 1
    Drug Tariff Price £13.72
    02.02.05 Mannitol 
    • Mannitol Infusion
    03.07 Mannitol (for inhalation) Osmohale®

    Mannitol, administered by inhalation, is agreed for use in bronchial hyper-responsiveness testing as part of difficult-to-diagnose asthma testing in the specialist asthma clinic.
     
     

    A2.04.01.01 maxijul® Super Soluble  Maxijul Super Soluble Powder
    Maxijul Super Soluble Sachets

    To be used on the recommendation of a dietitian only
    14.04 Measles, Mumps and Rubella Vaccine, Live (MMR) MMRvaxPRO®, Priorix®
    • MMRvaxPro® single dose brand excipients include porcine gelatine and neomycin
    • PRIORIX® vial (excipients include neomycin)
    05.05.01 Mebendazole 
  • Mebendazole Suspension
  • Mebendazole Tablets

  • 01.02 Mebeverine Hydrochloride  
  • Mebeverine Hydrochloride Tablets
  • Mebeverine Hydrochloride MR capsules
  • 06.01.06 Medisense Glucose Control Solution  Medisense Glucose Control Solution
    06.04.01.02 Medroxyprogesterone Acetate 
    07.03.02.02 Medroxyprogesterone Acetate Depo-Provera®

    Medroxyprogesterone acetate injection

    07.03.02.02 Medroxyprogesterone Acetate Sayana® Press

    Sayana® Press (medroxyprogesterone acetate suspension for injection in a pre-filled injector)

     An alternative to Depo-Provera® for self-administration, for long-term female contraception.

    08.03.02 Medroxyprogesterone Acetate 
  • Medroxyprogesterone Acetate Tablets
  • Medroxyprogesterone Acetate Injection
  • 10.01.01 Mefenamic Acid 
  • Mefenamic Acid Capsules
  • Mefenamic Acid Tablets
    Restricted to the treatment of dysmenorrhoea only
  • 08.03.02 Megestrol Acetate 
  • Megesterol Acetate Tablets
  • 04.01.01 Melatonin  Circadin ®
    • Melatonin M/R Tablets (Circadin)

    Restricted to paediatric patients only.

    04.01.01 Melatonin  
    • Melatonin 1mg/mL Liquid

    Restricted to paediatric patients only.

    08.01.01 Melphalan 
  • Melphalan Injection
  • Melphalan Tablets

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 04.11 Memantine 
    • Memantine Tablets
    • Memantine Oral Drops

    For use in-line with NICE TA217 (June 2018).

    09.06.06 Menadiol Sodium Phosphate 
    • Menadiol Sodium Phosphate

    Vitamin K formulation of choice for obstetric cholestasis (Unlicensed indication) supported by Royal College of Obstetrics Guidance, see below.

    14.04 Meningococcal ACWY polysaccharide vaccine 
    • For use within the Department of Health Primary Immunisation Schedule.
    14.04 Meningococcal Group B vaccine Bexsero®
    • For use within the Department of Health Primary Immunisation Schedule.
    14.04 Meningococcal group C conjugate vaccine 
    • Mejugate Kit® is also available in primary care as an alternative brand.
    A5.02.03 Mepitel One® 

    Mepitel One®

    Mepitel® One has an open mesh structure that allows for transfer of exudate and application of topical treatment. Safetac® Technology reduces pain and trauma during dressing changes.

    • 6cm x 7cm
    • 9cm x 10cm
    • 13cm x 15cm
    • 24cm x 27.5cm
    • 27.5cm x 50cm
    • 9.5cm x 150cm (Roll)
    15.02 Mepivacaine injection 
  • Mepivacaine Injection

    Reserved for use by chiropodists
  • 04.07.02 Meptazinol 
    • Meptazinol Injection
    09.08.01 Mercaptamine 
    • Mercaptamine
    08.01.03 Mercaptopurine 
  • Mercaptopurine Tablets

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • A2.02 Meretine Soup  Patients can buy this in the community but it cannot be prescribed by GP's
    05.01.02.02 Meropenem 
  • Meropenem injection

  • 01.05 Mesalazine Tablets Octasa®, Asacol®, Pentasa®, Mezavant®, Salofalk®
  • Tablets
  • Modified release tablets
  • Suppositories
  • Modified release sachets
  • Retention enema
  • Foam enema

    There is no evidence to show that any one oral preparation of mesalazine is more effective than another; however, the delivery characteristics of oral mesalazine preparations may vary.

    Octasa® is the preferred brand in terms of value for money.
  • Patients starting mesalazine treatment should be commenced on the Octasa® brand.
  • Patients stable on their current brand of mesalazine should not be switched
  • A switch to the Octasa® brand should be considered for patients who require a dose change
  • patients expressing a brand preference should have their wishes considered.
  • 08.01 Mesna 
  • Mesna Injection
  • Mesna Tablets
  • Mesna Infusion

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 13.02.02 Metanium® 

    Metanium Ointment

    Can be used on broken / excoriated skin

    02.07.02 Metaraminol 
    • Metaraminol Injection

    For use in cardiac catheter lab, theatre, ICU and A&E only.

    06.01.02.02 Metformin 

    Metformin tablets (500mg, 850mg) - No restriction

    Restricted Item Metformin solution (500mg/5mL)
    Metformin solution is expensive, and should only be used for patients who are unable to swallow tablets or with enteral feeding tubes

    Restricted ItemMetformin SR tablets (500mg, 750mg, 1gram)
    For patients developing intolerable GI side effects to immediate-release metformin after a minimum of 3-months treatment.
    Please prescribe Sukkarto SR brand in primary care. Sukkarto SR tablets are available as 500mg and 1gram tablets.

    04.10.03 Methadone 
    • Methadone Tablets
    • Methadone Mixture
    • Methadone sugar-free Mixture

    Restricted for treatment of opioid addiction

    Red Traffic Light Methadone Injection

    18 Methionine 500mg tablets  Used in the management of poisoning with paracetamol overdose when no IV access.
    08.01.03 Methotrexate 
  • Methotrexate Injection

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 10.01.03 Methotrexate  Consultant Rheumatologist use only
    Given as a once weekly dose
  • Methotrexate injection for subcutaneous use
  • Methotrexate Tablets
  • 01.06.01 Methylcellulose  
  • Methylcellulose Tablets

    Consultant Gastroenterologist initiation or recommendation only for occasional treatment of

    1. Distal colitis and proximal consiptation
    2. Diverticular disease
    3. Irritable Bowel Syndrome

  • 02.05.02 Methyldopa 
    • Methyldopa Tablets

    Methyldopa may be used for management of hypertension during pregnancy.

    01.06.06 Methylnaltrexone  
  • Methylnaltrexone Solution Injection

    Consultant initiation only

    This product is not kept in stock at ANHSFT. It will need to be ordered on request.
  • 04.04 Methylphenidate Hydrochloride Equasym®, Matoride®, Medikinet, Ritalin®, Concerta XL®
    • Methylphenidate Tablets 

    Restricted to Consultant Psychiatrist and Paediatrician initiation only.

    For use in line with NICE NG87: Attention deficit hyperactivity disorder: diagnosis and management (March 2018) - See link at the bottom of the section.

    Please prescribe by brand

    06.03.02 Methylprednisolone 

      Oral preparations

    • Methylprednisolone Tablets
      Used when a dose of 1g is required in oncology patients

      Oral preparations

    • Methylprednisolone Acetate Injection
    • Methylprednisolone Sodium Succinate Injection
    10.01.02.02 Methylprednisolone Acetate 
    10.01.02.02 Methylprednisolone Acetate with Lidocaine 
    04.06 Metoclopramide Hydrochloride Maxolon®
    • Metoclopramide Tablets
    • Metoclopramide Syrup
    • Metoclopramide Injection

    Metoclopramide should only be prescribed for short-term use (up to five days)

    02.02.01 Metolazone 
    • Metolazone Tablets (5mg) 

    UNLICENSEDItalian brand to be used only.

    Use approved for the short-term treatment of acute exacerbation of heart failure.

     

    02.04 Metoprolol  Green Traffic Light Metoprolol Tablets
    Green Traffic Light Metoprolol MR Tablets
    Red Traffic Light Metoprolol Injection


    05.01.11 Metronidazole  Green Traffic Light Metronidazole Suspension
    Green Traffic Light Metronidazole Suppositories
    Green Traffic Light Metronidazole Tablets
    Green Traffic Light Metronidazole Infusion

    13.10.01.02 Metronidazole Metrogel® Metronidazole (Metrogel) 0.75% Gel

    Reserved for patients with

    Acne Roacea

    Infection or colonisation of wounds with anaerobic bacteria may produce an offensive odour. Metronidazole is active against anaerobic organisms and topical use can lead to reduced smell.
    06.07.03 Metyrapone  
    • Metyrapone Tablets

    Specialist initiation only

    Restricted to Consultant Endocrinologist use.

     

     

    02.03.02 Mexiletine 
    • Mexiletine capsules
    12.03.02 Miconazole  Daktarin®
    • Miconazole 20mg/g Oral Gel (80g) Available for general use.
    • Miconazole 20mg/g Oral Gel (15g) Available for Children's Unit.
    13.10.02 Miconazole Cream  Miconazole nitrate 2% Cream
    07.02.02 Miconazole nitrate  
    04.08.02 Midazolam Buccolam®
    • Midazolam Oromucosal Solution - Buccolam ®

    Please note this is a different strength to the previously used, unlicensed product. It should be prescribed by the brand name with the dose in mLs and mgs. 
     
    Please note Schedule 3 CD and is subject to special prescription requirements and to safe custody requirements.

    15.01.04.01 Midazolam injection  Green Traffic Light Midazolam Injection
  • Theatres 1 -7 and recovery keep 2mg/2ml

    Green Traffic Light Midazolam Injection (Restricted)
  • Used in A&E, Catheter Lab, Radiology, Endoscopy and ICU for conscious sedation.

    Green Traffic Light Midazolam Injection (10mg/2ml) (Restricted)
  • Reserved for use in
    1. Aseptics for preparation of syringes,
    2. For oral buccal anaesthesia preoperatively for some patient attending for dental treatment
    3. For subcutaneous administration in palliative care

    Green Traffic Light Midazolam Injection (50mg/10ml) (Restricted)
  • Stock to be kept in theatre recovery and ward 17 only.
  • Reserved for sedation of patients in transit who are being transferred to other hospitals.
  • Use by the Embrace team from Sheffield who arrange transfer of children to paediatric intensive care units.
  • Can be issued to A&E if needed for the embrance team only but they don’t routinely keep it in stock.


  • 02.14 Midodrine Tablets 
    • Midodrine Tablets
    07.01.02 Mifepristone 

    Mifepristone Tablets

    02.01.02 Milrinone Primacor®
    • Milrinone Injection
    07.04.02 Mirabegron MR Tablets  Betmiga®

    Approved for use as a treatment option for the symptoms of overactive bladder only for patients in whom other antimuscarinic drugs are contraindicated or clinically ineffective or have unacceptable side effects (in line with NICE TA290).

     

    Approved in line with the AWC CCG/ ANHSFT Guidance for the Treatment for Overactive bladder in Females (at the top of the formulary section).

    04.03.04 Mirtazapine Zispin®
    • Mirtazapine Tablets
    • Mirtazepine Orodispersible Tablets
      Reserved for patients with swallowing difficulties only
    07.01.01 Misoprostol 

    Misoprostol tablets

    Rectal use (unlicensed)

    For second-line treatment of PPH after oxytocin / ergometrine or if oxytocin / ergometrine inappropriate

    07.01.01 Misoprostol 

    Misoprostol tablets
    Vaginal and oral use

    For medical management of miscarriages

    08.01.02 Mitomycin 
  • Mitomycin Injection
  • Mitomycin C Injection
  • Mitomycin C bladder instillation

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 08.01.02 Mitoxantrone (Mitozantrone) 
  • Mitoxantrone Injection

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 15.01.05 Mivacurium Chloride injection 
  • Mivacurium injection
  • 04.03.02 Moclobemide 
    • Moclobemide Tablets

    Restricted to Consultant Psychiatrist initiation only

    04.04 Modafinil 
    • Modafinil Tablets 

    Restricted to Respiratory Consultant use only for the treatment of excessive daytime sleepiness associated with narcolepsy

    A2.03.02 Modulen IBD  For use on the recommendation of a dietitian only
    12.02.01 Mometasone Furoate Nasonex®
    • Mometasone Furoate Aqueous Nasal Spray

    Prescribe generically in primary care.

    13.04 Mometasone Furoate 0.1% Elocon®

    Mometasone furoate 0.1% cream (Elocon)
    Mometasone furoate 0.1% ointment (Elocon)

    Mometasone furoate 0.1% scalp lotion (Elocon)

    A2.03.01 Monogen Powder  

    Specialist Medium Chain Triglyceride (MCT) feed used in liver disease, fat malabsorption and pancreatic insufficiency only.

    For use on the recommendation fromtertiary centre only.

    02.11 Monsels solution (ferric subsulfate 20%)  
    • Monsels solution

    For use in colposcopy clinic only.

    unlicensedunlicensed
    Use must be recorded on the unlicensed medicine ward stock record sheet for Monsels solution which is provided with each bottle supplied to the clinic.

    03.03.02 Montelukast  Montelukast Chewable Tablets
    Montelukast Tablets
    Montelukast Granules
    04.07.02 Morphine MST®, Zomorph®

    Green Traffic Light Morphine Sulphate Oral Solution
    Green Traffic Light Morphine Sulphate MR Sachets
    Green Traffic Light Morphine Sulphate MR Tablets - Please prescribe by brand.
    Green Traffic Light Morphine Sulphate Injection - Caution with different strengths. ANHSFT high strength for Aseptics only

    ANHSFT currently have stock of the Hameln brand of 10mg/1ml morphine sulphate injection. It does not contain preservatives and is available for spinal anaesthesia as an alternative during the diamorphine shortage.

     

    02.05.02 Moxonidine 
    • Moxonidine Tablets

    Supported for the treatment of resistant hypertension only.

    09.06.07 Multivitamin preparations Dalivit® and Abidec®
    • Dalivit Drops
    • Abidec Drops
    13.10.01.01 Mupirocin Bactroban® Mupirocin 2% Cream
    Mupirocin 2% Ointment
    08.02.01 Mycophenolate Mofetil 
  • Mycophenolate Mofetil Capsules

    Prophylaxis of acute renal, cardiac or hepatic transplant rejection (in combination with ciclsporin and corticosteroids) under specialist supervision

    Also supported for use by consultants for the following specialties (unlicensed uses):

    1. Rheumatology - Usually considered in active SLE or other serious connective tissue diseases and vasculitides
    2. Gastroenterology – considered in very occasional inflammatory bowel disease patients and autoimmune hepatitis
    3. Neurology – usually considered in myasthenia gravis as steroid sparing agent.
    4. Respiratory
    a. idiopathic pulmonary fibrosis intolerant to azathioprine often awaiting lung transplant
    b. pulmonary vasculitides (Wegner’s granulomatosis, CSS and microscopic polyangitis)
  • 27.07 NaCl 50mls for mechanical flush only Order Code: FB99849
    Pack Size: 10
    Drug Tariff Price £3.35
    02.06.04 Naftidrofuryl Oxalate 
    • Naftidrofuryl Capsules
    04.10.01 Nalmefene Selincro®
    • Nalmefene Tablets

    Restricted to use by Specialist Alcohol Services only

    01.06.06 Naloxegol Moventig® Restricted for opioid induced constipation, when initiated at a specialist centre in line with NICE TA345.

    Naloxegol is not routinely stocked at ANHSFT, but will be ordered on request for individual patients.
    15.01.07 Naloxone Hydrochloride injection 
  • Naloxone Injection (400micrograms/1ml)
  • Naloxone Injection (2mg/2ml)
  • 10.01.01 Naproxen 
  • Naproxen Tablets
  • Naproxen E/C Tablets
  • 03.01.05 Nebuliser kit® Drug Delivery Device Nebuliser kit with adult mask
    Nebuliser kit with mouthpiece
    11.04.02 Nedocromil  Rapitil®
    • Nedocromil 2% sodium Eye Drops (with preservative)
    04.07.01 Nefopam 
    • Nefopam Tablets 

    Under review - reserved for existing patients only.

    05.03.01 Nelfinavir  Nelfinavir Tablets (250mg)

    Reserved for patients as part of a HIV treatment plan under a HIV specialist consultant
    or
    Used for the purposes of HIV Post-Exposure Prophylaxis (PEP), in accordance with the local protocol
    A2.03.01 Neocate Advance  Not kept in stock

    Bought in on the request of dietitians only
    A2.03.01 Neocate LCP 
    A2.03.01 Neocate® Syneo Infant Formula  

    Infants with cow’s milk allergy who require an amino acid based formula with the addition of pre- and pro-biotics (Specialist initiation only)

     

    05.01.04 Neomycin 
    • Neomycin tablets

    For the treatment of acute hepatic encephalopathy during inpatient stay

    Consultant Gastroenterologist use only

    10.02.01 Neostigmine 
    15.01.06 Neostigmine injection 
  • Neostigmine Injection
  • 15.01.06 Neostigmine with Glycopyrronium 
  • Neostigmine with Glycopyrridium (Robinul-Neostigmine)
  • A2.03.02 Nepro® HP Liquid  For use on the recommendation of a dietitian only
    08.01.05 Neratinib  Nerlynx®
    • Niraparib tablets (Nerlynx®)

    Approved as an option for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab in-line with provisional NICE recommendations.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    04.06 Netupitant 300mg + palonosetron 0.5mg capsules Akynzeo®
    • Netupitant 300mg + Palonosetron 0.5mg Capsules

    Approved for a 12-month audit for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based chemotherapy.

    Restricted to Haematology / Oncology use only.

    05.03.01 Nevirapine  Nevirapine Tablets (200mg)

    Reserved for patients as part of a HIV treatment plan under a HIV specialist consultant
    02.06.03 Nicorandil 
    • Nicorandil Tablets
    04.10.02 Nicotine NiQuitin® CQ
    • Niquitin CQ Lozenges (2mg, 4mg)

    Initiated by smoking cessation nurse.

    04.10.02 Nicotine Nicorette®
    • Nicorette inhalator 10mg, 15mg Refill
    • Nicorette inhalator Starter Pack
    04.10.02 Nicotine Nicotinell®
    • Nicotinell 1mg Lozenges
    04.10.02 Nicotine NiQuitin® CQ
    • Niquitin CQ 7mg Patches (24 hour)
    • Niquitin CQ 14mg Patches (24 hour)
    • Niquitin CQ 21mg Patches (24 hour)
    • Niquitin Minis Lozenges 1.5mg, 4mg

    The 24 hour patches can be removed after 16 hours, if for example, nicotine replacement therapy is not required at night.

    04.10.02 Nicotine Nicorette®
    • Nicorette 2mg Gum

    Initiated by smoking cessation nurse.

    02.06.02 Nifedipine 
    • Nifedipine Capsules
    • Nifedipine MR Tablets
    08.01.05 Nilotinib Tasigna®
    • Nilotinib Tablets

      Blueteq® registration and approval for use is required for this product before it may be dispensed.
    02.06.02 Nimodipine 
    • Nimodipine Tablets

    Supported for the prevention and treatment of ischaemic neurological defects following aneurismal subarachnoid haemorrhage.

    08.01.05 Nintedanib capsules  Vargatef®
    • Nintedanib Capsules (Vargatef®)


    08.01.05 Niraparib Zejula®
    • Niraparib Capsules (Zejula®)


    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    Consultant Oncologist use only

    04.01.01 Nitrazepam 
    • Nitrazepam Tablets
    • Nitrazepam Oral Suspension

    Reserved for existing patients only

    05.01.13 Nitrofurantoin 
  • Nitrofurantoin Tablets
  • Nitrofurantoin Capsules
  • Nitrofurantoin MR Capsules
  • Nitrofurantoin Suspension

  • To minimise the incidence of gram-negative bloodstream infection, GPs and other primary care prescribers are being encouraged to use nitrofurantoin first-line, as opposed to trimethoprim
  • In secondary care, trimethoprim remains the first-line option for treatment of UTIs in patients who have not previously received treatment for UTIs as per local guidance (see below - ANHSFT access only)
  • Please note: Nitrofurantoin suspension is very expensive. Consult pharmacy if your patient requires a liquid preparation, as alternative options may be more appropriate.
  • 15.01.02 Nitrous oxide 
    08.01.05 Nivolumab Opdivo®
    • Nivolumab Infusion

    Consultant Oncologist use only.

    For use at Specialist Centres only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    A5.02.03 Non-adherent polyester mesh wound contact layer Atrauman® Non-adherent polyester mesh wound contact layer. 1mm pore size and impregnation of neutral triglycerides prevent penetration of granulation tissue into dressing. It is effective for up to 7 days. It is petrolatum free.

  • 5cm x 5cm
  • 7.5cm x 10cm
  • 10cm x 20cm
  • 20cm x 30cm

  • Note: This replaces the use of Silflex for all indications except those listed below.
    Ensure Atrauman® dressings are stored flat, to prevent drying out
  • A5.02.05 Non-adhesive foam dressing Tegaderm Foam®

    Alternative non-adhesive foam dressing product for community patients  + ANHSFT only
    Tegaderm® Foam Non-adhesive (Foam dressing)

    • 8.8cm x 8.8cm square (fenestrated)
    • 10cm x 10cm square
    • 10cm x 20cm rectangular
    • 20cm x 20cm square
    • 10cm x 60cm rectangular
       
    02.07.02 Noradrenaline (Norepinephrine) 
    • Noradrenaline (Norepinephrine) Infusion
    06.04.01.02 Norethisterone 
    07.03.02.01 Norethisterone Noriday®

    Norethisterone Tablets (Noriday)

    14.05.01 Normal Immunoglobulin Iqymune®, Privigen®, Kiovig®, Intratect® and others
    • Prescribing must be in-line with the Department of Health Clinical Guidelines for Immunoglobulin Use and the ANHSFT SOP. See the link below to the Pharmacy Aireshare page for more information

      Normal immunoglobulin 10%
    • Iqymune® 10% - the IVIG of choice at ANHSFT. It is administered via intravenous infusion.
    • Privigen® 10% is administered via intravenous infusion.
    • Kiovig® 10% and Intratect 10% are licensed for administration via intravenous infusion.

      Normal immunoglobulin 5%
    • Vigam® 5%, Intratect® 5% are licensed for administration via intravenous infusion.

      Normal immunoglobulin 16%
    • Subcuvia® 16% is licensed for use via subcutaneous or intramuscular administration. Reserved for use by consultant paediatricians only.

      Other brands may be supplied if required, on the advice of a specialist in a tertiary centre.

      For further information about the paperwork required for immunoglobulin supply, refer to the Pharmacy Aireshare pages at the link below (ANHSFT access only).
    04.03.01 Nortriptyline 
    • Nortriptyline Tablets

    Restricted to psychiatry specialist recommendation only

    Note: Nortriptyline is very expensive

    A2.05.02 Nutilis® Complete Stage 1  For restricted use in stroke patients with dysphagia who require oral nutritional supplements under the recommendation of a Speech & Language Therapist or a Dietician.

    Equivalent product for prescribing in community only
  • Continue in the community if Stage 1 fluids are advised.
  • Follow Speech & Language Therapist advice regarding fluid texture.
  • There are other Nutilis products for different stages.
  • A2.05.02 Nutilis® Complete Stage 2  For restricted use in stroke patients with dysphagia who require oral nutritional supplements under the recommendation of a Speech & Language Therapist or a Dietician.
    A2.05.02 Nutilis® Powder  Available as powder in a tin, or in sachets
    A2.05.02 Nutilis® Clear 

    Nutilis Clear is the thickener used at ANHSFT

    A2.03.01 Nutramigen Powder 1 and 2 
    A2.04 Nutricia preOp  Nutricia preOp drinks (200ml)

    For use in patients undergoing elective colorectal surgery as part of the Enhanced Recovery Programme
    A2.02 Nutricia Pre-Op  Restricted for use as part of the Enhanced Recovery Protocol only.
    09.03 Nutriflex Lipid 
    • Nutriflex Lipid Special Electrolyte Free (1250mL, 1875mL, 2500mL)
    • Nutriflex Lipid Peri (1250mL, 1875mL)
    • Nutriflex Lipid Special (1875mL)

     

    09.03 Nutriflex Lipid Plus 
    • Nutriflex Lipid Plus (1875mL)
    09.03 Nutriflex Omega Special 
    • Nutriflex Omega Special (1250mL)
    A2.01.03.02 Nutrini   For use on the recommendation of a dietitian only
    A2.01.03.02 Nutrini Energy   For use on the recommendation of a dietitian only
    A2.01.03.04 Nutrini Energy Multifibre 
    A2.01.03 Nutrini Fibre 
    A2.01.03.04 Nutrini Low Energy Multifibre  
    A2.01.01.01 Nutrini Peptisorb® 
    A2.01.02.03 Nutrison Concentrated  
    A2.01.01.01 Nutrison Low Sodium  
    A2.01.01.01 Nutrison Peptisorb 
    A2.01.01.01 Nutrison Water Pack 
    A2.01.01.01 Nutrison®  
    A2.01.02.01 Nutrison® Energy 
    A2.01.01.01 Nutrison® Energy Multi Fibre  
    A2.01.02.01 Nutrison® Energy Multi Fibre  
    A2.01.02.01 Nutrison® Protein Plus 
    A2.01.02.01 Nutrison® Protein Plus Multi-Fibre 
    A2.01.01.01 Nutrison® Soya  
    A2.01.01.01 Nutrison® Soya Multi Fibre  Restricted to dietitian recommendation only
    A2.01.01.01 Nutrison® Multi Fibre  
    13.04 Nystaform-HC®  Hydrocortisone 1%, nystatin 100,000units/g, chlorhexidine acetate 1% (Nystaform HC Ointment)

    Not stocked but will be ordered in if required
    12.03.02 Nystatin 
    • Nystatin 100,000units/mL Sugar Free Suspension

     

    01.09.01 Obeticholic acid  Ocaliva®
  • Obeticholic acid Tablets

    Approved in line with NICE TA443.
    Available via referral to commissioned specialist services only.
  • 08.02.03 Obinutuzumab Gazyvaro®
    • Obinutuzumab Infusion (Gazyvaro®)

    Consultant Haematologist use only

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    12.02.03 Octenidine Hydrochloride Octenisan®
    • Octenidine Hydrochloride Nasal Ointment

    For restricted use as a second-line option for MRSA decolonisation for patients resistant to or with contraindications to mupirocin.

    13.10.01.01 Octenidine hydrochloride Octenisan® Octenidine hydrochloride nasal gel (Octenisan®)
    Octenidine hydrochloride antimicrobial wash lotion (Octenisan®)


    For restricted use as a second-line option for MRSA decolonisation for patients resistant to or with contraindications to mupirocin.
    08.03.04.03 Octreotide 
  • Octreotide Injection

    1. Symptoms associated with carcinoid tumours with features of carcinoid syndrome.
    2. Prevention of complications following pancreatic surgery.
  • 06.04.01.01 Oestrogen transdermal HRT  For women post hysterectomy

    06.04.01.01 Oestrogens HRT tablets  For women post hysterectomy

    08.02.03 Ofatumumab  Arzerra®
    • Ofatumumab Infusion (Arzerra®) 
       
    05.01.12 Ofloxacin 
  • Ofloxacin Tablets

  • 13.02.01.01 Oilatum® Plus  Oilatum Plus Bath Additive(with antimicrobial)

    These are expensive and should only be used when other products have been tried
    04.02.01 Olanzapine Zyprexa®, Zalasta® Amber Traffic Light Olanzapine tablets

    Red Traffic Light Olanzapine injection

    Amber Traffic Light Olanzapine Orodispersible Tablets
  • Reserved for use in patients who cannot swallow tablets only

    Restricted for Psychiatry specialist recommendation only
  • 04.02.02 Olanzapine embonate ZypAdhera®
    • Olanzapine Embonate Depot Injection

    Restricted to Consultant Psychiatrist use only

    For 'named patient' use only

    08.01.05 Olaparib Capsules Lynparza®
    • Olaparib Capsules
       
    12.01.03 Olive Oil  
    • Olive Oil Ear Drops
    02.05.05.02 Olmesartan medoxomil 
    • Olmesartan medoxomil Tablets

    Reserved for existing patients only.

    03.01.01.01 Olodaterol Striverdi® Olodaterol
  • Solution for inhalation via Respimat® inhaler device
  • Licensed for COPD
  • 11.04.02 Olopatadine  Opatanol®
    • Olopatadine 0.1% Eye Drops (with preservative)

      Useful as twice daily dosage
    01.05.01 Olsalazine  
  • Olsalazine Capsules

    For the treatment of existing patients only
  • 03.04.02 Omalizumab  Omalizumab Injection

    For use by Respiratory Consultants for the treatment of severe persistent asthma. Supported for use in-line with NICE TA278 (April 2013).

    Blueteq® registration and approval for use is required for this product before it may be dispensed.
    05.03.03.02 Ombistavir/paritaprevir/ritonavir  Viekirax®
  • Ombistavir/paritaprevir/ritonavir (Viekirax®)

    For the treatment of hepatitis C in line with NICE TA365. Use restricted to Consultant Gastroenterologists only.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 02.12 Omega-3-Acid Ethyl Esters Omacor®
    • Omega-3-Acid Ethyl Esters 

    Restricted for the treatment of hyperglyceridaemia in those patients who are intolerant of other lipid-lowering agents or patients in whom other lipid-lowering agents have been ineffective.

    Green Traffic Light for secondary prevention in those who have had a myocardial infarction - NICE CG172 no longer recommends its use

    Green Traffic Light for the treatment of multiple sclerosis in-line with NICE CG186

    Green Traffic Light for hypertriglyceridaemia

    Not for routine prescribing in primary care in-line with NHSE recommendation (2017).

     

    01.03.05 Omeprazole  Losec® First choice
    Green Traffic Light 
  • Omeprazole Capsules

    In primary care prescribe 40mg dose as 2 x 20mg capsules as this is more cost-effective

    Restricted choice
    Green Traffic Light 
  • Omeprazole MUPS®

    Restricted to:
  • Patient with swallowing difficulties in whome lansoprazole orodispersible tablets are unsuitable. See SPC link to left hand side for administration guidance for patients with swallowing difficulties.
  • Paediatric patients at ANHSFT when recommended by a tertiary centre.
  • Omeprazole MUPS® are not suitable for use in compliance aids.

    Red Traffic Light 
  • Omeprazole Injection

    At the request of an endoscopist for patients who have undergone endoscopic treatment of bleeding duodenal ulcers, gastric ulcers and oesophageal ulcers.
  • 04.06 Ondansetron Zofran®
    • Ondansetron Tablets
    • Ondansetron Orodispersible Tablets
    • Ondansetron Syrup
    • Ondansetron Injection 

    Restricted Item Ondansetron 8mg/4ml injection and 8mg tablets are restricted to use by consultant haematologists and oncologists for the prevention of nausea and vomiting induced by highly emetogenic chemotherapy.

    04.09.01 Opicapone Ongentys ®
    • Opicapone Capsules

    For the treatment of late stage Parkinson’s disease with motor fluctuations as an alternative for patients unable to tolerate entacapone.

    Parkinson’s Disease Consultant or Consultant Neurologist initiation.

    06.01.06 Oral glucose tolerance test solution 

    Polycal® Liquid
    For oral glucose tolerance test (OGTT) - 113mL to be diluted with water to a total volume of 200 – 300mL.  For obstetrics use only.

    Rapilose OGTT

    07.03.02 Oral Progestogen-Only Contraceptives Femulen®

    Etynodiol Tablets (Femulen)

    07.03.02 Oral Progestogen-Only Contraceptives Norgeston®

    Levonorgestrel Tablets (Norgeston®)

    09.02.01.02 Oral Rehydration Salts Dioralyte®
    • Oral Rehydration Salts
    12.03.05 Oralieve®  
    • Oralieve® Moisturising Gel
    04.05.01 Orlistat 
    • Orlistat Capsules (120mg)

    Reserved for patients who are being treated according to NICE CG43

    04.09.02 Orphenadrine Hydrochloride 
    • Orphenadrine Elixir
    05.03.04 Oseltamivir Tamiflu®
  • Oseltamivir Capsules
  • Oseltamivir Suspension

    Reserved for prophylaxis and treatment of seasonal influenza when NICE guidance is active (See technology appraisals TA158 and TA168)
  • 08.01.05 Osimertinib mesylate  Tagrisso®
    • Osimertinib Tablets

    Consultant Medical Oncologist use only.

     

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    07.03.04 Other Contraceptive Devices  Diaphragm Flat Spring 60mm, 65mm, 70mm, 75mm, 80mm, 85mm, 90mm
    07.03.04 Other Contraceptive Devices  Diaphragm arching spring (various sizes bought in as necessary)
    12.01.01 Otocomb Otic 
    • Otocomb Otic Ear Ointment
    08.01.05 Oxaliplatin 
    • Oxaliplatin Injection
       
    04.01.02 Oxazepam 
    • Oxazepam Tablets
    07.04.02 Oxybutynin Hydrochloride 

    Oxybutinin tablets

    Oxybutinin Elixir

    Oxybutynin M/R Tablets (Lyrinel®XL) 

    Modified release oxybutinin is expensive compared with the standard release preparations. They should only be used where compliance is a problem.

    07.04.02 Oxybutynin patch 

    Oxybutynin patches

    Use third line after other treatments

    04.07.02 Oxycodone OxyContin®, OxyNorm®, Longtec®, Shortec®

    Green Traffic Light Oxycodone Capsules
    Green Traffic Light Oxycodone M/R Tablets
    Green Traffic Light Oxycodone Liquid
    Green Traffic Light Oxycodone SF Liquid

    Reserved for second line use.


    In primary care, please prescribe Longtec® and Shortec® brands, as they are the most cost-effective.
     
     Green Traffic Light  Oxycodone Injection - restricted to use in pharmacy aseptics for the preparation of syringes or palliative care.

    03.06 Oxygen 


     

    05.01.03 Oxytetracycline 
  • Oxytetracycline Tablets
  • 07.01.01 Oxytocin 

    Oxytocin Injection

    08.01.05 Paclitaxel 
    • Paclitaxel Injection
    • Paclitaxel Infusion
    • Paclitaxel as albumin-bound nanoparticles Infusion
       
    A2.04.02 Paediatric Seravit®  
    08.01.05 Palbociclib Ibrance®
    • Palbociclib capsules


    Blueteq® registration and approval for use is required for this product before it may be dispensed.

     

    04.02.02 Paliperidone Xeplion®, Trevicta®
    • Paliperidone Injection (Xeplion®) Product for monthly administration only.
    • Paliperidone Injection (Trevicta®) Product for three-monthly administration only.

    Restricted to Psychiatry Specialist initiation only

    05.03.05 Palivizumab 
  • Palivizumab Injection

    Consultant Paediatrician use only
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 04.06 Palonosetron Aloxi®
    • Palonosetron Soft Capsules

    Approved second-line for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy (as an alternative to aprepitant).

    01.09.04 Pancreatin Creon®
  • Pancreatin

    Consultant Gastroenterologist initiation or recommendation only
    See BNF for advice on the use of high strength pancreatin preparations
  • 15.01.05 Pancuronium Bromide injection 
  • Pancuronium Injection
  • 08.01.05 Panitumumab infusion Vectibix®
    • Panitumumab infusion (Vectibix®) 

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    08.02.04 Panobinostat Farydak®
    • Panobinostat Capsules


    Consultant haematologist only.

    01.03.05 Pantoprazole Protium® Reserved for existing patients only
    07.04.05 Papaverine 

    Papaverine Injection 

    Although not licensed the smooth muscle relaxant papaverine has also been given by intracavernosal injection for erectile dysfunction. Patients with neurological or psychogenic impotence are more sensitive to the effects of papaverine than those with vascular abnormalities.

    04.07.01 Paracetamol 
    • Paracetamol Caplets/Tablets
    • Paracetamol Suspension Paracetamol Suppositories
      Restricted Item Paracetamol Soluble Tablets (restricted to patients with swallowing difficulties only. Note: high sodium content of tablets and increased cost)
    04.07.01 Paracetamol  
    • Paracetamol Infusion

    Restricted to patients in whom the oral route isn't available or appropriate.

    04.07.01 Paracetamol and codeine Co-codamol
    • Co-codamol Tablets 30/500 (paracetamol 500mg, codeine phosphate 30mg)
    • Restricted Item Effervescent tablets are available, but are resticted to patients with swallowing difficulties because of the high sodium content and increased cost.
    • Co-codamol 8/500 (paracetamol 500mg, codeine phosphate 8mg).
    • Note, this strength is not included in the ANHSFT Acute pain analgesic ladder. Please refer to the link below for preferred products.
    • Restricted Item Effervescent tablets are available, but are resticted to patients with swallowing difficulties because of the high sodium content and increased cost.
    04.07.01 Paracetamol and dihydrocodeine Co-dydramol®
    • Co-dydramol 10/500 Tablets (paracetamol 500mg with dihydrocodeine 10mg)

    Note, this strength is not included in the ANHSFT Acute pain analgesic ladder. Please refer to the link below for preferred products.

    04.08.02 Paraldehyde 
    • Paraldehyde Injection
    • Paraldehyde/ Olive Oil Enema 50%
    15.01.04.02 Parecoxib injection 
  • Parecoxib Injection

    Consultant Anaesthetists use only
  • 04.03.03 Paroxetine Seroxat®
    • Paroxetine Tablets
    • Paroxetine SF Liquid

      Restricted to specialist initiation only
    09.03 Peditrace Solution 
    • Peditrace Solution (10mL)
    08.02.04 Peginterferon Alfa 
  • Peginterferon Alfa-2B Prefilled Pen

    Consultant Gastroenterologist use only for the treatment of hepatitis C in combination with ribavirin capsules in line with NICE TA106, TA200 and TA75.

  • 08.01.05 Pembrolizumab Keytruda®

    For use at specialist centres only in line with NICE TA357 and TA366.

    For treating for treating PD-L1-positive non-small-cell lung cancer after chemotherapy in-line with NICE TA428 and NICE TA447.

    For locally advanced or metastatic urothelial cancer after platinum-containing therapy in-line with NICE TA519

    Consultant Medical Oncologist use only

     

    Approved for Hodgkin lymphoma in-line with NICE TA540

    Consultant haematologist use only

     

    Approved for first-line treatment (in combination with pemetrexed and cisplatin chemotherapy) of metastatic, non-squamous non-small-cell lung cancer in patients with no EGFR or ALK-positive mutations with NICE TA557.

    Consultant Oncologist use only

     

    Approved for use (in combination with carboplatin and paclitaxel) as an option for untreated metastatic squamous NSCLC in-line with NICE TA600 

    Consultant Medical Oncologist use only

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    08.01.03 Pemetrexed 
    • Pemetrexed Injection
       


    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    10.01.03 Penicillamine  Penicillamine Tablets
    Consultant Rheumatologist use only
    18 Penicillamine  Used in the management of poisoning with copper.
    20 PENTOSAN POLYSULPHATE Capsules 50 mg 

    Pentosan Polysulphate Capsules (50mg)

    Black For new patients

    Red For existing patients only

     

    02.06.04 Pentoxifylline 
    • Pentoxifylline MR Tablets

    Consultant Gastroenterologist use only for the treatment of alcoholic liver disease in patients with contraindications to steroids (unlicensed indication).

    01.02 Peppermint Oil 
  • Peppermint Oil Capsules (Mintec®)
  • Peppermint Oil MR Capsules (Colpermin®)
  • 01.02 Peppermint Water BP  
    01.01.02 Peptac Liquid 
    A2.03.01 Pepti Junior 
    04.08.01 Perampanel Fycompa®
    • Perampanel Tablets

    Adjunctive treatment of focal seizures with or without secondary generalisation when at least two other antiepileptics recommended by NICE (carbamazepine or lamotrigine) in conjunction with a second-line antiepileptic (levetiracetam, sodium valproate) have failed to control seizures.

    Restricted to consultant neurologist initiation only

    02.05.05.01 Perindopril Erbumine 
    • Perindopril Erbumine Tablets

    Reserved for existing patients only.

    27.17 Peristeen anal irrigation  1 set of straps Order Code: 29124
    Pack Size: 1
    Drug Tariff Price £5.15
    27.17 Peristeen anal irrigation  2 tubes and blue connectors Order Code: 29125
    Pack Size: 1
    Drug Tariff Price £7.20
    27.17 Peristeen anal irrigation  1 control unit, 2 rectal catheters, 1 water bag, 1 strap set, 1 toilet bag Order Code: 29121
    Pack Size: 1
    Drug Tariff Price £72.04
    27.17 Peristeen anal irrigation  15 small rectal catheters, 1 water bag Order Code: 29127
    Pack Size: 1
    Drug Tariff Price £125.56
    27.17 Peristeen anal irrigation  10 rectal catheters Order Code: 29123
    Pack Size: 1
    Drug Tariff Price £80.28
    27.17 Peristeen anal irrigation  10 small rectal catheters Order Code: 29128
    Pack Size: 1
    Drug Tariff Price £80.28
    27.17 Peristeen anal irrigation  15 Rectal catheters, 1 water bag Order Code: 29122
    Pack Size: 1
    Drug Tariff Price £125.56
    27.17 Peristeen anal irrigation  1 control unit, 2 small rectal catheters, 1 water bag, 1 strap set, 1 toilet bag Order Code: 29126
    Pack Size: 1
    Drug Tariff Price £72.04
    27.15 Peristeen Anal Plug Large  Order Code: 1451
    Pack size: 20
    Drug Tariff Price £43.25
    27.15 Peristeen Anal Plug Small  Order Code: 1450
    Pack size: 20
    Drug Tariff Price £41.15
    13.10.04 Permethrin 5% Lyclear® Dermal Cream Permethrin 5% (Lyclear® Dermal Cream)
    08.01.05 Pertuzumab  Perjeta®
    • Pertuzumab Infusion

    Pertuzumab is also available for some indications via the CDF. For further information see the link below.  

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    04.07.02 Pethidine 
    • Pethidine Injection 

    Reserved for obstetric use only

    04.03.02 Phenelzine 
    • Phenelzine Tablets

    Restricted to Consultant Psychiatrist initiation only

    04.08.01 Phenobarbital 
    • Phenobarbital Tablets
    • Phenobarbital Elixir 
       

    MHRA recommends that patients should be maintained on a specific manufacturer’s product.

    Red Traffic Light  Phenobarbital Injection

    02.05.04 Phenoxybenzamine Hydrochloride 
    • Phenoxybenzamine Injection
    • Phenoxybenzamine Capsules

    Supported for the treatment of hypertensive episodes due to phaeochromocytoma.

    Specialist recommendation.

    05.01.01.01 Phenoxymethylpenicillin 
  • Phenoxymethylpenicillin Oral Solution
  • Phenoxymethylpenicillin Tablets
  • 02.05.04 Phentolamine Messilate 
    • Phentolamine Injection

    Supported for the treatment of hypertensive episodes due to phaeochromocytoma.

    02.07.02 Phenylephrine 
    • Phenylephrine Injection

    Use supported for the control of maternal hypotension during spinal anaesthesia managed caesarean section.

    11.05 Phenylephrine Hydrochloride Minims® Phenylephrine Hydrochloride
    • Phenylephrine 2.5%, 10% minims (preservative free)

      For use in patients where a preservative free product is necessary or an individual dose is required.
    04.08.01 Phenytoin 
    • Phenytoin Suspension
    • Phenytoin Sodium Capsules
    • Phenytoin Sodium Tablets

    MHRA recommends that patients should be maintained on a specific manufacturer’s product.

    Red Traffic Light Phenytoin injection

    A2.07 Phlexy-Vits®  Phlexy-vits sachets

    Bought in under recommendation of dietitians
    01.06.04 Phosphate Enema (133mL) Cleen® Ready-to-Use Enema
    09.05.02.01 Phosphate supplements Phosphate-Sandoz®
    • Phosphate-Sandoz
    09.06.06 Phytomenadione 
    • Green Phytomenadione Capsules (1mg)
    • Red Phytomenadione Injection (2mg/0.2mL) - Konakion MM Paediatric® 
    • Red Phytomenadione Injection (10mg/1mL)
    • unlicensed Unlicensed - Phytomenadione Chewable Tablets (10mg)

    1mg may be given as a single intramuscular injection at birth. This prevents vitamin K deficiency bleeding in virtually all babies.

    Vitamin K can be given orally for prevention of vitamin K deficiency in haemorrhagic disease of the newborn, where the injection is not appropriate. Two doses of 2mg should be given in the first week. For breast fed babies, a third dose of phytomenadione 2mg is given at one month of age: the third dose is omitted in formula fed babies because formula feeds contain vitamin K.

     

    11.06 Pilocarpine 
    • Pilocarpine 2% and 4% Eye Drops (with preservative)
    • Pilocarpine Nitrate 2% Eye Drops Minims (preservative free)
       
    • Pilocarpine 4% Ophthalmic Gel (with preservative)-
      Restricted for use following consultant recommendation only
    12.03.05 Pilocarpine Hydrochloride Salagen®
    • Pilocarpine Hydrochloride Tablets

    Supported for treatment of the symptoms of dry mouth and dry eyes in patients with Sjögren's sydrome.

    For use following consultant recommendation only.

    04.02.01 Pimozide 
    • Pimozide Tablets
       

    Reserved for existing patients only

    02.04 Pindolol 
    • Pindolol Tablets

    Reserved for existing patients.

    06.01.02.03 Pioglitazone 

    Diabetes

    • Glitazones should only be tried if HbA1C not reducing on metformin and sulphonylurea, and should be stopped if HbA1C is not reduced by 6mmol within six months.

      Non-Alcoholic Fatty Liver Disease (NAFLD)
    • Pioglitazone is recommended as an option for treating NAFLD. See NICE guidance link below. Note: this is an off-label use of pioglitazone.
    05.01.01.04 Pipericillin and Tazobactam  Current global shortage of pipericillin-tazobactam. See below for suggested clinical alternatives during the shortage.
    04.02.02 Pipotiazine palmitate 
    • Pipotiazine Injection

    Restricted to Psychiatry Specialist use only

    Note: the licensed products has been discontinued. An unlicensed, imported product is available.

    10.03.02 Piroxicam  Restricted to existing patients only.
    05.01.01.05 Pivmecillinam Hydrochloride 
  • Pivmecillinam Tablets

  • 08.01.02 Pixantrone intravenous infusion Pixuvri®
  • Pixantrone Intravenous Infusion

    Restricted for use as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas in-line with NICE TA306.
  • 04.07.04.02 Pizotifen 
    • Pizotifen Tablets
    A2.07 PKU Anamix® Infant  Bought under recommendation of dietitian
    09.01.07 Plerixafor Mozobil®
    • Plerixafor

    For use prior to patient transfer to registered tertiary centre for stem cell mobilisation in line with NHS England commissioned position SSC1655.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    13.02.01.01 Pliazon cream 

    Pliazon cream

    Restricted for patients with metastatic colorectal cancer with skin effects from anti-EFGR antibiotics.

    14.04 Pneumococcal Polysaccharide Conjugate Vaccine 13 valent Prevenar 13®
    • For use in children aged 2 months - 5 years
    14.04 Pneumococcal Polysaccharide Vaccine 23 valent  Pneumovax® II
    • Approved for use in adults and children over 2 years.
    • Contra-indicated for concomitant use with the high potency varicella-zoster vaccine (Zostavax®)
    A2.04.01.01 Polycal®   To be used on the recommendation of a dietitian only
    13.11.02 Polyhexanide 0.3% Foam Prontoderm® Polyhexanide 0.3% Foam (Prontoderm®)

    Third-line treatment option for MRSA skin decolonisation under the recommendation of the Infection Control Team.
    12.01.01 Polymyxin B Sulphate, Neomycin Sulphate, Hydrocortisone Otosporin®
    • Polymyxin B Sulphate, Neomycin Sulphate, Hydrocortisone Ear Drops
    09.02.01.01 Polystyrene Sulphonate Resins Calcium Resonium®
    • Polystyrene Sulphonate Resins
    11.08.01 Polyvinyl Alchohol SnoTears®, Liquifilm tears ®
    • Polyvinyl Alchohol (with preservative) SnoTears® 
    • Polyvinyl Alchohol (preservative free) Liquifilm tears® 

      Polyvinyl alcohol increases the persistence of the tear film and is useful when the ocular surface mucin is reduced.
    08.02.04 Pomalidomide Imnovid®
    • Pomalidomide Capsules
       

    Haematology use only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    08.01.05 Ponatinib Iclusig®
    • Ponatinib tablets

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    03.05.02 Poractant Alfa Curosurf® Poractant Alfa Suspension
  • Consultant Paediatrician use only
  • 09.02.01.01 Potassium Chloride Kay-Cee-L® and Sando-K®
    • Potassium Chloride
    09.02.02.01 Potassium Chloride 15% (20mmol in 10ml) 
    • Potassium Chloride 15% (20mmol in 10mL)

    Restricted to Children's Unit and Neonatal Unit

    09.02.02.01 Potassium Chloride and Glucose Intravenous Infusion  
    • Potassium Chloride 0.15% in Glucose 5% Infusion (1L)
    • Potassium Chloride 0.3% in Glucose 5% Infusion (500mL)

     

    Restricted

    • Potassium Chloride 0.6% in Glucose 5% Infusion (500mL)
      This product contains 80mmol K+ per litre for correction of severe hypokalaemia. Concentration exceeds that recommended for peripheral infusion.
    •  Potassium Chloride 0.15% in Glucose 10% Infusion (500mL)
      Ward 21 Maternity use only.
    09.02.02.01 Potassium Chloride and Sodium Chloride Intravenous Infusion 
    • Potassium Chloride 0.3% in Sodium Chloride 0.9% (500mL, 1L)
    • Potassium Chloride 0.15% in Sodium Chloride 0.9% (1L)

     

    Restricted

    • Potassium Chloride 0.6% in Sodium Chloride 0.9% (500mL)

    This product contains 80mmol K+ per litre for correction of severe hypokalaemia. Concentration exceeds that recommended for peripheral infusion.

    09.02.02.01 Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion 
    • Potassium Chloride 0.3% Sodium Chloride 0.18% Glucose 4% (500mL)
    • Potassium Chloride 0.3% Sodium Chloride 0.45% Glucose 5% (500mL)
    • Potassium Chloride 0.15% Sodium Chloride 0.45% Glucose 5% (500mL)
    • Potassium Chloride 0.15% Sodium Chloride 0.18% Glucose 4% (1L)

    Restricted

    Potassium 8mmol, Calcium 3mmol in Glucose 10% and Sodium Chloride 0.18% 500mL

    For use only under the recommendation of the paediatricians, mainly for patients on ANU but occasionally childrens unit. 

    07.04.03 Potassium Citrate  Potassium Citrate Mixture
    13.11.06 Potassium Permanganate Permitabs®
    20 Povidone Iodine 5% Sterile  Povidone Iodine 5% Sterile (10mL)
    A5.03 Povidone Iodine Dressings Povitulle®

    Povidone iodine dressing of choice at Airedale NHS Foundation Trust + community


    Wound contact layer antimicrobial iodine dressing

    • Povidone–Iodine Dressing 5cm x 5cm
    • Povidone–Iodine Dressing 9.5cm x 9.5cm
    13.11.04 Povidone-Iodine Videne®

    Povidone-Iodine 10% Antiseptic
    Povidone-Iodine 7.5% Surgical Scrub
    Povidone-Iodine 10% Alcohol

    18 Pralidoxime injection  Used in the management of poisoning with organo-phosphates.
    04.09.01 Pramipexole 
    • Pramipexole Tablets

    Green Traffic Light Restless legs - No restrictions on prescribing.

    Amber Traffic Light Parkinson's disease - Restricted to consultant neurologist and care of the elderly consulant initiation only, for use in patients who do not respond to, or are intolerant of ropinerole.

    Pipexus MR® is the preferred brand in primary care for the modified-release preparation.

    02.09 Prasugrel 
    • Prasugrel Tablets

    Consultant Cardiologist use only for patients returning from Leeds following PCI.

    Supported for use in-line with NICE TA317

    02.12 Pravastatin  
    • Pravastatin Tablets

    Reserved for patients for whom all other statins are not tolerated.

    02.05.04 Prazosin 
    • Prazosin Tablets
    01.05.02 Prednisolone 
    • Standard prednisolone tablets - No restrictions
    • Prednisolone Enema (Predsol®)
    • Prednisolone Suppositories


    Restricted Item Prednisolone 5mg/5ml oral solution - Restricted to paediatric patients who are not able to swallow tablets, and who do not tolerate crushed tablets.
    Restricted Item Soluble prednisolone tablets - Restricted to patients who cannot swallow tablets.
    Soluble prednisolone is not routinely available within Airedale NHS Foundation Trust. Plain prednisolone tablets can be dissolved in a small amount of water if necessary to aid administration.
    Restricted Item Enteric coated prednisolone tablets - Restricted to existing patients who cannot tolerate the gastric side effects of standard prednisolone tablets.
    Restricted Item Prednisolone foam enema (Predfoam®) - Restricted to consultant gastroenterologist use only, for patients who are unable to tolerate all other alternatives. 

    06.03.02 Prednisolone 

    Standard prednisolone tablets - No restrictions

    Crushing tablets is not recommended in primary care.

    Restricted Item Prednisolone 5mg/5ml oral solution - Restricted to paediatric patients who are not able to swallow tablets, and who do not tolerate crushed tablets.

    Restricted Item  Soluble prednisolone tablets - Restricted to patients who cannot swallow tablets.
    Soluble prednisolone is not routinely available within Airedale NHS Foundation Trust. At ANHSFT, plain prednisolone tablets can be dissolved in a small amount of water if necessary to aid administration.

    Note: this is an unlicensed route of administration. Unlicensed administration is not recommended in Primary Care.

    Restricted Item Enteric coated prednisolone tablets - Restricted to existing patients who cannot tolerate the gastric side effects of standard prednisolone tablets.

    11.04.01 Prednisolone  
    • Prednisolone 0.5% phosphate Eye/Ear Drops (with preservative)
    • Prednisolone 1% acetate Eye/Ear Drops (with preservative) Pred Forte®
       
       
      Restricted Item Prednisolone 0.5% phosphate Minims (preservative free)
      For use only in patients where a preservative free product is necessary.
      Other preservative-free strengths of prednisolone eye drops are non-formulary.
    04.07.03 Pregabalin 
    • Pregabalin Capsules

    For the treatment of neuropathic pain.

    A2.03.01 Pregestimil Powder  For use on the recommendation of a dietitian only
    15.02 Prilocaine Hydrochloride injection 
  • Prilocaine 1% Injection
  • 15.02 Prilocaine Hydrochloride with Felypressin 
  • Prilocaine 3% with felypressin Cartridge
  • 15.02 Prilocaine with Glucose 
  • Prilocaine hydrochloride with Glucose Spinal Injection

    For use by Anaesthetic Department only for short procedures below the umbilicus.
  • 05.04.01 Primaquine 
  • Primaquine Tablets

    Malaria prophylaxis is available Over the Counter or on Private Prescription. See links above for travel websites.
  • 04.08.01 Primidone 
    • Primidone Tablets

    MHRA recommends that patients should be maintained on a specific manufacturer’s product.

    09.02.02.01 Prismasol 
    • Prismasol 4 (5L)

    For use on ICU only for renal patients

    05.01.01.01 Procaine Penicillin G Injection  
  • Procaine penicillin G Vials

    For use on the recommendation of consultant microbiologist for the treatment of neuro syphyllis only.
  • 08.01.05 Procarbazine 
  • Procarbazine Capsules

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 04.06 Prochlorperazine Stemetil®, Buccastem®
    • Prochlorperazine Tablets
    • Prochlorperazine Injection
    • Prochlorperazine Buccal Tablets
    • Prochlorperazine Syrup
    01.07.02 Proctosedyl 
  • Proctosedyl Suppositories
  • Proctosedyl Ointment
  • 04.09.02 Procyclidine Hydrochloride Kemadrin® Green Traffic Light Procyclidine Tablets
    Green Traffic Light Procyclidine SF Syrup
    Red Traffic Light Procyclidine injection
    06.04.01.02 Progesterone Cyclogest®
    05.04.01 Proguanil Hydrochloride 
  • Proguanil Tablets

    Malaria prophylaxis is available Over the Counter or on Private Prescription. See links above for travel websites.
  • 04.02.01 Promazine Hydrochloride 
    • Promazine Tablets
    • Promazine Syrup

    Restricted to Psychiatry specialist recommendation only

    Note: Promazine tablets very expensive in primary care

    03.04.01 Promethazine Hydrochloride Phenergan® Green Traffic Light Promethazine Hydrochloride Elixir
    Promethazine Hydrochloride Tablets

    Red Traffic Light Promethazine Hydrochloride Injection
    04.06 Promethazine teoclate Avomine®
    • Promethazine Teoclate Tablets
    12.02.03 Prontoderm®  
    • Prontoderm Nasal Gel® Nasal

    For MRSA decolonisation.

    A5.03 Prontosan Wound Irrigation Solution  Prontosan Solution is a wound irrigation containing Betaine, a gentle effective surfactant which penetrates, disturbs and removes biofilm and wound debris, and PHMB (Polyhexamethylene Biguanide) to help control bacterial levels on the wound.

  • Prontosan irrigation solution 40ml
  • Prontosan irrigation solution 350ml
  • 15.01.01 Propofol Diprivan®
  • Propofol Injection 1%
  • Propofol Injection 2%
  • 02.04 Propranolol 
    • Propranolol MR Capsules
    • Propranolol SF Solution
    • Propranolol Tablets
    06.02.02 Propylthiouracil 

    Specialist recommendation only.

    A2.02.02.03 Prosource Plus® nutritional supplement  High-protein, low volume, low electrolyte nutritional supplement for use on ICU patients undergoing enteral feeding unable to meet daily protein requirements.

    Dietitian use only.
    27.09.02 ProSys Non Sterile Night drainage bag 2 litre  Order Code: PSU2
    Pack size: 10
    Drug Tariff Price £3.04
    27.04 Prosys Vesica Clinic Pack  Catheterisation procedure pack (contains no catheter or lubricant)
    Order Code: VESCP-01
    Pack Size: 1
    Drug Tariff Price £8.65
    02.08.03 Protamine Sulphate 
    • Protamine Sulphate Injection
    11.07 Proxymetacaine Hydrochloride Minims®
    • Proxymetacaine Hydrochloride (Preservative free)

      Proxymetacaine causes less initial stinging and is useful for children.
    01.06.07 Prucalopride  
  • Prucalopride

    For Consultant Gastroenterologist and Colorectal Surgeon initiation/recommendation only for the treatment of chronic constipation in women.
    Treatment will be initiated at Airedale (via recommendation on a GP Advice Note) and patients will be re-assessed in clinic after 4 weeks of treatment to establish effectiveness. If treatment is considered to have been effective, prescribing and supply will be continued by the patient’s GP.
    Supported use in-line with NICE TA 211 December 2010
  • A2.03.02 Pulmocare Liquid   Not kept in stock at ANHSFT.

    To be bought in and used on the equest of a dietitian only
    05.01.09 Pyrazinamide 
  • Pyrazinamide Tablets

    Available from IDIS on a Named Patient Basis only. The appropriate forms will need to be filled in by a consultant.
  • 10.02.01 Pyridostigmine Bromide 
    09.06.02 Pyridoxal 5 Phosphate 

    Following tertiary recommendation only

    09.06.02 Pyridoxine Hydrochloride 
    • Green Pyridoxine Oral Solution (100mg/5mL)
    • Green Pyridoxine Tablets (10mg, 50mg)
    • Red Pyridoxine Injection (100mg/2mL)  

     

    04.02.01 Quetiapine Seroquel®, Sondate XL
    • Quetiapine Tablets
    • Quetiapine MR Tablets

    Reserved for Psychiatry specialist recommendation only
    Note: Sondate XL® is the preferred brand of Quetiapine XL in primary care.

    27.17 Qufora monthly set pump, water bag, 15 cones, 15 waste bags and toilet bag Order Code: QTM
    Pack Size: 1
    Drug Tariff Price £101.66
    27.17 Qufora starter set pump, water bag, 5 cones, 5 waste bags and toilet bag Order Code: QTS
    Pack Size: 1
    Drug Tariff Price £77.80
    06.07.01 Quinagolide  Consultant Endocrinologist, Neurologist and Obstetrician initiation only.
    05.04.01 Quinine 
  • Quinine Sulphate Tablets

    Malaria prophylaxis is available Over the Counter or on Private Prescription. See links above for travel websites.
  • 10.02.02 Quinine sulphate  Quinine sulphate should only be considered in the following situations:
  • when nocturnal cramps cause regular disruption of sleep
  • when cramps are very painful or frequent
  • when other causes of cramp have been ruled out
  • when non-pharmacological measures have not worked.
    After initial trial of 4 weeks treatment, treatment should be stopped if there is no benefit.
  • 01.03.05 Rabeprazole Sodium Pariet® Reserved for existing patients only
    14.05.02 Rabies immunoglobulin 

    Rabies immunoglobulin

    • Clinical details should be discussed with the consultant virologist at Seacroft Hospital, Leeds, before supply can be authorised (due to very limited stocks).
    • Once the above authorisation is received,requests for supply should be made to the haematology department.
    14.04 Rabies vaccine 2.5units/1mL Rabipur®
    • Requires consultant virologist at Seacroft hospital LEEDS to agree to requests from medical staff to release supply of vaccine and immunoglobulin in view of limited stocks.
    06.04.01.01 Raloxifene Hydrochloride 

    For use as a 2nd/3rd line treatment if HRT causes unacceptable side effects

    02.05.05.01 Ramipril 
    • Ramipril Capsules
    • Ramipril Tablets
    11.08.02 Ranibizumab Lucentis®
    • Ranibizumab Solution for Intravitreal Injection 10mg/mL
      0.23mL

      For Consultant Opthalmologist use only.
      Use supported for the treatment of wet age-related macular degeneration in-line with NICE TA155
    01.03.01 Ranitidine  
  • Ranitidine SF Syrup
  • Ranitidine Injection
  • Ranitidine Tablets
  • 02.06.03 Ranolazine Ranexa®
    • Ranolazine MR Tablets

    For Consultant Cardiologist use only for patients with stable angina who are inadequately controlled on intolerant to first line therapies.

    04.09.01 Rasagiline Azilect®
    • Rasagiline Tablets

    Restricted to Consultant Neurologist and Department of Elderly Medicine Physician recommendation only.

    For patients intolerant of selegiline or who are likely to develop psychotic side effects or sleep disturbances as a result of treatment.

    10.01.04 Rasburicase  Consultant Haematologist use only.
  • For use during first cycle of chemotherapy in patients with a high tumour load and/or allopurinol intolerance
  • 04.03.04 Reboxetine Edronax®
    • Reboxetine Tablets

    Restricted to Consultant Psychiatrist initiation only

    13.11.02 Red staining dye  Red staining dye

    For addition to chlorhexidine gluconate 0.5% in ethanol 70% to improve visualisation of skin preparation prior to orthopaedic surgery.

    Theatre use only.
    15.01.04.03 Remifentanil 
  • Remifentanil Injection

  • 05.03.03.02 Ribavirin 
  • Ribavirin Capsules

    Reserved for the treatment of hepatitis C in combination with Peginterferon under the recommendation of Consultant Gastroenterologists
  • 05.03.05 Ribavirin 
  • Ribavirin Inhalation

    Consultant Paediatrician use only
  • 08.01.05 Ribociclib Kiskali®
    • Ribociclib Tablets

      Blueteq® registration and approval for use is required for this product before it may be dispensed.
    08.01.05 Ribociclib Kisqali®
    • Ribociclib tablets (Kisqali®)

    Approved by D&TC as a treatment option (with fulvestrant) for hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer in-line with NICE TA593

     

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    05.01.09 Rifampicin 
  • Rifampicin Capsules
  • Rifampicin Syrup
  • Rifampicin Infusion

    Red Traffic Light  Restricted to hospital specialist only when used for the treatment of Tuberculosis.
    Amber Traffic Light  For meningitis prophylaxis under the recommendation of the Health Protection Authority, or severe infections under the recommendation of a consultant microbiologist

  • Not for use as monotherapy, as resistance will develop rapidly.
  • 05.01.09 Rifampicin, isoniazid, pyrazinamide, ethambutol hydrochloride Voractiv®
  • Voractiv® tablets (rifampicin/isoniazid/pyrazinamide/ethambutol)

    For the treatment of tuberculosis.
  • 05.01.07 Rifaximin 550mg tablets Targaxan® For Consultant Gastroenterologist use only for the prevention of recurrence of episodes of hepatic encephalopathy. Treatment will be initiated by a hospital specialist and continued in Primary Care, with a review by the specialist after 6 months.
    04.09.03 Riluzole Rilutek®
    • Riluzole Tablets

    Restricted to Consultant Neurologist recommendation only. For patients with AML form of motor neurone disease

    06.06.02 Risedronate 

    Formulary      Green  -  Risedronate 35mg tablets - Once weekly preparations are recommended

    Restricted Drug Restricted Amber  - Risedronate 30mg tablets - Risedronate 30mg tablets are reserved for the treatment of Paget's disease in patients under the care of Consultant Endrocrinologist. Dose 30mg daily for 2 months; may be repeated if necessary after at least 2 months.

     

     

    04.02.01 Risperidone Risperdal®
    • Risperidone Tablets
    • Risperidone Liquid
      Restricted to patients who are unable to swallow tablets.
    • Risperidone Orodispersible Tablets
      Reserved for patients who do not tolerate risperidone liquid, do to high cost.

    Restricted to Psychiatry specialist recommendation only

    04.02.02 Risperidone Risperdal Consta®
    • Risperidone Intramuscular Injection

    Restricted to Psychiatry Specialist initiation only

    08.02.03 Rituximab MabThera® Truxima®
    • Rituximab Infusion
    • Rituximab Subcutaneous Injection
    10.01.03 Rituximab   Consultant Rheumatologist use only for patients who have had an inadequate response to or intolerance of other DMARDs (inc. one or more TNF inhibitor)
    02.08.02 Rivaroxaban Xarelto®
    • Rivaroxaban Tablets

    Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation in-line with NICE recommendations.
     

    Treatment of DVT and the prevention of recurrent DVT and PE in adult patients, in-line with NICE guidance.

    04.11 Rivastigmine Exelon®
    • Rivastigmine Capsules
    • Rivastigmine Oral Solution
    • Rivastigmine Transdermal Patches

    For the treatment of Parkinson’s disease dementia. Treatment initiated at ANHSFT and continued in Primary Care under a Shared Care Guideline.

    For other indications - Restricted to Bradford District Care Trust and existing patients. 

    For use in-line with NICE TA217 (June 2018).

    04.07.04.01 Rizatriptan Maxalt®
  • Rizatriptan tablets
  • Rizatriptan orodispersible tablets - Please do not prescribe lyophilisates or by brand due to high cost
  • 27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 3 standard length with extra wide adhesive 41mm Order Code: TF34130
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 2 shorter length 41mm Order Code: TF24130
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 3 standard length with extra wide adhesive 32mm Order Code: TF33230
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 1 standard length 32mm Order Code: TF13230
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 2 shorter length 25mm Order Code: TF22530
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 1 standard length 41mm Order Code: TF14130
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 2 shorter length 32mm Order Code: TF23230
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 2 shorter length 29mm Order Code: TF22930
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 1 standard length 36mm Order Code: TF13630
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 3 standard length with extra wide adhesive 29mm Order Code: TF32930
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 1 standard length 25mm Order Code: TF12530
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 2 shorter length 36mm Order Code: TF23630
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 3 standard length with extra wide adhesive 36mm Order Code: TF33630
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 3 standard length with extra wide adhesive 25mm Order Code: TF32530
    Pack size: 30
    Drug Tariff Price £46.95
    27.12 Rochester Freedom Transfix 100% clear silicone sheath Style 1 standard length 29mm Order Code: TF12930
    Pack size: 30
    Drug Tariff Price £46.95
    27.02 Rochester ReleaseNF  Standard length only (long term catheter 12 weeks)
    Gauge/Ch size 12S-22S
    Order Code: D2365
    Drug Tariff Price £9.49
    15.01.05 Rocuronium Bromide 
  • Rocuronium Injection
  • 03.03.03 Roflumilast Daxas®

    Roflumilast film-coated tablets

    Supported for chronic obstructive pulmonary disease in-line with NICE TA461.

    For respiratory consultant initiation only

    09.01.04 Romiplostim Nplate®
    • Romiplostim

    Treatment option for chronic immune (idiopathic) thrombocytopenic purpura in-line with NICE TA221. Consultant haematologist use only.

    04.09.01 Ropinirole 
    • Ropinirole Tablets
    • Ropinirole SR Tablets -Please prescribe Ippinia XL® or Spiroco XL® brands in primary care
    • Ropinirole Starter Pack

    Green Traffic Light Restless legs - No restrictions on prescribing.

    Amber Traffic Light Parkinson's disease - Restricted to consultant neurologist and care of the elderly consulant initiation only.

    02.12 Rosuvastatin 
    • Rosuvastatin Tablets

    Reserved for third-line use, for patients with resistant raised cholesterol, unresponsive to other statins.

    14.04 Rotavirus Vaccine Rotarix®
    • Approved for use within the Department of Health primary immunisation schedule.
    04.09.01 Rotigotine 
    • Rotigotine Transdermal Patches

    Restricted to use in patients with advanced Parkinson’s disease with swallowing difficulties

    27.09.03 Rusch Belly Bag 1000ml (short outlet tube with sample port)  Order Code: B1000P
    Pack size: 1
    Drug Tariff Price £10.50
    27.09.03 Rusch Belly Bag 1000ml (short outlet tube)  Order Code: B1000
    Pack size: 1
    Drug Tariff Price £10.50
    27.09.03 Rusch Belly bag with extra long (60cm) outlet tube  useful for wheelchair users Order Code: B1000CT
    Pack size: 1
    Drug Tariff Price £10.50
    27.01 Rusch Brilliant Aquaflate  Gauge/Ch size 12-16
    Order Code: DA2101
    Drug Tariff Price £6.00
    27.01 Rusch Brilliant Aquaflate  Gauge/Ch size 12-16
    Order Code: DA3101
    Drug Tariff Price £6.00
    27.01 Rusch Brilliant Silflate  Gauge/Ch size 12-16
    Order Code: DG2101
    Drug Tariff Price £6.99
    27.01 Rusch Brilliant Silflate  Specialist
    Gauge/Ch size 12-16
    Order Code: DG3101
    Drug Tariff Price £6.99
    27.01 Rusch Sympacath Aquaflate  Gauge/Ch size 12-16
    Order Code: DH2101
    Drug Tariff Price £6.05
    27.01 Rusch Sympacath Aquaflate  Gauge/Ch size 12-16
    Order Code: DH3101
    Drug Tariff Price £6.05
    08.01.05 Ruxolitinib Jakavi®
    • Ruxolitinib Tablets


    02.05.05.02 Sacubitril and Valsartan Entresto®
    • Entresto Tablets

    Approved for the treatment of chronic heart failure in line with NICE TA388

    For initiation by a Consultant Cardiologist or Heart Failure Nurse Specialist only.

    04.09.01 Safinamide Xadago®
    • Safinamide Tablets

    Approved for the treatment of idiopathic Parkinson’s disease in adult patients, as add-on therapy to a stable dose of Levodopa (L-dopa) alone or in combination with other PD medicinal products in mid-to late-stage fluctuating patients.

    Reserved for use in patients in whom selegiline and rasagiline are not tolerated or not appropriate.

    Use restricted to consultant neurologist and care of the elderly physician consultants only.

    03.01.01.01 Salbutamol Salamol®, Ventolin® Green Traffic Light 
    FIRST CHOICE
  • Salbutamol Metered Dose Inhaler

    SECOND CHOICE
  • Salbutamol Accuhaler
  • Salbutamol Easi-breathe
  • Salbutamol Easyhaler
  • Salbutamol Nebuliser Solution

    Red Traffic Light 
  • Salbutamol injection (for SC, IV or IM use)
  • Salbutamol solution for intravenous infusion (dilute before use)
  • 03.01.01.01 Salmeterol  Serevent® Salmeterol
  • Accuhaler
  • Metered dose inhaler
  • Licensed for asthma and COPD (but combination devices preferred for asthma)
  • 09.05.01.01 Sandocal-1000® 
    • Sandocal 1000 tablets
    • effervescent, orange flavour
    • calcium lactate gluconate 2.263g, calcium carbonate 1.75g, providing 1g calcium (Ca2+ 25mmol)
    10.01.03 Sarilumab Kevzara ®
  • Sarilumab subcutaneous injection
    For the treatment of moderate to severe, active rheumatoid arthritis (with or without methotrexate) in-line with NICE TA485. Consultant Rheumatologist use only.
  • 06.01.02.03 Saxagliptin Onglyza®

    Specialist recommendation use only.

    A2.04.01.02 Scandishake® Mix   Equivalent product for prescribing in community only
  • Aymes Shake sachet - add 200ml full fat milk.
  • Complan Shake sachet - add 200ml full fat milk.
  • 13.05.03 Secukinumab  Cosentyx
    • Secukinumab Injection

    Approved for use in line with:

    • NICE TA350 (plaque psoriasis - at specialist centres only)
    • NICE TA407 (active ankylosing spondylitis).
    • NICE TA445 (active psoriatic arthritis after inadequate response to DMARDs)

      Refer to the relevant NICE documents below
    04.09.01 Selegiline Hydrochloride Eldepryl®, Zelapar®
    • Selegiline Tablets
    • Selegiline Liquid
    06.01.02.03 Semaglutide Ozempic®
    • Semaglutide Pre-filled Pen

    First line long acting GLP-1 receptor agonist, in-line with NG28.

    01.06.02 Senna  
  • Senna Syrup
  • Senna Tablets

    Within ANHSFT - 150mL TTO Pack reserved for ward 17 use only
  • 04.03.03 Sertraline Lustral® Sertraline Tablets
    15.01.02 Sevoflurane (250mL) 
    02.05.01 Sildenafil Viagra®, Revatio®
    • Tablets
    • Suspension

    Supported for the treatment of digital ulceration in line with NHSE commissioning policy below.

    Consultant rheumatologist recommendation only

    Supported for the treatment of scleroderma associated with Reynaud’s syndrome (unlicensed indication).

    For initiation by Consultant Rheumatologists only.

    07.04.05 Sildenafil 

    Sildenafil Tablets

    Sildenafil for penile rehabilitation  post radical prostatectomy or radiotherapy

    05.03.03.02 Simeprevir Olysio®
  • Simeprevir Capsules

    For use by the Gastroenterologists for the treatment of chronic hepatitis C in combination with ribavirin and pegylated interferon only if funding is agreed by NHSE.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 01.01.01 Simeticone  
  • Simeticone SF Liquid

    For use orally within endoscopy only
  • 27.10 Simpla Catheter leg bag straps  Order Code: 380812
    Pack size: 10
    Drug Tariff Price £14.89
    27.05 Simpla Catheter Valve  Order Code: 380851
    Pack Size: 5
    Drug Tariff Price £12.80
    27.06 Simpla G Strap (Abdominal strap)  Order Code: 383003
    Pack Size: 5
    Drug Tariff Price £15.05
    27.06 Simpla G strap (leg Strap)  Order Code: 383001
    Pack Size: 5
    Drug Tariff Price £13.64
    27.09.02 Simpla S5 night bag  Order Code: 346145
    Pack size: 10
    Drug Tariff Price £12.31
    27.09.01 Simpla Trident 2 Long tube 500ml leg bag  Order Code: 376139
    Pack size: 10
    Drug Tariff Price £29.05
    27.09.01 Simpla Trident 2 Short tube 350ml leg bag  Order Code: 376137
    Pack size: 10
    Drug Tariff Price £28.75
    27.09.01 Simpla Trident 2 Short tube 500ml leg bag  Order Code: 376138
    Pack size: 10
    Drug Tariff Price £29.05
    27.09.01 Simpla Trident T1 Long tube 500ml leg bag  Order Code: 370817
    Pack size: 10
    Drug Tariff Price £28.62
    27.09.01 Simpla Trident T1 Short tube 350ml leg bag  Order Code: 370802
    Pack size: 10
    Drug Tariff Price £28.41
    27.09.01 Simpla Trident T1 Short tube 500ml leg bag  Order Code: 370807
    Pack size: 10
    Drug Tariff Price £28.62
    03.09.02 Simple Linctus, BP 

    Simple linctus (SF)
    Not recommended for prescribing in primary care, due to lack of evidence to support use

    02.12 Simvastatin 
    • Simvastatin Tablets
    06.01.02.03 Sitagliptin Januvia® Supported as first-line monotherapy choice for patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance.

    13.02.01 Skin Kind Products  Skin Kind products


    Black Traffic Light  Not routinely commissioned


    A2.01.03.01 SMA Gold Prem 1 

    Inpatient use only

    A2.01.03.01 SMA Gold Prem 2 

    On discharge for premature babies without specialist nutrtional needs.

    09.03 Smofkabiven® Extra Nitrogen  
    • Smofkabiven® Extra Nitrogen

    For restricted use by the dietitians for critically ill patients with a BMI >30kg/m2 who require TPN.

     

    09.08.01 Sodium Benzoate  
    • Sodium Benzoate

    09.02.01.03 Sodium Bicarbonate 
    • Sodium Bicarbonate

    Sodium bicarbonate oral solutions 8.4% are packaged in pharmacy (ANHSFT only)

    09.02.02.01 Sodium Bicarbonate Min-I-Jet® Sodium Bicarbonate
    • Sodium Bicarbonate 8.4% Miniject (50mL)

    Long-term supply problem (October 2015)

    12.01.03 Sodium Bicarbonate 
    • Sodium Bicarbonate 5% Ear Drops
    09.02.02.01 Sodium Bicarbonate Infusion 
    • Sodium Bicarbonate 1.26% Infusion (500mL)
    • Sodium Bicarbonate 2.7% Infusion (500mL)
    • Sodium Bicarbonate 4.2% Infusion (500mL)
    • Sodium Bicarbonate 8.4% Infusion (200mL)
    • Sodium Bicarbonate 8.4% Injection (10mL)
    • Sodium Bicarbonate 8.4% Injection (100mL)


       

    18 Sodium calcium edetate injection  Used in the management of poisoning with heavy metals.
    09.02.01.02 Sodium Chloride 
    • Sodium chloride tablets (600mg)
    • Sodium chloride oral solution

    Sodium chloride 5% oral solution can be made up in pharmacy from polyfusors.

    In primary care prescribe sodium chloride 1mmol/mL oral solution by brand. Sodium chloride 5mmol/ml can be prescribed as generic.

    11.08.01 Sodium Chloride 
    • Sodium Chloride 5% Eye Drops
    • Sodium Chloride 0.9% Eye Drops Minims (preservative free)
    • Sodium chloride 0.9% (Minims) Restricted to consultant ophthalmologist recommendation only.

     

     

    11.08.01 Sodium Chloride 
    • Sodium Chloride Balanced Salt Solution
       
      For use in eye theatre only
    12.02.02 Sodium Chloride 
    • Sodium Chloride Nasal Spray
    • Sodium Chloride Nasal Drops
    13.11.01 Sodium Chloride Normasol® Sodium Chloride 0.9% Irrigation Sachets
    13.11.01 Sodium Chloride 0.9%  Sodium Chloride 0.9% Irrigation
    Sodium Chloride 0.9% Irrigation
    09.02.02.01 Sodium Chloride and Glucose Intravenous Infusion 
    • Sodium Chloride 0.18% Glucose 10% Infusion (500mL)
    • Sodium Chloride 0.18% Glucose 4% Infusion (500mL, 1L)
    • Sodium Chloride 0.45% Glucose 5% Infusion (500mL)
    • Sodium Chloride 0.45% Glucose 2.5% Infusion (500mL)
    • Sodium Chloride 0.45% Glucose 10% Infusion (500mL) (Unlicensed)
    • Sodium Chloride 0.9% Glucose 5% infusion (500mL)

    09.02.02.01 Sodium Chloride Intravenous 
    • Green Sodium Chloride 0.9% Injection (10mL)
    • Green Sodium Chloride 0.9% Infusion (50mL, 100mL, 250mL, 500mL, 1L)
    • Red Sodium Chloride 0.18% Infusion (500mL)
    • Red Sodium Chloride 0.45% Infusion (500mL)
    • Red Sodium Chloride 1.8% Infusion (500mL)
    • Red Sodium Chloride 2.7% Infusion (500mL)
    • Red Sodium Chloride 5% Infusion (500mL)
    • Red Sodium Chloride 30% Injection (10mL) Aseptics only
    15.01 Sodium citrate 0.3M oral solution  
  • Sodium citrate 0.3M oral solution

    For gastric acid neutralisation prior to general anaesthesia for emergency Caesarean section to prevent gastric acid aspiration.
  • 01.06.04 Sodium Citrate micro-enema Micolette®
    06.06.02 Sodium Clodronate 
    11.04.02 Sodium Cromoglicate  Catacrom®, Cromolux®, Opticrom®, Optrex®, Pollenase
    • Sodium Cromoglicate 2% Eye Drops (with preservative)

      Used for vernal keratoconjunctivitis and other allergic forms of conjunctivitis.
    09.08.01 Sodium Dichloroacetate 
    • Dichloroacetate Sodium

    For metabolic disorders only usually in paediatric patients.

    09.01.01.01 Sodium Feredetate Sytron®
    • Sodium feredetate liquid

     

    05.01.07 Sodium fusidate  Sodium Fusidate Tablets
  • Consultant microbiologist recommendation only
  • Not for use as monotherapy, as resistance will develop rapidly.
  • 07.04.04 Sodium hyaluronate Cystistat® and Hyacyst®

    Sodium hyaluronate intravesicle solution

    For use by Consultant Surgeon only for patients with intractable interstitial cystitis

    11.08.01 Sodium Hyaluronate Hyloforte®, Hylotear®
    • Sodium Hyaluronate 0.2% Eye Drops (preservative free) (Hyloforte®)
    • Sodium Hyaluronate 0.1% Eye Drops (preservative free) (Hylotear®)

    Hyloforte® and Hylotear® are the preferred preparation, and can be used for up to six months after opening. Contains 300 applications.

    • Sodium Hyaluronate 0.2% unit dose vials are available if required (Blink Intensive Tears)

    Restricted Item Sodium hyaluronate 0.4% (preservative free) (Clinitas®)
    Restricted Item Sodium Hyaluronate 0.1%, carmellose sodium 0.5%, glycerol 0.9% Eye Drops (Optive Fusion®)

    Restricted to Consultant Ophthalmologist recommendation only.

    11.08.02 Sodium hyaluronate  Provisc®
    • Sodium hyaluronate (Provisc®) is used during surgical procedures on the eye.
    09.08.01 Sodium Phenylbutyrate 
    • Sodium Phenylbutyrate
    09.05.02.01 Sodium Phosphate 
    • Sodium Phosphate 0.5mmol/mL

    Reserved for SCBU only - hypophosphataemia in neonates.

    01.06.02 Sodium Picosulfate  
  • Sodium Picosulfate Elixir
  • 01.06.05 Sodium picosulfate/magnesium citrate  Citrafleet®, Picolax® For bowel evacuation prior to colonic surgery, colonoscopy, or radiological examination in accordance with Trust procedures
  • Note Citrafleet are not licensed for children under 18 years.

  • 02.13 Sodium Tetradecyl Sulphate 
    • Sodium Tetradecyl Sulphate Injection
    04.08.01 Sodium Valproate 

           Sodium Valproate - Epilim® brand

    • Sugar free Liquid
    • Enteric-Coated Tablets
    • Enteric-Coated, Modified-Release Tablets (Epilim Chrono®)
    • Crushable Tablets
    • Syrup

      Sodium Valproate - Orlept® brand
    • Sugar-free Liquid
    • Enteric-Coated Tablets

      Sodium Valproate - Episenta® brand
    • Modified-release Capsules
    • Modified-release Sachets

    Red Traffic Light Sodium Valproate (Epilim®) Injection
    Red Traffic Light Sodium Valproate (Episenta®) Injection

    The MHRA recommends that the need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer taking into account factors such as seizure frequency and treatment history.

    Valproate can seriously harm an unborn child when taken during pregnancy and should be not taken by women of child-bearing age unless other treatments are ineffective or not tolerated. Female patients of child-bearing age taking valproate must be using reliable contraception.

    Pregnancy Prevention Programme materials available below:

    05.03.03.02 Sofosbuvir Sovaldi® Use supported for the treatment of hepatitis C in-line with NICE TA 330. Use restricted to Consultant Gastroenterologists only.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
    05.03.03.02 Sofosbuvir/ledipasvir Harvoni®
  • Sofosbuvir/ledipasvir (Harvoni®)

    For the treatment of hepatitis C in line with NICE TA363. Use restricted to Consultant Gastroenterologists only.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 05.03.03.02 Sofosbuvir/velpatasvir Epclusa®
  • Sofosbuvir/velpatasvir (Epclusa®)

    For the treatment of hepatitis C in line with NICE TA430. Use restricted to Consultant Gastroenterologists only.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 05.03.03.02 Sofosbuvir-velpatasvir-voxilaprevir  Vosevi®
    • Sofosbuvir-velpatasvir-voxilaprevir (Vosevi®)

      Use supported for the treatment of chronic hepatitis C in-line with NICE TA507 and NHS England commissioning criteria. Use restricted to the Consultant Gastroenterologists.
      Blueteq® registration and approval for use is required for this product before it may be dispensed.
    07.04.02 Solifenacin Succinate Vesicare®

    Solifenacin tablets

    2nd line use by Consultant Urologists and Gynaecologists for patients with known detrusor instability, who are unable to tolerate oxybutynin

    09.03 Solivito N Injection 
    • Solivito N
    27.07 Solution R Citric acid 6% Twin 2 x 30mls Order Code: 9746625
    Pack Size: 10
    Drug Tariff Price £4.59
    06.05.01 Somatropin 

    For Consultant Paediatricians and Consultant Endocrinologist initiation only.

    The choice of brand is patient led, dependent on the most preferred device for administration.

    • Omnitrope® - First Choice
    • Genotropin®
    • Humatrope®
    • Norditropin SimpleXX®
    • NutropinAq®
    • Omnitrope®
    • Saizen®
    • Zomacton®

      Children
      Prescribed in joint clinic by consultant paediatricians from Airedale and Leeds. Once stable, this may be appropriate for shared care management using the Leeds Shared Care Guideline as below.
       
    A5.02.06 Sorbsan 

    For community patients only + ANHSFT
     
    Alginate standard dressing

    • Sorbsan Flat 5cm x 5cm
    • Sorbsan Flat 10cm x 20cm
    • Sorbsan Flat 10cm x 10cm (latex free)
    • Sorbsan Packing 2g
       
       
    02.04 Sotalol 
    • Sotalol Tablets

    Reserved for existing patients.

    A5.02.03 Specialist foam dressing Mepilex Border® Alternative specialist foam dressing product for community patients only
  • 7cm x 7.5cm
  • 10cm x 12.5cm
  • 15cm x 17.5cm
  • 17.5cm x 20cm

    Not available at Airedale NHS Foundation Trust
  • 07.03.03 Spermicidal Contraceptives Gygel®

    Nonoxinol gel

    02.02.03 Spironolactone 

    Red Spironolactone 50mg/5mL SF Suspension

    Green Traffic Light Spironolactone tablets (First choice product (over amiloride) for Chronic Heart Failure. 

     

    A5.02.04 Standard hydrocolloid dressing Tegaderm Hydrocolloid® Standard hydrocolloid dressing of choice for community patients only
    Tegaderm Hydrocolloid dressing
  • 10cm x 10cm square
  • 15cm x 15cm square
  • 10cm x 12cm oval including border
  • 13cm x 15cm oval including border
  • 17.1cm x 16.1cm sacral including border

    Not available at Airedale NHS Foundation Trust
  • A5.02.04 Standard Hydrocolloid Dressing DuoDERM Signal® Standard hydrocolloid dressing of choice at Airedale NHS Foundation Trust
    Standard Hydrocolloid dressing
  • 10cm x 10cm square bevelled edge
  • 14cm x 14cm square bevelled edge
  • 20cm x 20cm square bevelled edge
  • 03.01.05 Standard range peak flow meter Pulmo-Aide®

    Peak flow meter (Pulmo-Aide standard range)

    13.11.07 Sterile Larvae (Maggots) LarvE® Larvae Biobag Extra Large (10cm x 10cm) Order code BB400
    Larvae Biobag Large (6cm x 12cm) Order code BB300
    Larvae Biobag Medium(5cm x 6cm) Order code BB200
    Larvae Biobag Small (4cm x 5cm) Order code BB100
    Larvae Biobag Extra Small (2.5cm x 4cm) Order code BB50

    Larvae Free Roaming 300
    Larvae Free Roaming 150

    Under recommendation of the diabetic team, vascular team and Tissue Viability Nurse
    27.10 Sterile water for injection 10mls plastic vials Pack size: 10
    Drug Tariff Price £2.93
    12.02.01 Sterimar 
    • Isotonic sea water Nasal Rinse
    04.08.01 Stiripentol sachets  
    • Stiripentol Sachets 

    Restricted to consultant neurologist initiation only

    02.10.02 Streptokinase 
    • Streptokinase Infusion
    27.07 Suby G Citric acid 3.23% Twin 2 x 30mls Order Code: 9746609
    Pack Size: 10
    Drug Tariff Price £4.59
    01.03.03 Sucralfate 
    • Sucralfate Liquid
    • Sucralfate Tablets

      Sucralfate is only available as an unlicensed medicine currently, due to a long-term manufacturing problem. Stock is provided by ANHSFT.
    13.02.02 Sudocrem® 

    Sudocrem Cream

    First choice for use in children

    Not recommended in adults

    15.01.06 Sugammadex injection 
  • Sugammadex Injection

    Approved for the emergency reversal of rocuronium and vecuronium and in situations where surgery has been discontinued prematurely. A 12-month audit of use of sugammadex should be carried out.
  • 01.05.01 Sulfasalazine 
  • Sulfasalazine Suspension
  • Sulfasalazine Tablets
  • Sulfasalazine EC Tablets
  • Sulfasalazine Suppositories
  • 10.01.03 Sulfasalazine  Restricted to Consultant Rheumatologist use only when used for inflammatory arthritis.
    See section 1.5 for use in Ulcerative colitis
    10.01.04 Sulfinpyrazone  Consultant Rheumatolgist use only
  • Approved for the third-line treatment of chronic gout (after allopurinol and febuxostat) for use during supply problems with licensed sulfinpyrazone.
  • 04.02.01 Sulpiride 
    • Sulpiride Tablets

    Restricted to Psychiatry specialist recommendation only

    Note: In primary care 2 x 200mg is much more cost effective than 1 x 400mg tablets

    04.07.04.01 Sumatriptan 
  • Sumatriptan Tablets
  • Sumatriptan Nasal Spray
  • Sumatriptan Syringe pre-filled syringes
  • 15.01.05 Suxamethonium Chloride injection 
  • Suxamethonium Injection
  • 04.07.02 Syrup 
    • Syrup BP (66.7%) 50ml (Special)

    For neonatal use only

    08.02.02 Tacrolimus Adoport®, Advagraf®, Prograf®

    For existing patients only. Prescribe by brand name.

    07.04.05 Tadalafil 

    Tadalafil Tablets

    Restricted to patients who are unable to tolerate sildenafil tablets. For use as required only.

      
    BlackTadalafil for daily administration is not for prescribing.

    11.06 Tafluprost  Saflutan®
    • Tafluprost 15 microgram/mL Unit Dose Eye Drops (preservative free)

      For use following consultant recommendation only
    20 TALC BP purified sterile  
    • Talc Dusting Powder (Sterile)
    08.03.04.01 Tamoxifen 
  • Tamoxifen Tablets
  • Tamoxifen SF Solution

  • 07.04.01 Tamsulosin Hydrochloride M/R Capsules  

    Tamsulosin M/R Tablets /Capsules

    05.01.07 Taurolidine citrate 4% Taurolock® Approved for use for intravascular catheter salvage under the recommendation of microbiology
    05.01.07 Taurolidine citrate 4% and heparin 500 units/mL Taurolock HEP-500 Approved for use for intravascular catheter salvage under the recommendation of microbiology
    17 Taurolodine and Citrate 4% TauroLock® Approved for use for intravascular catheter salvage under the recommendation of microbiology
    05.01.07 Teicoplanin 
  • Teicoplanin Injection

  • 05.03.03.02 Telaprevir  Incivo®
  • Telaprevir Tablets

    Use supported for the treatment of hepatitis C (genotype 1) in combination with peginterferon and ribavirin in-line with NICE TA 253 (April 2012). Use restricted to the Consultant Gastroenterologists.
    Blueteq® registration and approval for use is required for this product before it may be dispensed.
  • 02.05.05.02 Telmisartan 
    • Telmisartan Tablets
    04.01.01 Temazepam  Green Traffic LightTemazepam SF Solution
    Green Traffic LightTemazepam Tablets

    Green Traffic Light (Restricted) For premedication before surgery.


    Note: Temazepam is very expensive in primary care
    02.10.02 Tenecteplase 
    • Tenecteplase Injection

    Restricted to use on CCU and A&E.

    05.03.03.01 Tenofovir Disproxil  Use supported for the treatment of patients with chronic hepatitis B in adults with compensated liver disease in-line with NICE TA173 Consultant Gastroenterologist use only.
    02.05.04 Terazosin 
    • Terazosin Tablets
    05.02 Terbinafine 
  • Terbinafine Tablets
  • 13.10.02 Terbinafine 1% cream 

    Terbinafine 1% Cream

    03.01.01.01 Terbutaline Bricanyl® Green Traffic Light 
  • Terbutaline Turbohaler

    Red Traffic Light 
  • Terbutaline injection (for SC, IM or IV injection)
  • 06.06.01 Teriparatide  Consultant Endocrinologist and Rheumatologist use only. For postmenopausal women with severe osteoporosis who are intolerant of/non-responsive to bisphonates, in-line with NICE TA161
    06.05.02 Terlipressin 
    06.01.06 Test strips One Touch® Ultra One Touch Ultra testing strips
    06.01.06 Test strips Precision Xceed Pro Glucose Test Strips® Precision Xceed Pro Glucose testing strips
    06.01.06 Test strips Dirui H10® Dirui H10 testing strips
    06.01.06 Test strips Precision Pro Ketone Test Strips® Precision Pro Ketone testing strips
    06.04.02 Testosterone gel  Tostran® Testosterone 2% Gel multidose cannister
    Second-line transdermal gel testosterone preparation

    Consultant Endocrinologist recommendation only
    06.04.02 Testosterone gel  Testogel®

    Testosterone Gel Sachets (50mg)
    First-line transdermal gel testosterone preparation

    • Consultant recommendation only
    • Note: Testim® gel discontinued from February 2018
    06.04.02 Testosterone injection Sustanon 250®

    Sustanon Injection (250mg)
    First-line injectable testosterone preparation

    Consultant endocrinologist recommendation

    06.04.02 Testosterone injection Nebido®

    Testosterone undecanoate injection (250mg)
    Second-line injectable testosterone preparation

    Consultant endocrinologist recommendation only

    06.04.02 Testosterone Propionate Injection 

    Testosterone propionate injection (100mg/2ml)

    14.05.02 Tetanus immunoglobulin 

    Tetanus immunoglobulin

    • Limited supplies of licensed tetanus immunoglobulin are available from Bio Products Laboratory Limited.
    • Unlicensed, intramuscular injection available in case of shortage.

    In addition to immunoglobulin, tetanus vaccine is also offered to individuals following a tetanus prone injury, depending on their immunisation history.

    04.09.03 Tetrabenazine 
    • Tetrabenazine Tablets

    Restricted to specialist recommendation only

    11.07 Tetracaine 
    • Tetracaine (Amethocaine) 1% Minims (preservative free)

      Tetracaine produces a more profound anaesthesia and is suitable for before minor surgical procedures.
    15.02 Tetracaine  Ametop®
  • Tetracaine 4% Gel with Dressings
  • Tetracaine 4% Gel without Dressings
  • 06.05.01 Tetracosactide Synacthen®
    05.01.03 Tetracycline 
  • Tetracycline Tablets
  • 08.02.04 Thalidomide 
    • Thalidomide Capsules

    Consultant Haematologist use only

    03.01.03 Theophylline Uniphyllin® Continus, Nuelin® SA Uniphyllin® Continus
  • Modified release tablets

    Restricted Item Nuelin® SA
  • Modified release tablets
  • Restricted to existing patients only
  • 09.06.02 Thiamine 
    • Thiamine
    A5.02.04 Thin Hydrocolloid Dressing DuoDERM Extra Thin® Thin hydrocolloid dressing of choice for Airedale NHS Foundation Trust and community patients
    DuoDERM® extra thin
  • 10cm x 10cm
  • 15cm x 15cm
  • A5.02.04 Thin Hydrocolloid dressing Tegaderm Hydrocolloid Thin® Thin hydrocolloid dressing of choice for community patients only

  • 13cm x 15cm oval including border
  • 10cm x 10cm square
  • 10cm x 12cm oval including border

    Not available at Airedale NHS Foundation Trust
  • 15.01.01 Thiopental injection 
  • Thiopental Injection
  • A2.05.02 Thixo-D® Powder  
    06.04.01.01 Tibolone 

    Tibolone Tablets 
     
    Consultant Gynaecologist only

    02.09 Ticagrelor 
    • Ticagrelor Tablets
    • Ticagrelor Orodispersible Tablets

    Consultant Cardiologist use only, for the treatment of acute coronary syndromes in-line with West Yorkshire Cardiovascular Network Guidelines.

    Supported for use in-line with NICE.

    05.01.03 Tigecycline 
  • Tigecycline Injection

    Restricted to prescribing by Consultant Microbiologist only. MHRA guidance states tigecycline must only be used where other agents are not suitable.
  • 13.04 Timodine®  Hydrocortisone 0.5%, nystatin 100,000units/g, benzalkonium chloride solution 0.2% , dimeticone ‘350’ 10% (Timodine Cream)
    11.06 Timolol  Timoptol®, Tiopex®
    • Timolol Eye Drops 0.25% (with preservative)
    • Timolol 0.25% Single Dose Eye Drops (preservative free)

      For use following consultant recommendation only
    02.08.01 Tinzaparin Innohep® For the PREVENTION of venous thromboembolism for adult patients
    Patient weightTinzaparin dose
    Under 50kg3,500 units ONCE daily
    50-120kg4,500 units ONCE daily
    Over 120kg8,000 units ONCE daily

    For patients with Renal impairment
  • If eGFR <30mL/min/1.73m2 then calculate the creatinine clearance
  • If CrCL <20mL/min and patient is >45kg give tinzaparin 3,500units DAILY
  • If CrCL <20mL/min and patient is <45kg give tinzaparin 2,500 units DAILY
  • Do not give tinzaparin if CrCL is less than 15mL/min. Give unfractionated heparin 5,000units SC BD regardless of bodyweight and monitor APTT


    For the PREVENTION of venous thromboembolism during PREGNANCY
    Patient weightTinzaparin dose
    Under 50kg3,500 units ONCE daily
    50-90kg4,500 units ONCE daily
    90-130kg7,000 units DAILY (2 x 3,500 unit syringes)
    130-170kg9,000 units DAILY (2 x 4,500 unit syringes)
    Over 170kg75 units/kg bodyweight ONCE daily (rounded to the nearest whole syringe)

  • For patients with severe renal impairment (CrCl less than 20ml/min give half the above dose

    For the TREATMENT of venous thromboembolism
  • Refer to the links below for prescribing information
  • 03.01.02 Tiotropium Braltus®, Spiriva®

    Tiotropium solution for inhalation via Spiriva Respimat® device
    Green Traffic Light Licensed for COPD
    Green Traffic Light Licensed for asthma

    • Restricted to respiratory specialist recommendation, for the treatment of severe asthma (at BTS step 4).

      Tiotropium capsules for inhalation via Zonda® inhaler device.
      Green Traffic Light Licensed for COPD
      Note: tiotropium (Braltus®)13 micrograms via the Zonda® device is equivalent to tiotropium (Spiriva®) 18 micrograms via the handihaler® device. For either product, the dose is one capsule for inhalation per day.
    03.01.04 Tiotropium/olodaterol Spiolto® Respimat
  • Solution for inhalation via the Respimat® device
  • Licensed for COPD
  • 02.09 Tirofiban 
    • Tirofiban Infusion

    Consultant cardiologist use only.

    10.02.02 Tizanidine  Consultant Neurologist use only for patients who have failed on oral baclofen
    05.01.04 Tobramycin 
  • Tobramycin Injection

    Reserved for paediatric patients requiring an aminoglycoside on the recommendation or transfer from Leeds Teaching Hospitals NHS Trust
  • 10.01.03 Tocilizumab RoActemra®
    • Tocilizumab subcutaneous injection
    • Tocilizumab infusion

      Consultant rheumatologist use only
    • Supported for use in line with NICE TA247: Rheumatoid arthritis (August 2010)
    • Tocilizumab for giant cell arteritis in patients with relapsing or refractory disease in-line with NICE TA518.



      Tocilizumab for the treatment of juvenile idiopathic arthritis (in line with NICE TA373) is used at specialist centres only. 
    01.05.03 Tofacitinib Xeljanz®
    • Tofacitinib film-coated tablets
       
      Supported for moderatley to severely active ulcerative colitis in line with NICE TA547.
    10.01.03 Tofacitinib Xeljanz®

    Consultant Rheumatologist Use only

    • Supported for use in line with NICE TA480 for the treatment of moderate to severe, active rheumatoid arthritis.
    • Second-line JAK inhibitor for this indication.
    • Supported for the treatment of active psoriatic arthritis after inadequate response to DMARDS in-line with NICE TA543

     

    06.01.02.01 Tolbutamide 

    Reserved for existing patients only

    07.04.02 Tolterodine Tartrate 

    Tolterodine M/R Capsules
    Tolterodine Tablets

    2nd line use by Consultant Urologists and Gynaecologists for patients with known detrusor instability, who are unable to tolerate oxybutynin

    04.08.01 Topiramate 
    • Topiramate Tablets
    • Topiramate Sprinkle Caspules
      Reserved for patients unable to swallow tablets only due to high cost.

    Green For migraine prophylaxis

    Amber Traffic Light For epilepsy


    Restricted to Consultant Neurologist recommendation only

    08.01.05 Topotecan 
    • Topotecan Injection 
       
    04.07.02 Tramadol Marol®, Zydol®.

    Green Traffic Light Tramadol Capsules - First choice product
    Green Traffic Light Restricted Item Tramadol M/R Tablets and Capsules - Not to be used for patients with acute pain
    Green Traffic Light Restricted Item Tramadol Soluble Tablets - Reserved for patients with swallowing difficulties only

    In Primary care, please prescribe Marol®, the most cost-effective brand.

    Red Traffic Light Tramadol injection

    02.11 Tranexamic Acid 

    Green Traffic Light Tranexamic Acid Tablets
    Red Traffic Light Tranexamic Acid injection

    08.01.05 Trastuzumab Herceptin® Ontruzant®
    • Trastuzumab Intravenous Injection (Herceptin®)
    • Trastuzumab Subcutaneous Injection (Herceptin ®)
       
    08.01.05 Trastuzumab emtansine Kadcyla®
    • Trastuzumab emtansine Powder for Concentrate for Solution for Infusion (Kadcyla®
       
    11.06 Travoprost Travatan®
    • Travoprost Eye Drops (40micrograms/ml) (2.5ml) (with preservative)

      For use following consultant recommendation only
    11.06 Travoprost with Timolol DuoTrav®
    • Duotrav Eye Drops (travoprost 40micrograms/ml and timolol 5mg/ml) (with preservative)

      For use following consultant recommendation only
    04.03.01 Trazodone Hydrochloride 
    • Trazodone Tablets
    • Trazodone Capsules
    • Trazodone SF Liquid
    06.03.02 Triamcinolone  Triamcinolone acetonide injection (40mg/ml, 50mg/5ml)

    Injectable preparations. Note different routes of administration for different branded products. See individual formulary entries for further information
    10.01.02.02 Triamcinolone Acetonide Adcortyl®, Kenalog®
  • Adcortyl®
  • Triamcinolone 10mg/ml injection
  • For intra-articular or intradermal administration
    See SPC for information relating to licensing.

  • Kenalog®
  • Triamcinolone 40mg/ml injection
  • For intramuscular and intra-articular administration only.
    See SPC for information relating to licensing.
  • 04.02.01 Trifluoperazine 
    • Trifluoperazine Tablets
    • Trifluoperazine Syrup 
    • Trifluoperazine Solution

    Restricted to Psychiatry specialist recommendation only

    08.01.03 Trifluridine-tipiricil Lonsurf®
    • Trifluridine Tipiricil Tablets (Lonsurf®) 


     
    Consultant Medical Oncologist use only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    04.09.02 Trihexyphenidyl Hydrochloride 
  • Trihexyphenidyl Syrup
  • Trihexyphenidyl Tablets
  • 05.01.08 Trimethoprim 
  • Trimethoprim Tablets
  • Trimethoprim SF Suspension

  • To minimise the incidence of gram-negative bloodstream infection, GPs and other primary care prescribers are being encouraged to use nitrofurantoin first-line, as opposed to trimethoprim
  • In secondary care, trimethoprim remains the first-line option for treatment of UTIs in patients who have not previously received treatment for UTIs as per local guidance (see below - ANHSFT access only)
  • 13.04 Trimovate®  Clobetasone butyrate 0.05%, Oxytetracycline 3%, nystatin 100,000 units/g Cream (Trimovate Cream)
    06.07.02 Triptorelin Gonapeptyl Depot®

    For use by Consultant Paedicatricians for the treatment of precocious puberty.

    11.05 Tropicamide  Mydriacyl®
    • Tropicamide 0.5% Eye Drops (with preservative)
    • Tropicamide 1% Eye Drops (with preservative)
    • Tropicamide 1% Minims (preservative free)
    • Tropicamide 0.5% Minims (preservative free)
      For use in patients where a preservative free product is necessary or an individual dose is required
    07.04.02 Trospium Chloride 

    Trospium Tablets (20mg) - 2nd line use by Consultant Urologists and Gynaecologists for patients with known detrusor instability, who are unable to tolerate oxybutynin.

    Trospium 60mg M/R Capsules (Regurin®)

    14.04 Typhoid Polysaccharide vaccine for injection Typhim Vi®
    • Reserved within ANHFT for laboratory staff handling specimens from suspected cases. Currently unavailable
    • Typherix may be used as an alternative brand in primary care.
    07.03.05 Ulipristal Acetate Esmya®

    Ulipristal acetate 5mg Tablets

    • Previously approved for pre-operative treatment of moderate to severe symptoms of uterine fibroids as an alternative to leuporelin, but not currently recommended whilst EMA review is in process. No new treatments to be started.

              Single 3-month course of treatment.

    • Intermittent treatment of moderate to severe symptoms of uterine fibroids in-line with NICE CG44.
      Maximum of four 3-month courses of treatment.

      Each course must be initiated by Consultant Gynaecologist.


    07.03.05 Ulipristal Acetate EllaOne® Ulipristal acetate 30mg Tablets

    03.01.04 Umeclidinium and vilanterol Anora®Ellipta
  • Dry powder for inhalation via Ellipta® device
  • Licensed for COPD
  • 03.01.02 Umeclidinium inhaler Incruse® Ellipta Umeclidinium bromide 55 micrograms
    Incruse® Ellipta

  • Dry powder inhaler
  • Licensed for COPD
  • 13.02.01 Unguentum M®  Unguentum M Cream
    13.02.01 Urea Cream 10%  Urea 10% Cream
    12.01.03 Urea-hydrogen Peroxide Otex®, Exterol®
    • Urea-hydrogen Peroxide 5% Ear Drops
    A5.04 UrgoClean Range  These products are required for patients who are following the BDCFT Leg Ulcer Pathway and will be ordered on a named patient basis by the TVN.

    Soft adherent hydro de-sloughing absorbent dressing for non-infected, exuding and/or sloughy wounds

  • 6cm x 6cm
  • 10cm X 10cm
  • 15cm x 20cm
  • 2.5cm x 40cm (rope)
  • 5cm x 40cm (rope)
  • A5.04 UrgoStart  These products are required for patients who are following the BDCFT Leg Ulcer Pathway and will be ordered on a named patient basis by the Tissue Viability Nurse.

    Non-adherent, non-occlusive contact layer derived from LipidoColliod technology. The dressing is composed of polyester mesh impregnated with hydrocolloid and petroleum jelly and Nano-Oligosaccharides Factor particles in demonstrated to promote faster healing in chronic wounds. Use for minimum of 4 weeks to see benefits.

  • 6cm x 6cm
  • 10cm X 10cm
  • 12cm x 19cm
  • 15cm x 20cm
  • 02.10.02 Urokinase 
    • Urokinase Injection
    01.09.01 Ursodeoxycholic acid 
  • Ursodeoxycholic acid Tablets
  • Ursodeoxycholic acid Liquid
  • 10.01.03 Ustekinumab Stelara® Consultant Rheumatologist use only.
    Supported for the treatment of:
  • NICE TA340 - Treatment of Psoriatic Arthritis
  • NICE TA180 - Treatment of Psoriasis - Available via referral to specialist centres
  • NICE TA455 - Treatment of plaque psoriasis in children and young people - Available via referral to specialist centres
  • 01.05.03 Ustekinumab injection 
  • Ustekinumab injection

    For the treatment of moderately to severely active Crohn’s disease in-line with NICE TA456.

    Gastroenterology use only
  • 13.08.01 Uvistat®  Uvistat SPF 30 Sun Cream
    04.02.03 Valproic Acid Depakote®
    • Valproic Acid as Semi Sodium Valproate Tablets

    For Consultant Psychiatrist initiation only.

    Please ensure all products are prescribed by brand

    Valproate can seriously harm an unborn child when taken during pregnancy and should be not taken by women of child-bearing age unless other treatments are ineffective or not tolerated. Female patients of child-bearing age taking valproate must be using reliable contraception.

    Pregnancy Prevention Programme materials available below:

    02.05.05.02 Valsartan 
    • Valsartan Tablets
    • Valsartan Capsules

    Reserved for existing patients only.

    09.03 Vaminolact  
    • Vaminolact (100mL)
    05.01.07 Vancomycin  Green Traffic Light Vancomycin Injection

    Green Traffic Light Vancomycin Capsules (Restricted)
  • Reserved for 2nd line treatment of Clostridium Difficile

    Green Traffic Light Vancomycin Oral Solution (Restricted)
  • Product prepared to order by pharmacy.
  • Reserved for 2nd line treatment of Clostridium Difficile
  • 07.04.05 Vardenafil  Vardenafil Tablets

    Restricted to patients unable to tolerate sildenafil tablets
    04.10.02 Varenicline Champix®
    • Varenicline Tablets 

    Initiated by smoking cessation nurse

    For use in-line with NICE TA123 (July 2007)

    14.05.02 Varicella zoster immunoglobulin (VZIG) 

    Varicella zoster immunoglobulin

    • Discuss the case with the antenatal coordinator if the supply is required for a pregnant woman.
    • Clinical details should be discussed with the consultant virologist at Seacroft Hospital, Leeds, before supply can be authorised (due to very limited stocks).
    • Once the above authorisation is received,requests for supply should be made to the haematology department.
    14.04 Varicella-zoster vaccine Varivax®
    • Approved for use within ANHSFT for seronegative staff in direct contact with patients and for paediatric patients on Consultant request only
    • In primary care Varilix® is available as an alternative brand.
    06.05.02 Vasopressin Argipressin

    Restricted to the treatment of refractory shock, on the recommendation of a consultant anaesthetists only. Inform ICU pharmacist of all uses.

    01.05.03 Vedolizumab Entyvio®
  • Vedolizumab Injection

    For use in-line with NICE guidance
  • 08.01.05 Venetoclax 
    • Venetoclax film-coated tablets 

    Consultant Haemotologist use only.

    Blueteq® registration and approval for use is required for this product before it may be dispensed.

    04.03.04 Venlafaxine Efexor®
    • Venlafaxine Tablets
    • Venlafaxine M/R Capsules
      Reserved for use in patients who have already been stabilised on venlafaxine immediate release tablets
       

    Supported for use in line with NICE CG90: Depression in adults: recognition and management.
    Amber Traffic Light  Doses greater than 150mg daily are restricted to psychiatry specialist recommendation only.

    02.06.02 Verapamil Hydrochloride  Green Traffic Light Verapamil Tablets
    Green Traffic Light Verapamil MR Capsules
    Green Traffic Light Verapamil SF Solution
    Red Traffic Light Verapamil Injection
    04.08.01 Vigabatrin 
  • Vigabatrin Tablets
  • Vigabatrin Sachets

    It is usually unnecessary to ensure that patients are maintained on a specific manufacturer’s product unless there are specific concerns such as patient anxiety, and risk of confusion or dosing errors.
  • 08.01.04 Vinblastine Sulphate 
  • Vinblastine Injection

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 08.01.04 Vincristine Sulphate 
  • Vincristine Injection

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 08.01.04 Vinorelbine 
  • Vinorelbine Injection
  • Vinorelbine Capsules

    Restricted for use within agreed protocols under the supervision of appropriate specialists
  • 11.08.01 Viscoat 
    • Viscoat Solution (0.75ml)

      For use in eye theatre only
    11.08.02 Vision Blue  
    • Vision Blue 0.5ml Solution

      For Eye Theatre use only.
    11.08.01 VITA POS  
    • VITA POS ointment (250IU/g) retinol palmitate, liquid paraffin, light liquid paraffin, wool fat and white soft paraffin (preservative free)

      Eye ointments containing a paraffin may be used to lubricate the eye surface, especially in cases of recurrent corneal epithelial erosion. They may cause temporary vision disturbance and are best suited for application before sleep. Ointments should not be used during contact lens wear.
    A2.01.02.01 Vital 1.5 k cal  Available as sip feeds and ready-to-hand enteral feed.
    Restricted to dietitian and gastroenterologist recommendation only.
    09.06.07 Vitamin and mineral supplements Forceval®
    • Forceval Capsules
    • Forceval Soluble Tablets

    For the prevention of re-feeding syndrome. Use to be restricted to patients at high risk of re-feeding syndrome for a treatment period of 10 days in-line with NICE guidance.

    Forceval Soluble tablets are for patients at risk of re-feeding syndrome who are unable to swallow Forceval capsules.

    Forceval capsules contain soya bean oil and should not be taken by patients with soya bean oil or peanut allergy.

    09.06.07 Vitamin and mineral supplements Ketovite®
    • Ketovite Liquid
    • Ketovite Tablets
    09.06.02 Vitamin B complex preparations Vigranon B®
    • Vitamin B

    Liquid oral Vitamin B preparation restricted for patients with NG tubes at risk of refeeding syndrome.

    (Compound vitamin B is required for NG fed patients they need to be crushed and do not fully dissolve so risk of blocking NG tubes)

    09.06.02 Vitamin B Compound Strong 
    • Vitamin B Compound Strong

    NICE CG115/SIGN no longer recommend use of Vitamin B Compound Strong for the prophylaxis of Wernicke’s Encephalopathy or alcohol related peripheral neuropathies.

    Vitamin B Compound Strong can be prescribed for patients at risk of refeeding syndrome but only for a 10 day course which will be supplied from the hospital. The discharge letter must be marked to indicate that this treatment should not continue beyond the 10 days. One pack of 28 tablets should be supplied.

    09.06.07 Vitamin Tablets 
    • Vitamin Tablets

    Patients should purchase over the counter from pharmacies.

    09.06.01 Vitamins A and D 
    • Vitamins A & D Capsules

    Restricted to patients with malabsorption syndromes.

    09.06.01 Vitamins A, C and D 
    • Vitamins A, C and D

    Via Healthy Start Scheme or purchased over the counter.

    09.06.02 Vitamins B and C Pabrinex®
    • Vitamins B and C I/M High Potency Injection
    • Vitamins B and C I/V High Potency Injection
    09.03 Vitlipid N Adult 
    • Vitlipid N Adult (10mL)
    09.03 Vitlipid N Infant  
    • Vitlipid N Infant (10mL)
    03.01.05 Volumatic® Drug Delivery Device Volumatic
    Volumatic with paediatric mask
    05.02 Voriconazole 
  • Voriconazole Tablets

    Oral use supported for the treatment of systemic fungal infections 2nd line after amphotericin B
  • 04.03.04 Vortioxetine Brintellix®
    • Vortioxetine Tablets

    For major depressive episodes in line with NICE TA367, when initiated and monitored by a Consultant Psychiatrist at BDCT only.

    02.08.02 Warfarin 
    • Warfarin Tablets
    • Warfarin Suspension - available by special order only
      Reserved for patients who are unable to swallow tablets.
    09.02.02.01 Water for Injection 
    • Water for Injections (5mL, 10mL, 100mL)
    13.11.01 Water For Irrigation  Water for irrigation

    Can be used for irrigating wounds
    12.02.02 Xylometazoline Hydrochloride Otrivine®
    • Xylometazoline Hydrochloride Nasal Spray
    • Xylometazoline Hydrochloride Nasal Drops
    13.02.01 Yellow Soft Parrafin BP  Paraffin Yellow Soft BP
    05.03.04 Zanamivir Relenza®
  • Zanamivir capsules for inhalation and diskhaler.

    Reserved for prophylaxis and treatment of seasonal influenza when NICE guidance is active (See technology appraisals TA158 and TA168)
  • A5.01.02 Zetuvit® E  Absorbent dressing of choice at Airedale NHS Foundation Trust
    Zetuvit® E (Non-adhesive absorbent dressing)
  • 10cm x 20cm
  • 20cm x 20cm
  • 20cm x 40cm
  • A5.01.02 Zetuvit® Plus  Super absorbent dressing of choice for Airedale NHS Foundation Trust and community patients
    Zetuvit Plus® Plus (Non-adhesive superabsorbent dressing)
  • 10cm x 20cm
  • 15cm x 20cm
  • 20cm x 25cm
  • 20cm x 40cm
  • 05.03.01 Zidovudine 
  • Zidovudine Capsules
  • Zidovudine SF Solution

    Reserved for patients as part of a HIV treatment plan under a HIV specialist consultant
  • 09.05.04 Zinc Sulphate Solvazinc®
    • Zinc Sulphate
    06.06.02 Zoledronic Acid (4mg/100ml) Zometa®
  • For the treatment of tumour induced hypercalcaemia and adverse skeletal events associated with malignancy
  • For use as an alternative to ibandronic acid for the reduction of bone damage in bone metastases in breast cancer.
  • For use in post-menopausal women with breast cancer to reduce the risk of recurrence where ibandronic acid is unsuitable, for three years. (Unlicensed indication).
  • 06.06.02 Zoledronic Acid (5mg/100ml) Aclasta® For Consultant Rheumatologist use only for patients intolerant of oral bisphosphonates
    04.07.04.01 Zolmitriptan Zomig®
  • Zolmitriptan tablets
  • Zolmitriptan orodispersible tablets - Please note 5mg orodispersible tablets are significantly more expensive than the 2.5mg strength in primary care
  • 04.01.01 Zolpidem 
    • Zolpidem Tablets
    04.01.01 Zopiclone 
    • Zopiclone Tablets
    04.02.01 Zuclopenthixol (as dihydrochloride salt) 
    • Zuclopenthixol Tablets

    Restricted to Psychiatry specialist recommendation only

    04.02.01 Zuclopenthixol Acetate 
    • Zuclopenthixol Injection

    Consultant Psychiatrist use only.

    04.02.02 Zuclopenthixol Decanoate 
    • Zuclopenthixol Decanoate Injection

    Restricted to Psychiatry Specialist initiation only

    Joint Medicines Formulary